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This thesis reports the use of Proton Transfer Reaction-Mass Spectrometry (PTR-MS) in 
the health sciences.  Here we provide the details on volatiles emitted from the shisha paste 
and when shisha paste undergoes combustion follows on from this, the analyses of which 
are aided by GC-MS (Gas Chromothography-Mass Spectrometry) measurements. This 
work presents the first PTR-MS study of shisha smoking, a poster for which won the best 
poster award at the Breath Research Conference in Zürich 2016. Presented first is a pre-
investigation of two key compounds, menthol and vanillin, expected in some shisha 
pastes to determine the product ions together with related compounds that have 
differences in their functional groups. Details on the reactions of H3O
+ with several 
fluorinated anaesthetics are presented, with the objective to provide details on which 
product ions should be monitored in a planned study of washout characteristics of 
anaesthetics following surgery. Breath washout characteristics for volatiles present in the 
blood following the ingestion of a peppermint oil capsule are presented, being part of a 
much larger European study dealing with breath standardisation. Here we present details 
on intra- and inter- individuals variability. The final results chapter looks at volatiles in 
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1.1  Background 
Owing to the absence of phenotypic signs and symptoms during the development of many 
chronic diseases, they can remain unidentified and this could lead to fatality. These 
diseases can either be cured or in remission, a manageable state. For example, diseases 
like diabetes and cancer in the early stages of development can be managed and controlled 
well to prevent severity and recurrence if the diseases can be identified and treated 
quickly.  
Medical diagnosis for diseases involves a complex process. Certain prognosis are 
time consuming and involve invasive techniques. Most of the medical diagnosis 
concentrates on the investigation of biological fluids such as blood, urine and tissue 
cultures in order to get more details about the disease for further medical observation and 
treatment planning by the clinician. This has encouraged the development of sophisticated 
instruments to facilitate medical diagnosis, treatment and therapy for better healthcare of 
patients. Scientists are still working on new techniques to get prompt diagnosis of 
diseases.  
Proton Transfer Mass Spectrometry (PTR-MS) is a very sensitive analytical 
technique which has been developed to detect Volatile Organic Compounds (VOCs). In 
medical and health sciences, it is used as a potential non-invasive technique to investigate 
or examine VOCs from various medical conditions. This technique does not require a 
complex sample or no sample preparation.   




Application of PTR-MS for breath analysis in the clinical field would aid to 
produce potential biomarkers for several diseases [1].  For example, Fernandez del Rio et 
al. have suggested that limonene from exhaled breath could be used as a potential 
biomarker for liver disease [2]. 
PTR-MS also has been used in the operating theatre to measure VOCs during 
operations for multiple reasons [3, 4]. Some studies on anaesthetics were carried out to 
highlight the occupational exposure in operating theatres. The most recent study on 
anaesthetics is about elimination of isoflurane via exhaled breath after post liver surgery 
[5]. It explained that isoflurane can be eliminated easily and quickly via breath, urine and 
sweat, which is hard to be eliminated by liver [6].  
Breath and headspace analysis using PTR-MS is unique because it can provide 
further details about metabolic pathways and physiological mechanisms that occur in the 
human body. Owing to know all the advantages of PTR-MS, it still has not been utilised 
in any of the clinical practice [7]. 
 The only drawback of this technique is that there is no standard protocol for 
breath and headspace sampling. This has led to an enormous variety of outcomes with a 
very low certainty level. In addition to that, breath contains an assortment of volatiles 
with a huge range of concentrations. There are many studies which correlate the 
biomarkers for diseases without proper assignments or without concrete justification to 
be used in the clinical practice. However, only a limited number of studies have proved 
that volatile compounds in breath correspond to a biomarker of a specific illness or 
lifestyle [2, 8]. 




In addition to that, this technique has also been used as a fundamental research 
tool in many public health fields, especially in research to interrogate harmful chemicals 
being emitted from any particular human or industrial activities (man-made) to protect 
public from unnecessary exposure from the toxic chemicals and also to consider 
occupational health and safety. Experts used PTR-MS for breath analysis to identify the 
VOCs from smoking conventional [8, 9] and e-cigarettes [10].  
PTR-MS is used for preliminary studies in most Universities and Research 
Centres. However, research expansion using this technique is limited due to the huge 
amount of data generated for analysis and the cost involved to maintain the instrument.  
The aim of this research work is on the application of PTR-MS in health sciences. 
The analytical application in health sciences focuses on VOCs associated with Shisha 
smoking; investigation on vanillin,  menthol associate compounds; H3O
+ and O2
+ 
reactions with general anaesthetics; temporal profile breath measurements of ingested 
peppermint capsules to monitor liver washout characteristics; measurement of the breath 
of rugby players who had concussion and comparison with healthy rugby players. This 
technique has a high capability to be used as a non-invasive tool for screening, diagnosis 
and monitoring of disease and any physiological changes in the body in the future. This 
technique also can be used to detect VOCs in a complex chemical which has complicated 
characteristics such as high vapour pressure, using the headspace method to identity the 
VOCs being emitted from the specific chemical e.g. for Shisha and to identify product 
ions from anaesthetic compounds. The primary outcome of the work in this thesis is to 
confer the volatiles in the complex breath profile and VOCs emitted from complex 
chemicals. 




1.2 Thesis Outline 
This thesis contains a further nine chapters. Chapter 2 explains about the theoretical 
aspects of PTR-MS and ion-molecule chemistry reactions. The explanation of the breath 
sampling protocol and the development of alveolar breath collection is given in Chapter 
3. It also explains briefly about off-line measurements by PTR-MS. Chapter 4 deals with 
VOCs associated with shisha smoking and includes a brief description of headspace 
analysis, and also explains the identification of VOCs from shisha paste with and without 
burning charcoal. Meanwhile, Chapter 5 is a follow-up chapter from Chapter 4 which is 
linked with shisha. In this chapter, the associate compounds related with two flavour 
compounds vanillin (vanilla shisha paste) and menthol (mint shisha paste) were 
investigated. 
  Chapter 6 describes and explains about H3O
+ and O2
+ reactions with general 
anaesthetics using headspace analysis. Product ions are identified and the product ions 
branching ratios of each anaesthetic compounds as a function of the reduced electric field 
are calculated. Chapter 6 presents work on breath analysis of rugby players who had a 
concussion. This chapter elaborates the comparison of VOCs concentration between 
healthy rugby players (control) and players who had a concussion. Chapter 7 describes 
about the temporal profile measurements of ingested peppermint capsules. This chapter 
concisely describes about how quick peppermint can be washed out by the liver using 
breath analysis technique.  
Each experimental chapter has introduction, methodology, results and discussion. 
  This thesis ends with Chapter 9 which consists of further discussion. It also 
includes conclusion, summary of findings, limitation of the techniques and discussion of 




the PTR-MS application in the health sciences and future direction of PTR-MS in medical 
and health sciences. 
1.3 AREAS INVESTIGATED 
The work presented in this report involves PTR-MS and its analytical applications in 
health sciences. As mentioned earlier, Chapters 4-8 are based on PTR-MS experimental 
measurements. The aim of the project is listed as below: 
1.3.1 VOLATILE ORGANIC COMPOUNDS ASSOCIATED WITH 
SHISHA PASTE AND SHISHA SMOKING 
Headspace analysis of shisha paste measurements was undertaken to identify  
Few studies have been undertaken to ascertain how safe these forms of smoking 
are. The key aims of the “smoking” projects are: 
a) Identification of volatile compounds released from the headspace of vanilla, 
 strawberry, mint and double apple flavoured shisha paste. 
b) Determining the concentration (relative intensity to 100) of harmful volatiles, such as 
benzene after lighting the charcoal at time intervals of approximately 3-12 minutes 
coming directly from the shisha pipe  
c) To prove that a shisha pipe with ‘water bubbling’ is not really functioning as a  
 filter by measuring the VOCs being emitted from the shisha pipe. 
 
 




1.3.2 INVESTIGATION OF THE PRODUCT IONS RESULTING FROM 
THE REACTIONS OF H3O+ WITH VANILLIN, MENTHOL AND 
ASSOCIATED COMPOUNDS (CYCLOHEXANOL, PHENOL, ANISOLE, 
BENZALDEHYDE AND GUAIACOL) 
The objective of the study is to monitor the fragmentation pattern and identify the product 
ions from vanillin and menthol. In addition to that, benzene ring which associated with 
vanillin and menthol were investigated using different functional group such as 
cyclohexanol for menthol and phenol, benzaldehyde, anisole and guaicol for vanillin. 
1.3.3 PTR-TOF-MS STUDIES OF THE REACTIONS OF H3O+ AND O2+ 
WITH THE GENERAL ANAESTHETIC GASES HALOTHANE, 
ISOFLURANE, ENFLURANE, SEVOFLURANE,  DESFLURANE AND 
METHOXYFLURANE 
a) The motivation of this study was to provide the necessary identification of product ions 
and possible reaction channel by analysing the reactions of H3O
+ and O2
+ with anaesthetic 
gases halothane, isoflurane, desflurane, sevoflurane, enflurane and methoxyflurane as a 
function of reduced electric field from 80 Td to 220 Td using PTR-ToF-MS. 
b) This study would be useful for further studies on anaesthetics in exhaled breath for 
patients who have undergone surgery and for the staff who work in the operation theatres 
for occupational health and safety purposes. This study also could be used as a follow up 
study to monitor the anaesthetic isoflurane in blood and breath as the wash out 
characteristics for post liver transplant a few days after the operation [5].  
 




1.3.4 BREATH ANALYSIS TO DETERMINE HUMAN WASHOUT 
CHARACTERISTICS OF KEY VOLATILE ORGANIC COMPOUNDS 
CONTAINED IN PEPPERMINT OIL 
This project is an European project which coordinated by Dr. Simone Cristescu 
(University of Nijmegen, The Netherlands)  and Professor Paul Thomas (University of 
Loughborough, United Kingdom). One of the aims of this work is to investigate the 
potential of PTR-MS for detecting and monitoring peppermint washout characteristics by 
the liver applying non-invasive techniques and real time measurement by using breath 
analysis technique. This will provide breath data of healthy volunteers which later would 
be used for followed-up study for liver disease patients.  Also this study would aid in the 
benchmarking endeavour to estimate the range of results between participating 
laboratories. 
In this study, peppermint capsule [Peppermint oil 200mg, The Boots Company 
PLC, Nottingham, England NG2 3AA] was used to monitor the washout characteristics. 
The peppermint capsule contains some series of monoterpenes such as menthol, 
menthone, menthofuran , isomenthone and some minor compounds such as 1,8‐cineole, 
menthylacetate, α-Pinene, β‐pinene and limonene [11]. After ingestion of the peppermint 
oil contained capsule, it will absorbed into the bloodstream and some compounds are 
being released in the breath.  
In this preliminary study, investigation on washout characteristic of peppermint 
oil contained capsule which contains the blood-born volatile compounds in breath was 
performed by taking breath samples before and after ingestion of the peppermint capsule 
for 6 hours from healthy volunteers. In addition to that, the VOCs from the exhaled breath 
from the peppermint oil contained capsule were identified.  Also, the headspace 




measurements for the associated compounds with peppermint were investigated to 
identify the product ions.  This project has been carried out at the Institute of Breath 
Research, Dornbin, Austria and University of Birmingham, UK.  
1.3.5 BREATH ANALYSIS OF RUGBY PLAYERS WHO HAD A 
CONCUSSION (HEALTHY AND INJURED) 
This study was the first clinical trial using breath analysis. In this study, PTR-MS was 
used to measure the exhaled breath of healthy rugby players and rugby players who had 
suffered a concussion during a rugby match. They were initially diagnosed with various 
medical diagnostic tools such as MRI (Magnetic Resonance Imaging), a CT scan 
(Computed Tomography) or a focused orientation exam, which tests for short term 
memory recall, and a focused neurological exam either at the Brain Imaging Centre of 
Queen Elizabeth Hospital, Birmingham or in the School of Sports Science at the 
University of Birmingham. The objective was to observe if there is a change in the major 
breath volatiles especially isoprene, acetone and methanol. In addition to that, comparison 
of VOCs concentration from the exhaled breath was done in between pre (healthy) and 
post (injured) for two players who had given pre and post breath samples.   
N-acetylaspartate is a common metabolite in the brain, which depletes following 
a brain injury. It is suggested that this decrease is a result of the compound passing across 
the blood-brain barrier after which it is metabolised in the body. Therefore, the 
investigation also was done corresponding to N-acetylaspartate (NAA) from the exhaled 
breath due to concussion injury. NAA plays many important roles in the physiology and 
metabolic processes of the brain [12].  




The conclusion of these results will be discussed in terms of medical relevance and 
possible advancements in sampling technique and measurement.  Having said this, this 
study is purely an exploratory study which can help us to decide whether a potentially 
PTR-MS can be used for further investigation.
 





2 PRINCIPLE OF PROTON TRANSFER REACTION 
MASS SPECTROMETRY   
2.1  Background and Development of PTR-MS Instruments  
The detection and monitoring of trace quantities of Volatile Organic Compounds (VOCs) 
are important in many areas of industry and science, especially involving food, the 
environment, homeland security and health applications [1]. For example, the atmosphere 
contains VOCs coming from plants and trees and anthropogenic sources such as car 
exhausts, biomass burning and industrial processes, which have significant impact on air 
quality. In human breath there are VOCs typically at parts per billion by volume (ppbv), 
such as acetone, isoprene and methanol, often resulting from metabolic processes in the 
human body which are transported via the bloodstream to the lungs where they are 
exhaled. In such environments, changes in VOC concentrations can occur in seconds. To 
detect such VOCs in low concentrations, and especially for those whose concentrations 
change rapidly, in the last two decades analytical chemical techniques have been 
developed based on soft chemical ionisation mass spectrometry [13]. 
The origins of soft chemical ionisation mass spectrometry date back to the 1960s through 
a development by Munson and Field, [14]. Chemical ionisation results in a lower energy 
process than the more common form of mass spectrometry which uses electron ionization, 
and hence results in less fragmentation resulting in a simpler spectrum which is easier to 
interpret. Chemical ionisation involves the production of product ions via a reaction 
process, the main ones of which are [1]; 
 




• Proton Transfer XH+ + M → MH+ + X    (2.1) 
• Charge transfer X+ + M → M+ + X                                                      (2.2) 
• Hydride (H-) transfer  X+ + MH → M+ + HX    (2.3) 
• Adduct formation  X+ + M + Z → MX+ + Z    (2.4) 
Where Z is a third body to stabilize the adduct MX+. 
Reactions (2.1) and (2.2) are the major ion-molecule processes used in this study. 
Reaction (2.1) proceeds with unit efficiency providing the proton affinity (PA) of X is 
less than that of  M. Reaction (2.2) is exothermic provided the ionisation energy of X is 
greater than that of M, with the reaction rate coefficient not necessarily being at the 
collisional value [1]. Although the reactions (2.1) and (2.2) are shown to be non-
dissociative, the transfer of charge can lead to fragmentation.  
A mass spectrometer is an instrument which produces numerous ions from the 
sample under examination and separates the ions according to their specific mass-charge-
ratio (m/z) where, 
The basic equation for sector mass spectrometers with  
c = instrument constant,  
B = magnetic field strength and  




=C* B2/ V 
 The instrument contains three major components ion source, analyser and 
detector system.  Ion source plays an important role in ionizing atoms or molecules by 
knocking one or more electrons off to give positive ions. This is followed by ion 
accelerations where all the ions have the same kinetic energy.  These ions with the same 
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kinetic energy will be deflected by a magnetic field. The most deflected ion has the 
smallest value of m/z (lightest ions) compared to the heavier ones. The ions appearing 
from the final analysis will be detected by the ion detector where the it produces electrical 
signals in proportion to their abundance and processed by an amplifier which shapes it 
and makes it larger for further analysis. The processed signals from the detector will be 
transmitted and displayed as a mass spectrum (detailed explanantion in section 2.1.9). 
Followed by this, identification of specific compounds in a gas can be done based on the 
mass spectrum obtained.  
A mass spectrum shows the final output of mass spectrometer by presenting a 
distribution of ions. A mass spectrum simply represents a “stick diagram” which shows 
the relative current generated by ions of varying mass/charge ratios. The vertical axis of 
a mass spectrum is usually labelled as either relative intensity or relative abundance. 
Meanwhile, the horizontal axis is labelled as mass to charge ratio (m/z). 
 Hence, there are several analytical methods used to analyse compounds in trace 
quantities. These respective techniques have their pros and cons. The common method of 
mass spectrometry to identify the VOCS are high-performance Liquid Chromatography-
Mass Spectrometry (HPLC-MS), selected ion flow tube mass spectrometry (SIFT-MS), 
Ion mobility Spectrometry (IMS) and gas chromatography mass spectrometry (GC-MS). 
Among these, the most established technique in many laboratories is gas chromatography 
(GC) which has been used for more than 50 years [15, 16]. GC combined with mass 
spectrometry and an electron impact ionisation source, takes a longer time to get an 
analysis done. However, to overcome this problem, GC fast was introduced, but this 
technique still requires a few minutes for a complete separation [15, 16]. Therefore, it is 
crucial to monitor any incidents quickly where remedial action may be required, e.g. 
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environmental contamination, security and safety. In SIFT-MS, reagent ions are 
introduced into a carrier gas via a quadrupole mass filter where they are convected into a 
reaction region (flow tube) to react with the VOCs present. SIFT-MS is capable of 
achieving ppbv sensitivity and has the ability to study reaction kinetics for a series of 
reagent ions. The drawback of SIFT-MS is that it requires a different pressure in the 
reaction region (1-3 mbar) compared to the injection and detection regions  (≤ l0−4mbar). 
Ion Mobility Spectrometry (IMS) is another analytical instrument which has been mainly 
used for homeland security and military applications, but is also finding use in medical 
diagnosis, food quality and environmental chemistry [17]. IMS performance depends on 
the mobility of the ions within the gas phase in an electric field of a drift tube at ambient 
pressure. Physical parameters such as size, shape and charge of ions and also type of 
buffer gas used in IMS are very important because they influence the collision cross 
section of the neutral gas molecules and the ions. The disadvantage of IMS is that it has 
a poor temporal resolution and selectivity which could lead to false positives. PTR-MS 
can overcome these problems where it has some similarities with IMS such as the drift 
tube, but at different pressures and no pulsing involved. However, PTR-MS has special 
characteristics and it has a high certainty level in chemical compound assignment due to 
its mass spectrometry capabilities. 
PTR-MS is a robust, sensitive, analytical technique with minimal sample 
preparation and was developed in the mid-90s by scientists at the Institute of Ion Physics 
at the Leopold-Frances University of Innsbruck (Austria) led by Werner Lindinger [13]. 
They developed the system based on the soft chemical ionization mass spectrometry for 
online and real time VOCs analysis. Lindinger and co-workers also introduced a simple 
and compact instrument by replacing the mass-selected H3O
+ source with a hollow 
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cathode discharge which yields a > 99.5% H3O
+ [1]. PTR-MS has been used in numerous 
analytical sciences such as, homeland security, food sciences, environmental sciences and 
health sciences [1]. In comparison to SIFT-MS, PTR-MS provides a better sensitivity and 
selectivity by adding two major changes to SIFT-MS . Firstly, they introduced a short 
drift tube instead of the flow drift tube. Secondly, they injected the analyte gas rather than 
inert carrier gas in SIFT [1]. These had made the technique simple by creathing faster 
reactions using shorter drift time. 
The first PTR-MS instruments used quadrupole mass spectrometers. However, in 
2007, time of flight (TOF) mass spectrometric techniques were developed and introduced 
in 2008. TOF-MS is based on the time taken by the ions to travel a known distance and 
electric field strength where the different m/z hit the detector (Micro Channel Plate) at 
different times. It has number of advantages compared to Quad-MS, including higher 
selectivity owing to its higher mass resolution compared to the unit mass resolving power 
of a quadrupole mass spectrometer [1].  
2.1.1 Advantages of PTR-MS technology  
i) The measurement can be done within a short period of time 
ii)  PTR-MS can do on-line measurements using direct breath samples from a patient 
or volunteer. This will help in reducing the risk of sample degradation or contamination. 
iii)  It does not require sample preparation unlike GC-MS which involves many 
protocols in preparing the samples. 
iv)  Air can be used as a buffer or carrier gas with minimum reaction in the instrument 
except for O2
+ and NO+ which can be seen as a low contaminant and negligible. 
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v) There will be no reaction with main constituents in air (N2, O2, Ar, CO2, etc.) 
which has proton affinity less than water. 
vi)  It uses a lower energy reaction (soft CI), unlike GC-MS which requires 70 eV 
energy (electron impact) in order for the reaction to happen. Therefore, there will be a 
minimal fragmentation and easy interpretation can be done on the spectrum obtained. 
vii) It can detect low concentration of VOCs due to high sensitivity (as low as ppbv) 
and the instrument is transportable to different locations and areas. 
2.1.2 Principles of Proton Transfer Reaction Mass Spectrometry  
PTR-MS is a soft chemical ionization technique often used for on-line measurements of 
trace chemical compounds with detection concentrations as low as a few parts per trillion 
per volume (pptv) [18, 19]. The first commercial model of PTR-MS was constructed by 
IONICON Analytik Technology GmbH (figure 2.1) which used a quadrupole mass 
analyser. Later, KORE Technology Ltd designed PTR-MS with time of flight (figure 2.2).  
For PTR-MS, a flow tube is not used in order to reduce the size of the instrument 
and the pumping requirements. Instead a drift tube is employed so that ions migrate into 
and through the reaction region under the influence of an electric field (E). Both 
instruments have their own advantages and disadvantages, but both have been 
successfully demonstrated for their application in the health sciences, the key area for this 
current report.  
 
 





Figure 2.1 Photograph of the a) top view and b) hollow cathode and drift tube of a PTR-
















Figure 2.2 Photograph of the a) top view and b) hollow cathode and drift tube a PTR-
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Two different PTR-MS instruments have been used in this study. The one used for breath 
analysis, employed a quadrupole mass spectrometric filter and the other used for head 
space analysis a time-of-flight (ToF) mass spectrometer. The high resolution PTR-TOF-
MS is required to do headspace analysis which involves complex chemical and 
identifying numerous product ions accurately. Meanwhile, PTR-MS quadrupole was used 
for breath analysis which requires high sensitivity in identifying compounds from exhaled 
breath. Besides that, this similar instrument has been used by other researchers in institute 
for breath analysis and it would be helpful to compare some of the results obtained from 
these studies and theirs for future research studies. 
Figure 2.3 [20] shows a schematic diagram of the quadrupole PTR-MS system 
used in this study, which has higher sensitivity for detecting VOCs than the ToF 
instrument, but has lower mass resolution. This instrument was used for breath analysis 
of rugby players who had concussion injuries and also for the rugby players’ control 
group. A schematic representation the KORE PTR-ToF-MS is shown in figure 2.4. 
 
Figure 2.3 Schematic diagram of an Ionicon PTR-MS instrument (Quadrupole) taken 
from Hansel et al. 1995 [21]. 
Quadrupole- MS 
 




Figure 2.4 Schematic of the KORE PTR- TOF-MS [22] 
The reagent ion commonly used in PTR-MS is H3O
+. However, H3O
+ and O2
+  have been 
used as reagent ions for headspace of anaesthetic studies and only H3O
+ reagent ions for 
breath and Shisha measurements. Reagent ions H3O
+ reacts with VOCs via proton transfer 
(Reaction (2.5). O2
+ reagent ions react via charge transfer with VOCs. 
 
                                         H3O
+ + VOC → H2O + VOC·H
+                                                             (2.5) 
 
                                  O2
+ +VOC→ O2 + VOC
+                                                                      (2.6) 
 
Both processes, as mentioned earlier can be dissociative. For the reactions to proceed 
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(Ionization Potential) (VOC) < IP (O2), respectively. Importantly H3O
+ reagent ions 
cannot react with the major constituents in air because they all have much lower proton 
affinities than water (691 kJ mol-1) (A detailed explanation about proton affinity is in 
section 2.1.3). This makes H3O
+ an ideal reagent ion for detecting VOCS in breath and 
the atmosphere. 
In addition to H3O
+ reagent ions being present in the reaction region, there are protonated 
water clusters, formed via a 3rd body reaction (2.7) the intensities of which are dependent 
on instrumental operating conditions and humidity [19]. 
                    H3O
+ (H2O)n-1 + H2O + X → H3O
+(H2O)n+ Z                       (2.7) 
Where, Z is a 3rd body. 
Water clusters possess higher proton affinities than H2O, and the more water molecules 
the greater is the proton affinity of the water cluster up to a certain limit. This means that 
some proton transfer reactions that occur with H3O












2.1.3 Proton Affinity and protonation 
 
                                                 H3O
+  + M →MH+ +H2O                                           (2.8) 
Reaction (2.8) shows gas phase proton transfer to an analyte molecule M which will be 
detected by PTR-MS.  
Proton affinity (PA) is the negative enthalphy change of the reaction in equation 
(2.8). It always has been used to check whether a proton transfer reaction is likely to be 
thermodynamically spontaneous. This process which is better known as an exothermic 
reaction in gas by releasing energy. This process is well explained by the change in the 
standard Gibbs free energy at certain temperature T, ΔG𝑇
0  where a negative of the enthalpy 
change of the reaction (2.8) happens by proton donation to the compound of interest 
which has PA more than H2O (691 kJ mol
-1). Table 2.1 shows the PA of the most abundant 
components in clean air. The majority of common VOCs have higher proton affinities 
(table 2.2), allowing for spontaneous protonation. However, the predominant inorganic 
gases in the environment such as N2, O2 and CO2 have lower proton affinity than the H2O. 
Ideally, H3O
+ is the only ion that should react with the analyte gas and it is an ideal reagent 
ion in our studies to measure and identify VOCs in gas phase samples. However, 
hydronium water clusters of the form 𝐻3𝑂
+. 𝑛𝐻2𝑂, (𝑛 ≥ 1) are formed in most of the 
experiments especially using a lower energy and temperatures. Generally, these water 
clusters have a higher proton affinity (table 2.3). For example H2O.H2O has a proton 
affinity of 833 kJ mol-1[23]. As the PA of the water clusters increases with growing n, the 
reaction become more selective.   
 








Proton affinity (kJ/mol) 
Oxygen (O2) 421 
Nitrogen (N2) 494 
Carbon dioxide (CO2) 541 
Water (H2O) 691 
 
Table 2.2 Proton affinities of some common volatile organic compounds [24].  
 















               Table 2.3 Proton affinities of water and water clusters  [23, 25]. 







2.1.4 Fragmentation  
Although proton transfer is considered soft ionization, it does not mean that there will be 
no fragmentation. Fragmentation results from dissociative proton transfer, which can be 
instantaneous owing to the chemistry involved or can be a result of collisional induced 
dissociation occurring through energy gained by the reagent and/or protonated parent in 
the electric field of the drift tube. Non-dissociative proton process results in the 
protonated parent being observed. Often both the protonated parent and fragment ions are 
observed.  For example, for limonene and using reduced electric fields in the range of 80-
200 Td, proton transfer from H3O
+ results in product ions being observed at m/z 137, 
which corresponds to the protonated parent C10H17
+ and m/z 81, which is a fragment ion 
(C6H9
+). The fragmentation pattern in a mass spectrum can be useful to  determine 
structural information of an unknown molecule.  In comparison, acetone, whose proton 
affinity is high (table 2.4), shows no fragmentation resulting from reactions with H3O
+, 
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and only the protonated parent is observed for all reduced electric fields investigated to 
date, whereas the reaction of H3O
+ with isoprene, whose proton affinity is similar to 
acetone, results in the protonated parent m/z 69 and product ions at m/z 41 [25] and m/z 
39 [26]. Table 2.4 shows the proton affinities of various chemical compounds e.g. 
acetone, isoprene, methanol and other relevant molecules which have been used to make 
a comparative study between the healthy rugby players and players who had a concussion 
injury. On the other hand, some claimed that isoprene can  fragment but some claimed it 
does not fragment [20, 26, 27].  
 
Table 2.4 Proton affinities of acetone, isoprene, and limonene. For comparison the 




 kJ mol-1 
Formula 
acetone 812 (CH3)2CO 
 
isoprene 826 CH2=C(CH3)CH=CH2 
 
limonene 875 C10H16 
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2.1.5 Components of a PTR-MS 
The proton transfer reactions mass spectrometer consists of four different sections.  
1. An ion source is the region where the H3O
+ ions are produced by a hollow cathode 
discharge (HC) in water vapour. 
2. Drift tube. This is the reaction region. The air which contains traces of volatile organic 
compounds enters into the drift tube where the proton transfer reaction takes place.  
3. Mass spectrometer (analyser). In this region the ions are separated according to 
mass/charge ratio.   
4. An ion detector  
The ions are detected by a secondary electron multiplier (SEM) for the PTR-Quad-MS 
instrument and by microchannel plates (MCP) for PTR-ToF-MS. 
2.1.5.1 Hollow Cathode  
A detailed description of the operation of the hollow cathode is to be found in Chapter 3 
of the book “Proton Transfer Mass Spectrometry by Ellis and Mayhew [1]. The details in 
that book have been adapted for this section. Basically, a reservoir of distilled water 
provides the water vapour that enters the hollow cathode (HC) ion source via a mass flow 
controller, bringing the pressure inside to about 2 mbar. An electrical discharge results in 
ionisation and dissociation of the water, leading to ions such as H2O
+, OH+, O+, and H+, 
all of which react with water, which through a series of ion-molecule reactions leads to 
the formation of H3O
+. This is the terminal ion, because it does not bimolecularly react 
with water – it can only associate via a three body process, leading to protonated water 
clusters. In addition to H3O
+, back diffusion of the air into the HC, leads to the discharge 
 





+ and NO+. N2
+ reacts with water via charge transfer, so those reagent 
ions are ultimately converted to H3O
+. O2
+ and NO+ cannot react with H2O and hence are 
considered impurity ions in the HC which enter the drift tube. These are usually about 








 Figure 2.5 Hollow cathode discharge 
 
 H3O
+ is a terminal ion produced through a series of ion-molecule processes 
following the electron impact ionization of molecules in the hollow cathode, reactions ( 
equations (2.9-2.15) [30]. All of these reactions are fast in order of magnitude 10-9 cm3 s-










Anode dark space 
Negative glow 
 




+ + H2O → H3O
+ + OH               k= 1.8 × 10-9 cm3 s-1                  (2.9) 
OH+ + H2O → H3O
+ + O   k= 1.3 × 10-9 cm3 s-1                  (2.10) 
                   → H2O
+ + OH k= 1.8 × 10-9 cm3 s-1                  (2.11) 
H2
 +
 + H2O → H3O
+ + H              k= 3.4 × 10-9 cm3 s-1                  (2.12) 
                  → H2O
+ + H2             k= 3.7 × 10-9 cm3 s-1                  (2.13) 
 H+ + H2O → H2O
+ + H               k=8.2 × 10-9 cm3 s-1                 (2.14) 
  
As pointed out earlier, some air entering into the discharge region of the PTR-MS 




+ is rapidly removed by a charge exchange reaction with H2O [1].  
N2
+ + H2O → H2O
+ + N2                                                                       k=2.8 × 10-9 cm3 s-1                (2.15) 
Therefore, the presence of N2
+ leads to formation of H3O
+ via a reaction of H2O
+ with 
H2O (reaction 2.9). 
The ionization energy of O2 (12.06 eV) is less than H2O (12.6 eV). Thus, O2
+ 
cannot react with H2O by charge transfer. Hence, O2
+ will be seen as a low level 
contaminant reagent ion in PTR-MS experiments. Besides that, NO+ is another impurity 
reagent ion owing to the rcombination energy of NO. NO+ is formed via reaction  (2.15). 
N+ + O2 → NO
+ + O                                                 k=2.6 × 10-10 cm3 s-1                        (2.16) 
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However,the concentrations of O2
+ and NO+ can be reduced to negligible levels by 
selecting appropriate experimental conditions and by altering gas flow conditions. 
Typically, the ion intensities of these ions are below 3% of the total reagent ion signal. 
2.1.5.2 Drift Tube 
The drift tube is where the soft chemical ionisation occurs. The drift tube is formed of a 
series of equally spaced electrodes, separated by insulating spacers which control the 
voltages applied to each electrode. The important role of the drift tube is to produce a 
uniform electric field which will cause the ions to migrate along the length of the drift 
tube. The drift tube in the PTR-MS is operated using a set reduced electric field, which is 
the ratio of the electric field strength E to the number density of gas, N, units of V cm2. 
E/N (Td) where Td is the unit for E/N also known as the townsend. It can be defined as 1 
Td = 10 -17 V cm2. E/N provides a measure of the ions’ kinetic energy in the drift tube 
(E/N will be discussed in more detail in section 2.1.6). A typical length for a drift tube in 
PTR-MS is approximately 10 cm. The electric field is important because it gives energy 
to the ion–molecule collisions limiting clustering of neutral molecules, especially H2O to 
ions. The usual drift tube pressure for sufficient reactive collisions to happen is 
approximately 1-2 mbar and operating temperatures used is between 50-200oC. With 
suitably applied drift tube voltages this results in operating E/N values of between 120 to 
140 Td (1Td = 1 Townsend = 10-17 V cm2).  
  A source drift tube region is added between the HC and the Drift tube to enhance 
the yield of H3O
+ through additional ion-molecule reactions away from the hollow 
cathode source. It also aids fragmenting protonated water clusters to the monomer. 
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2.1.6 The ratio of electric field and number density of buffer gas - reduced 
electric field (E/N) 
The average ion energy in a PTR-MS is determined by the reduced electric field E/N. The 
electric field, E in the PTR-MS provides the driving force for the ions to migrate down 
the drift tube. It also provides sufficient energy to ions to prevent excessive clustering 
with water molecules. The electric field E is given by 𝐸 = 𝑉/𝑑 where V is the potential 
difference across the drift tube and d is the length of the drift tube (typically 10 cm in a 
PTR-MS). However, E alone is not the important parameter, because ions lose energy in 
collisions, which depends on the neutral number density N. Hence it is the ratio of E/N 
which is important in determining the mean drift velocity and hence mean kinetic energy 
of the reagent and product ions. This can be calculated from: 







                                                   (2.17) 
Where, NA is Avogadro’s number (6.022 x 10
23 mol-1), VM (22414 cm
3 mol-1) is the molar 
volume of an ideal gas at 1 atmosphere of pressure (101.325 kPa) at a temperature of 
273.15 K. Td is the operational temperature of the drift tube (in Kelvin), and Pd is the gas 
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2.1.7 Ion Mobility 
The ions which enter the potential gradient inside the reactor will be accelerated towards 
the most negative potential. The ions collide with the neutral buffer gas due to relatively 
high pressure and the swarm reaches a constant drift velocity, Vd [1].  
Vd  is the ion drift velocity, which is linearly dependent on the electric field (E) at low 
electric fields. The following equation explained about the ion drift velocity, 
                                                          𝑉𝑑 = 𝐾𝐸                                                          (2.18) 
where, K is the coefficient known as the ion mobility. The equation describes the mean 
drift velocity of the ion swarm and not the velocity of the individual ions. The ion mobility 
coefficient is a function of temperature and pressure of the ions [1]: 





𝐾0                                                  (2.19) 
In the above equation, T is temperature (Kelvin) in the drift tube and P is the pressure 
(Torr) in the drift tube and K0 is the reduced mobility.  





𝐾0𝐸                                                   (2.20) 





N0 = 2.687 × 1019 cm-3 gas number density under standard temperature and 
pressure (equation 2.19 and 2.20) (i.e. T = 273.15 K and P = 101.325 k Pa) and K0 is 
known as the reduced mobility of the ion for a given analyte molecule. The drift tube 𝑣𝑑 is 
proportional to the electric field. Following equation expressed about 𝑣𝑑 : 
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                                                  𝑣𝑑 =  𝐾0 𝑁0 
𝐸
𝑁
                                                        (2.21) 
The drift velocity is inversely proportional to the pressure. Therefore, the drift velocity 
decreases as the drift tube pressure increases. The above equation (2.21) shows that, the 
effect of the gas is expressed here in terms of number density (N) rather than pressure. As 
a consequence, it can be seen that by varying the electric field strength, one can vary the 
drift velocities of the ions which leads to a change in the collisional energies within the 
drift tube. Owing to the low bond energies associated with the protonated water clusters, 
increasing collision energies will lead to lower concentrations in the drift tube of these 
ions. If the E/N is sufficiently low that the collisional energies are insufficient to limit 
clustering then protonated water clusters dominate formed through the reaction: (H3O
+ + 
(H2O)n (n = 0),  via the following general process [19]; 
 
                 H3O
+ + (H2O)n-1 + H2O + X  H3O
+  (H2O)n + X                       (2.22) 
With the knowledge of ion mobilities, it is possible to calculate the transit time for 
(H3O
+) through a drift tube by considering ion mobilities in air and nitrogen are similar. 
We also assume the conditions for H3O
+ are far more abundant than hydrated hydronium 
cluster ions [1]. 






                                                      (2.23) 
For example, by using a drift tube length of 10 cm and using No=2.687 x 10 
19 cm-3, Ko= 
2.81 cm2 V-1s-1 and E/N= 120 Td (1.2 x 10 -15 V cm2) results in a drift time of td =110 µs 
and 906 ms-1 as a mean drift time velocity [1]. 
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2.1.8 Quantitative characteristics of PTR-MS 
 
The description for this section and the equations were adapted from Ellis and Mayhew’s 
book on ‘Proton Transfer Mass Spectrometry’ [1]. The PTR-MS can be used to measure 
the absolute concentration of a specific constituent of a gas mixture by using a 
measurement of the ion signals. Taking into account that H3O
+ is the proton source,  an 
assumption can be made by considering that this reaction only occurs with a single 
organic gas. For example, in this case M is assigned as the organic gas. The proton 
reaction is shown as in equation (2.24). 





+][M]                                       (2.24) 
 
By assuming that [M] >> [H3O
+] even at trace levels, we can assume that [M] remains 
constant, and hence the reaction is pseudo first order and this explains in equation (2.25) 
where concentration of protonated reagent ions as a function of time t,  
                                              [H3O
+]𝑡 = [H3O
+]0 𝑒
−𝑘[𝑀]𝑡                                        (2.25) 
The reaction time t is the time taken by the reagent ion where the concentration of 
protonated reagent ions H3O
+ lost in time t, in this scenario,  
                                             [MH+ ]𝑡 = [H3O
+]0 - [H3O
+]𝑡                                     (2.26) 
provides substituting into Equation 2.27, 
                                           [MH+ ]𝑡 = [H3O
+]0[1 − 𝑒
−𝑘[𝑀]𝑡]                                  (2.27) 
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According to description by Ellis et al [1], assumption is made according to the condition 
and usually the condition is chosen. For instance,  only a small proportion of H3O
+ is 
consumed by the reaction in order to obtain the following conditions, [H3O
+]0 ≈
 [H3O
+]𝑡, or equivalently [MH
+ ] ≪  [H3O
+] where  k[M]t << 1. This provides that M 
presents lower than the parts per million level. Equation 2.28 explains about the 
concentration of M. 






 = k[M]t                                          (2.28) 
[MH+ ]
 [H3O+] 
 is the concentration at the end of the drift tube. i is the ratio of currents for the 
measured count rates of these two ions at the detector of the mass spectrometer. It is 
possible to calculate the concentration of gas M in the drift tube by having measured the 
ratio of 𝑖(MH+ )/𝑖(H3O
+) (Equation 2.28).  
2.1.9 Detection system of Mass Spectrometer (MS) 
2.1.9.1 TOF MS Analyser 
 
The following description has been adapted from Ellis et al [1]. 
The time-of-flight mass analyser was used to separate out the ions according to their flight 
times where the heavier ions have a longer flight time than the lighter ions.  The ions exit 
the drift tube and enter into a short acceleration region (referred as the x direction). This 
acceleration region (figure 2.4) has two electrodes (repeller and extractor electrodes, ). 
The extractor allows most of the ions to enter into the flight tube via a high transmission 
grid using a differential pumping stage. There is no electrical field inside the flight tube 
before they hit the detector. Therefore, the velocities of the ions as they leave the 
acceleration region are maintained through the flight tube. 
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In order to prevent the deflection of the incoming ions, initially the electrical 
potential is kept the same for both the repeller and extractor. The voltage state is adjusted 
continuously such that the repeller has a higher voltage compared to the extractor in order 
to obtain a mass spectrum. A pulse of ions is sent into the flight tube using this potential 
gradient. Collisions with the background gases should be avoided in order to get an 
effective collision between reagent ions and analytes by providing a good vacuum system 
preferably < 10-5 mbar pressure. Ions with positive charges q near to the repeller surface 
will have the same kinetic energy when they enter the flight tube, E, which is governed 
by the following equation:  









)2                                                                  (2.29) 
Where; V is the potential different between the extractor and repeller electrodes, m is mass 
of the ion, v is the velocity of the ions in the drift tube, l is the length of the flight tube 
and t is the time taken by the ions to reach the detector. 
The ions fly into a ‘field free region’ (FFR) before reaching the reflectron. All the 
ions are reflected and returned back through the field free region to strike the detector. 
The FFR is divided longitudinally to ensure that the blanking plates (figure 2.4) do not 
affect ions travelling towards the reflectron. Aperture plates are mounted in the flight path 
before and after the blanking plates to reduce the influence of any ions except those 
passing through between them.  
 ToF-MS made by KORE Technology Ltd., has another important part known as 
the reflectron. This consists of a piece of apparatus which is made up of a series of 
electrodes known as a reflector array. The same m/z ions can move at different velocities 
depending on the distribution of energy that ions have within the flight tube. Therefore, 
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the faster moving ions for a given m/z will penetrate deeper into the reflectron than the 
slower ones. The reflector voltages can be adjusted so that the ions with the same m/z 
with have different speeds reach the detector at a similar time. This improvement in 
temporal resolution results in an improved mass resolution.  
A Microchannel Plate (MCP) Detector is used in the PTR-TOF-MS as the 
detector. It consists of a resistive glass plate with numerous narrow channels organised in 
a honeycomb structure. Each channel acts as a miniature electron multiplier. A MCP has 
a larger surface area for incoming ions compared to the discrete dynode and channeltron 
detectors. This allows a systematic ion collection from a spatially broad source while 
achieving a high gain. The transit distance via MCP is short (0.5-2.0 mm) compared to 
other detectors such as channeltron and discrete detector. This results in a MCP detector 
to have a high time resolution (< 1 ns). These have had made MCP a suitable detector for 
use in TOF-MS [1]. 
Two plates have been used in the MCP detector we have used, with a Chevron 
configuration (pair of microchannel plates) in order to achieve a high gain (figure 2.6) 
and to minimise ion feedback. Every individual channel has an entrance diameter in the 
region of 10 µm and the channel walls are aligned at an angle to the surface of the plate 
to maximise the incoming charged particles to strike the wall. Positive ions enter the MCP 
detector via a conducting mesh. This is usually maintained at Earth potential after which  
the ions are accelerated through a voltage of ~ 2 kV whereupon they strike the channel 
walls to generate one or more secondary electrons. Consequently, this initiates a cascade 
process as the newly generated electrons are accelerated to the back of the second plate 
by the increasingly positive electrical potential.  
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The signal (electron) is pre-processed by using an amplifier and then converted to 
a digital signal using time to digital converter (TDC). The final signal will be recorded as 
a pulse representing the arrival of one ion.  
 
 
Figure 2.6 Schematic diagram of a microchannel plate (MCP) detector. Reproduced with 















The quadrupole mass selector (QMS) usually uses a secondary electron multiplier (SEM) 
to detect ions. The quadrupole mass filter sequentially scans over m/z range by applying 
a superposition of AC and DC voltages to four parallel rods (figure 2.7). An oscillating 
electric field is generated in the x-y plane when an electrical voltage is applied to the four 
parallel electrodes. The ions with positive charge will enter the region between the 
electrodes. The repulsion increases from the nearest rod and will drive the ion to opposite 
electrode. As the repulsion increases the ions oscillate from one side to other side. For 
particular AC and DC fields only ions with a given m/z ratio can pass through, all other 
ions are lost on the surfaces of the rods. The selected ions are deflected by 90° where they 
are incident on a secondary electron multiplier (SEM).  
The quadrupole mass spectrometer has a limited m/z range, usually not much more 
than 1000 amu, and a not much better than unit mass resolution (low mass resolving 
power) allowing only nominal m/z detection.  It is therefore difficult to discriminate 
different compounds which have the same nominal mass (isobaric). For example, the 
protonated nominal mass of furan is 69 but the exact mass is 69.03349. Whilst, protonated 
isoprene’s exact mass is m/z 69.06988. In this case, if both compounds are present only a 



















 ɸ=𝑈+𝑉 cos 2𝜋𝑣𝑡 
 
 where applied electrical potentials (ɸ) of equal magnitude 
applied to the four electrodesn and r = 1.148 r0 where  𝑟0 is the field radius in a square 
array.  
Figure 2.7 Side view of Quadrupole mass analyser [1]. 
 
The advantage of a quadrupole system is its low cost compared to TOF and it has the 
ability to perform both qualitative and quantitative analysis. In addition to that, it can 
increase the sensitivity by MID (multiple ion detection mode).  
The SEM gives an electrical pulse for each incident ion. As the SEM lifetime decreases, 
it drops sensitivity and this has to be checked regularly. The ideal operating voltage for a 
-ɸ/2 
-ɸ/2 






Ions in  
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SEM can be determined from where its response plateaus. If there is no characteristic 
signal maximum visible (“Plateau”) while the operating voltage is increased then SEM 
has to be replaced. If the voltage is too high the signal to noise ratio declines and causes 
a dark current which produces a poor quality signal. More than one million CPS incidents 
on the SEM leads to losses in linearity of the output signal. Figure 2.8 shows the SEM 
used in a PTR-MS Quadrupole instrument. 
 
 
Figure 2.8 Photograph of a new secondary electron multiplier. The dynodes are visible 
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2.2 PTR-MS Data Analysis 
The PTR-MS quadrupole is operated using the software for data collection provided by 
Balzers QMS-422. The software contains a different set of controller programs to operate 
the PTR-MS system. Workplace is a program which aids control and handling of the 
PTR-MS to make measurements and analysis much easier and also used to optimize the 
ion source. For example, it also allows us to control different settings such as controlling 
water flows, inlet flows, and voltages in the drift tube. Besides that, the online 
concentration analyser gives an immediate preview of measured data with all the detailed 
parameters for further analysis.  
There are two ways to generate a mass spectrum in the PTR-MS Quadrupole. 
Firstly, a mass spectrum can be generated by using ion count rates versus mass m/z 
(molecular mass). This mass spectrum generation is also known as mass scan mode from 
m/z 30-300. Figure 2.9 shows a typical mass spectrum of alveolar breath which used mass 
scan mode. Prior to running the sample, in the software settings, a specific dwell time was 
set in the mass scan mode for the complete cycle because the software does not allow 
setting an individual mass. In the mass scan mode, the dwell time can be set between 0.5 
ms up to 60 s per channel as displayed on the settings. In this study, 0.5 s was used to get 
an optimal data acquisition. A complete scan cycle is considered finished when the set 
range of m/z has been scanned over a stated dwell time for each point. The dwell time 
also plays an important role to improve signal to noise ratio. For example, shorter 
integration time was used for the volatiles with higher concentration e.g. higher than 100s 
of ppbv. However, for volatiles with lower concentration, typically for several ppbv, a 
longer integration time is needed. 
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A mass spectrum also can be obtained by using ‘multiple ion detection’ (MID). 
MID is the the mass scan mode where only selected m/z of interest will be chosen for any 
measurements over a time period of scanning (dual time). Generally, for the unknown 
VOCs samples, mass scan mode has been used. It also can be employed to monitor the 
change in concentration over time. The data extraction and analysis for PTR-MS 
Quadrupole (QMS 422, Balzers) instrument which was used for the breath analysis 
investigation was not an instant and automated process. In order to get the data, every 
obtained cycle during the measurement was converted to an ASCII file using the Balzers 
Quadstar 422 software package and then copied to Excel spreadsheets. 
 
  
Figure 2.9 Example of PTR-MS alveolar breath spectrum of a healthy rugby player 


























In PTR-TOF-MS, GRAMS/AI TOF-MS software is used to collect the data. The 
KORE Workbook program contains interface, customisation of the toolbar and menus. 
There are normally four pages in the workbook where the first page is related to set 
parameters to collect spectra, load spectra and perform the actual collection. The other 
three pages are related to calibration tools, printing facilities and provides an interface for 
chromatography collection. In PTR TOF-MS, mass spectra (figure 2.10) can be acquired 
using theoretical mass/charge (m/z) values versus measured time of flights. The spectrum 
acquisition parameters adjusted based on length of experiments (sec), length of cycle 
(cycle time) and the width of each time bin in nanoseconds. All spectra are collected as 
time spectra and stored to disk format. Conversion of time data to mass is achieved as the 
spectrum is loaded. The mass conversion for PTR-TOF-MS (KORE) is based on t0, Cb 
and t (equation 2.30).  
 
                                                      𝑚 = (
𝑡−𝑡0
𝐶𝑏
)                                                          2.30 
 
where t0 and Cb are unknown, in this case, these parameters will be determined 
by the software provided by the manufacturer and t is measured flight time. The data are 






















3 Breath Sampling for Clinical Screening, Diagnosis and 
Monitoring  
3.1 Introduction  
Breath consists of mixture of a number of dominant gases, such as nitrogen, oxygen and 
carbon dioxide, and also some water vapour. A typical concentration of normal human 
inhaled air contains 79% of nitrogen, 21% oxygen and a small percentage of argon, 
carbon dioxide, neon, hydrogen, helium and water vapour. However, exhaled breath 
typically contains 78 % nitrogen, 18 % oxygen and 4% carbon dioxide. 
 Besides that, it also has some inert gases and trace amounts (from parts per 
million to parts per trillion by volume) of volatile organic compounds (VOCs). Although, 
these gases are in low concentrations, they are the result of metabolic processes in the 
body [2, 31]. Endogenous VOCs produced in the body are products of normal activities 
based on normal metabolism and metabolic pathways. Some VOCs are produced due to 
modified metabolisms because of a certain disease or illness. Exogenous VOCs are 
transported to the lungs via the bloodstream where they contribute to exhaled breath. 
Breath analysis can be applicable to people of all ages and certain medical conditions. It 
also involves a harmless and no risk procedure to the patients. Breath sampling gives a 
possible way to identify a dangerous disease, screening and monitoring disease growth, 
behaviour and the reaction towards the treatment. 
The possibilities of breath analysis have been proven by clinicians ‘smelling’ 
some kind of odours in their patients’ exhaled breath. As a consequence, the adjectives 
of uremic, hepatic and acetone in the breath corresponding to several diseases have been 
used for many years [32]. However, the limitation of this approach towards some diseases 




was only noticed at chronic stage of the respective disease when the systemic metabolism 
was fully adjusted [32].  
 Rather than smelling breath, which has been done since the ancient Greeks, a new 
analytical age of breath analysis started approximately 40 years when Linus Pauling and 
co-workers found 250 VOCs in an ordinary breath sample [33], using breath analysis 
technique. The results were that some of these VOCs were associated with certain 
systemic disorders and pathological conditions [33]. A more recent pioneer of breath 
analysis is Michael Philips at the New York Medical College, US who is the founder and 
chief executive officer of Mensanna Research. He has claimed that breath test can be the 
least invasive compared to the all diagnostic tests and technical advances encouraged his 
research group to introduce a new role for breath testing in detecting early stage of disease 
[34]. His research team also have developed a portable breath collection device where 
breath samples can be collected anywhere. This remarkable advancement in the 
identification capability of breath analysis has stimulated the exploration of airway 
diseases by interpretation of biomarkers deriving from the airways and lung structures. 
 As mentioned earlier, odour from the breath may be used to detect certain diseases 
in their advanced stages. For example, the breath of diabetic patients has a fruity odour 
which is linked to the high concentration of acetone in the body and hence in the breath 
due to the lack of insulin produce by the pancreas. Therefore, the level of glucose in the 
body goes extremely high and is unused. This leads to the body using the stored fat as a 
substitute source for energy. As a consequence, acidic ketones build up in the body and 
are detectable via the breath.  
 




 Some researchers used breath analysis to detect VOCs from critically ill patients, 
such as oxidative stress, lung, liver, and kidney diseases, and organ dysfunction or tissue 
rejection where there found unusual VOCs via exhaled breath due to change in 
pathophysiology and metabloisme [35]. For example, Scott et al., claimed to have found 
biomarkers in the breath of patients suffering from cystic fibrosis lung and tuberculosis 
[36, 37].  
 
Besides that, Micheal Philips evaluated a breath test for VOCs from breast cancer patients 
to prevent unnecessary mammogram screening which involves radiation exposure and 
potentially introduces a painless screening test [38]. Recently in 2016, Fernandez et al. 
used breath analysis without involving any painful procedure and found three VOCs 
(limonene, methanol, and 2-pentanone) associated with liver cirrhosis patients from a 
study involving pre and post liver transplant patients [2]. In addition to this, O’Hara et al. 
have linked limonene in exhaled breath to No-HCC (Hepatocellular) and/or hepatic 
encephalopathy (HE) [31]. 
On the other hand, there are a few challenges involved in breath sampling to have 
reproducible results. The breath sample is humid and transitory. No one has done any 
studies on how long the breath sample can be kept under certain conditions to obtain good 
results. In addition to that, the exhaled breath sample is not homogenous a sample. 
Therefore, the challenge of segregation and collection of alveolar from dead space (a 
portion of breath volume contained in the upper airways) has to be tackled. The ‘alveolar’ 
air can be defined as the air from the deeper expiration where the equilibrium happens 
between lungs and blood. This produces a maximum concentration of endogenous VOCs 
in the exhaled breath. In order to achieve the alveolar phase for clinical purposes such as 




monitoring, diagnosis, and screening, a standard breath protocol is needed. For this 
purpose, CO2 levels can be monitored during breath sampling.  
Therefore, to meet the challenges, PTR-MS has been used as an analytical 
instrument to detect VOCs from breath for the last 20 years. Recently, most of the 
universities and research centres have used PTR-MS for their breath analysis research 
work.  
3.1.1 Breath composition  
The volatile compounds in the exhaled breath can be categorized into two groups, 
exogenous and endogenous. The human body naturally produces some VOCs in breath 
based on common metabolism and daily activities and also food intake. Some of the 
VOCs in the exhaled breath originate from current or previous environmental exposure 
(exogenous compounds).  
Diet and drug intake can be considered as exogenous compounds. Benzene and 
acetonitrile are also considered as exogenous compounds which have been found in 
higher concentrations in the exhaled breath from smokers compared to non-smokers. 
Allicin (an odourless compound in garlic) can be turned into organosulphides by crushed 
or cutting the garlic [39]. Some obvious compounds were found in the breath of people 
after ingesting garlic e.g. allyl methyl sulphide, diallyl sulphide, diallyl disulphide, dialyl 
trisulfide and dimethyl sulphide. In particular, concentrations of diallyl sulphide and allyl 
methyl sulphide are markedly increased as a result of metabolic processes in the body 
[13]. This early work demonstrated how volatiles in breath resulting from a metabolic 
process can be monitored as a function of time using PTR-MS, with a resolution of 
hundreds of millisecond. 




 Endogenous compounds are produced in the body by internal metabolic activities 
(anabolic and catabolic). For example, the most abundant VOCs from the normal breath 
are isoprene, acetone, methanol, ethanol, and propanol [13, 40-42]. Deficiency or excess 
of isoprene and acetone can be linked to certain conditions or diseases. Isoprene 
production is related to the isoprenoid biosynthetic pathway. Isoprene which believed to 
be produced from cholesterol metabolism, considered as the most abundant product of 
isoprenoid and found in the exhaled breath [43] [44]. Acetone is produced via ketogenesis 
metabolism. People who are suffering from diabetes and also people who are starving 
produce a high level of acetone in the breath [45]. In addition to that, there are other 
endogenous compounds produced due to different pathologies and diseases [44] [46]. 














Table 3.1 Example of classes of Volatile Organic Compounds in the Breath taken from 
Mazzone in Journal of Thoracic Oncology, 2008 [47]. 
 
Class of VOC Example Example of  





Lipid peroxidation of fatty acid 
components of cell membranes–triggered 
by reactive oxygen species 
Unsaturated 
hydrocarbons 




Acetone Decarboxilation of acetoacetate from 




























3.2 Human Respiratory System  
 
The primary goal of the respiratory system is the exchange of gases especially between 
the circulatory system and the outside atmosphere. The respiratory system is located in 
the upper part of body known as the thorax. It consists of the organs of the mouth, 
pharynx, larynx, trachea, bronchi and bronchioles, lungs, and the muscles of the 
respiration system (figure 3.1). Air always goes through in the upper airways (the nasal 
cavity, pharynx and larynx) and then to the lower airways (trachea, primary bronchi and 
bronchial tree). The air then goes into the small bronchioles and alveoli within the lungs.  
 
Every branch of the bronchial is divided to terminal bronchioles which end with alveoli. 
There are millions of alveoli in both lungs where normally the exchange of gases take 
place. There are two types of gas respiration involved in a respiratory system. The first is 
known as an external respiration where the gas exchange process happens between the 
air filling the alveoli and blood in the capillaries surrounding the alveoli walls. Internal 
respiration occurs in the distal respiratory tree and it includes gaseous exchange from 
higher concentration to a lower concentration where O2 containing blood is transported 
to the peripheral tissue of the body. Thereafter, the O2 will be absorbed by the tissues and 
produce CO2 as a waste product where it will be diffused back into blood and transported 













Figure 3.1 Human Respiratory System and the structure of the alveoli in the lungs 
Reprinted from Lumen Learning, The Respiratory System and Direct Diffusion with the 
permission of Lumen Learning copyright [48]. 
 
3.2.1 Gas exchange in Humans 
 
Gas exchange is an important process in the lungs of a human body. There are two types 
of respiratory gases involved in a respiration system. The distribution of oxygen from the 
alveoli into the blood and carbon dioxide from the blood into alveoli is performed by the 
exhalation process. The carbon dioxide is removed via air sacs (alveoli) at the end of the 
bronchial tubes from exhalation and is considered as a waste metabolic product from 




respiration. For example, during a person’s breath in (inhalation), oxygen shifts from the 
alveoli to the surrounding capillaries and into the bloodstream. Meanwhile, during breath 
out (exhalation), carbon dioxide shifts from the bloodstream to the capillaries and into 
alveoli. Figure 3.2 summarizes a respiratory event. There are several processes involved 
for the transfer of oxygen from outside air to body by the blood flow to the lung: 
 
1) Breathing is a process of moving the air into and out of the lungs also known as 
‘Ventilation’ 
 Ventilation in breathing: 
• Inhalation- air inspires into the lungs 
  -Exchange of gases happen between the blood and body cells 
• Exhalation- air is forced out of the lungs  
  - Exchange of gases happen between the lungs and blood 
Ventilation is the process where the air in and out of the lung occurs due to differences in 
pressure brought by the variation in the thorax volume e.g. when the air goes into the 
lungs, the pressure inside must be lower than the atmospheric pressure. 
 
2) Gas transport by blood – This process happens when the oxygen is transported to the 
body cells and carbon dioxide will be returned as a waste product. The oxygen (98 %) 
will be carried in the blood by attaching to the haemoglobin which is also known as a 
type of protein in the red blood cells to form oxyhaemoglobin with each haemoglobin 
molecule binds up to four oxygen molecules. 
 
3) Cellular Respiration- This is a process where the oxygen in the cells goes through a 
few processes and the final production is carbon dioxide. 










3.2.2 Lung capacities and volumes 
 
The total lung capacity of a normal human being is usually 6-7 litres. Figure 3.3 shows 
the lung volumes and their measurement. The lung capacities can be categorized to 
several volumes: 
i) Tidal volume (TV or VT) 
ii) Expiratory volume (ERV) 
iii) Residual volume (RV) 
iv) Inspiratory volume (IRV) 
 
During normal respiration, about 0.5 L of air is taken in and it is defined as the 
resting tidal volume (TV or VT). Meanwhile, the inspiration volume can be expanded by 
an additional 3 L which is known as an inspiratory reserve volume (IRV). Furthermore, 
Breathing
External Respiration
Gas Transport by Blood
Internal Respiration
Cellular Respiration




expiration can be expanded by approximately 1.7 L more on forced (maximum) 
expiration. This volume is defined as the expiratory reserve volume (ERV) [49]. 
Normally, this reserve volume will be used during physical exercise or when normal tidal 
volume is insufficient. Residual volume (RV) is the volume (1.3 L) which remains in the 
lungs after the forced expiration. Lung capacity can be defined as the sum of the 
individual lung volumes. Besides that, the vital capacity (VC) is the maximum volume of 
air which can be carried in and out in a single breath. Consequently, the VC =VT + IRV 
+ ERV [49]. The VC decreases as the RV increases with age (1.5 L to 3L). Therefore, the 
total lung capacity is 6 to 7 L (VC and RV) and the functional residual capacity is the 
total of ERV and RV (figure 3.3). A Spirometer is used to measure the total ventilation 
per unit time, O2 consumption and dynamic function tests. For a normal variation, the 
normal range of lung volumes and capacities depend on age, height, physical condition 

















         Figure 3.3 Lung volumes and their measurement. Reprinted from   
                  https://clinicalgate.com/mechanics-of-ventilation [50]. 
3.3 Methods of Alveolar Breath Sampling collection 
Mixed expiratory breath samples were collected either by using Tedlar bags, Tenax Tubes 
or Polypropylene by some research groups [51-53]. One of the most obvious problems 
faced by researchers involves mixed expired air in the breath which includes the dead 
space air. It is complex to control a portion of the dead space air, especially when it varies 
from individual to individual. It also varies within individuals and depends on how strong 
and deep the inhalation is before giving the sample.  
A number of studies were done using various breath sampling procedures to measure 
VOCs from breath which have been exhaled [54]. Some groups collected late expiratory 
breath samples using Tedlar bags for their studies [54-56] . This method has improved 
the breath sampling protocol by discarding the first portion of dead space and maximizes 
the contribution of endogenous compounds [54, 57]. In this work, only the end of breath 
sample is used to avoid a mixed air sample.  




  Meanwhile, other research groups have used end tidal or alveolar breath using 
either Tenax tubes or Tedlar bags [58, 59]. Alveolar breath contains high concentrations 
of endogenous VOCs and least contamination. However, it could mislead the result by 
giving an incorrect alveolar concentration because the VOCs exchange may be happening 
with the airways as mentioned by Anderson et al., [60, 61]. 
O’Hara et al., have developed a simple breath sampling protocol using a 
rebreathing method which enables mixed air breath to be measured that is reliable and 
reproducible [62]. Besides that, this method would provide equilibrium between any bag 
or canister (container), the airways and bloodstream [54].  
Anyhow, there will be condensation which would affect the stability of VOCs and 
this approach is not applicable for clinical studies. Despite the large number of studies, 
no standardised protocol for breath sample collection has been adopted [63].  











3.4 Glass syringes and other consumables for breath sampling  
O’Hara et al., used Tedlar bags (5 L), with 22 mm outer diameter, 10 mm inner diameter 
and polypropylene EAF fitting (SKC, USA) to develop their initial rebreathing protocol 
to determine the dependence of concentration of VOCs in the breath with the number of 
re-breaths and also to compare isoprene, acetone and methanol concentration in single 
mixed expired breaths [62]. However, Tedlar bags are costly (approx. £55 each), they are 
difficult to sterilize, they are not reusable and long-time storage of VOCs is not possible, 
and there is contribution contaminant to the end result [62, 64]. In order to avoid all these 
problems, Teflon bags were used (5 L, Welch Fluorocarbon, NH, USA) for her 
measurement on endogenous VOCs in breath of healthy volunteers which does not emit 
any contaminants [65].  
The main reasons for an optimization of the protocol are: i) there is a great 
difference in breath sampling because of the widespread of breath analysis techniques ii) 
potentially there are extensive variety of compounds presents in the breath iii) to avoid 
the big discrepancy in breath patterns in the analytical instrument, iv) to minimize the 
confounding factors [66]. A few groups have suggested a number of techniques to 
improve the method of breath sampling [66-68]. Figure 3.4 shows the standard work flow 
of breath analysis which summarizes breath sampling protocols. 
For a standardized breath protocol especially for sampling, Fortuna® Optima 
glass syringe (100 ml, Sigma Aldrich) is recommended to use because it is easy to clean 
and decontaminate (sterilization) via autoclave and it is also re-usable (figure 3.5). 
Fernandez del Rio et al., have introduced an improved breath collection technique based 
on Rostock group’s work, which uses 100 ml glass syringes to take breath samples by 
monitoring the alveolar breath using a capnography equipment (CO2 controlled) to 




maximise VOC concentrations. The syringe is connected to the capnograph before breath 
sample collection. By using this improved method, biomarkers have been found for liver 
associated diseases from comparisons to pre- and post-liver transplant breath samples [2]. 
These studies have proved that using CO2 controlled end exhaled sampling using 
capnography can be practiced as a standard protocol in Breath Research [69].  
 
 






Figure 3.4 Workflow of steps in a breath analysis study, Reprinted with permission 
form the Journal of Breath research, 2014 [66]. 





Figure 3.5 Photograph of a) Fortuna® Optima glass syringe (Sigma Aldrich) b) B-braun 
stopcock and c) Elbow gas sampling port (Intersurgical complete respiratory system) 
 
3.5 Capnometry (Capnography) for alveolar breath sampling 
 
In breath sampling, there is a portion of the exhaled breath which is not involved in gas 
exchange known as dead space. In a standardized breath analysis protocol, a capnograph 
is used to monitor the exhaled breath non-invasively. The display and waveform of CO2 
on a capnometer monitor is defined as capnography [70]. In order to establish alveolar 
breath sampling, a capnometer, equipped with an airway adapter, reference cell and 
capnostat (figure 3.6), is used to determine when end tidal breathing has been reached. 
Capnography provides information about CO2 production, pulmonary perfusion, alveolar 
ventilation, respiratory patterns, and elimination of CO2. Capnography also measures 
partial pressure (unit as a percentage or in units of mmHg) of carbon dioxide in exhaled 
breath. It is usually used in the clinical field especially in ITU (Intensive care unit) and in 
a) 
b) Stopcock 
c) Elbow gas 
sampling port  




the operating theatre by the anaesthetist to monitor the patient’s breathing. This practise 
has been adopted to standardize the breathing protocol to measure the CO2 end tidal by 
using a capnometer. It is easy to monitor the CO2 concentration via a capnogram during 
the respiratory cycle. The measured CO2 at the airway either can be presented as a function 




Figure 3.6 Photograph of Capnometer a) capnograph b) airway adapter c) reference cell 
d) capnostat. 
 
The basic principle of the capnometer is based on absorption of infrared (IR) radiation at 
a very specific wavelength (4.26 µm) which matches a vibrational mode of the infra-red 
active CO2 molecule [70]. This occurs when the CO2 breath concentration has reached 
the plateau where there is maximum CO2 concentration [71]. The Beer Lambert Law 
(equation 2.30)  [72] is used: 
                                 











                                                      I= Io e
-ɛbc                                                                 2.30                                  
 
where I is the infrared intensity, b is the path length of the sample region and c is the 
concentration of the compound, and ɛ is the molar absorptivity. The average EtCO2 (End 
tidal capnography) is approximately from 35 to 42 mm Hg or 5 % to 6 % CO2 [70]. 
 A Reference cell is used to calibrate the capnometer before sampling the breath 
to set up the sampling operation and error threshold. Figure 3.7 shows an example of 





  Figure 3.7 Breath profile of a volunteer using a Capnograph 1265 from Novametrix   











3.6 Exhaled breath sampling protocol 
Breath samples from the volunteers were sampled using a portable capnometer as 
described in the protocol of section 3.6. Figure 3.7 represents a breath sampling system 
where a syringe is connected to the respiratory apparatus tubing using a 3-way luer-lock 
stopcock (Braun Medical Limited) with a respiratory collection system. Breath samples 
were only collected using syringes when the capnograph showed that the alveolar phase 
of the exhaled breath had been achieved (figure 3.8). Usually, for the breath analysis, 
typically 3-4 breath samples (replicates) were collected using separate 100 ml syringes to 
increase the accuracy and decrease the statistical error. Besides that, the extra samples 
were useful to check the repeatability. Prior to measurements, the breath samples from 
the volunteer were placed in an incubator for 10-15 min at 37 - 40°C to reduce 
condensation. 
The capnograph of a volunteer can be observed on the screen on the capnometer (figure 
3.8). Figure 3.10 shows a volunteer giving his breath sample sitting down in a relaxed 
state. The volunteer was requested to breathe normally without any extra force using a 
gas tight respiratory system. The respiratory system which has an inline CO2 mainstream 
sensor was connected to a fast-time response capnometer. 
As described earlier, a capnometer is used to determine when the end tidal part of the 
breath has been reached. For each 100 ml glass syringe, 3 to 4 end tidal breaths were 
taken. The withdrawal of the breath samples from the volunteer are done manually into 
the syringe. 
 




The background air of the specific location (e.g. the School of Sports Science and 
Exercise or Brain Imaging Centre, University Hospital Birmingham) of the breath 
sampling was also taken to check for background contamination. The collected breath 
samples were placed on an adjustable table located near to PTR-MS. The breath sample 
which were sealed with a 3-way stopcock connector (2 female luer locks) were connected 
to the PTR-MS inlet using a 4 inch Swagelok adapter (figure 3.10 and figure 3.11). The 
samples were covered with a heated blanket maintained at 45 °C to maintain the humidity 








Figure 3.8 Normal breath profile. 
 
 
1) A–B demonstrates the exhalation of the dead space 
2) B–C represents lower airway exhalation 
3) C–D represents alveolar exhalation, as measured from the lips or nostril 
4) D–E represents expiration 
5)     End Tidal 














Figure 3.9 Schematic diagram of a breath sampling system. The diagram is reprinted  
from a figure given by Fernández del Río et al. in the Journal of EBioMedicine [2]. 
 
 
    Figure 3.10 A healthy volunteer giving a breath sample. The syringe is coupled   
    with a luer lock and elbow sampling gas port. 












   Figure 3.12 Heating blanket and plastic cover used to maintain the humidity of  
   the breath sample.





4 VOLATILE ORGANIC COMPOUNDS ASSOCIATED 
WITH SHISHA PASTE AND SHISHA SMOKING 
4.1 Introduction 
Chapter 4 provides details on the first PTR-MS study of shisha smoking, which won the 
best poster award at the Breath Research Conference in Zürich 2016.  
Shisha smoking, also known as hookah, narghile, water pipe, hubble bubble, or ghoza 
social activity, has increased sharply in the Middle East and Asia [73-77], and has spread 
rapidly to Europe and the United States, becoming either an alternative or an addition to 
conventional cigarette smoking. For an example, in a 2008 cross sectional study among 
the student population at the University of Birmingham in the UK, 37.9% had tried Shisha 
smoking. Among them, 8.0% claimed to be regular shisha smokers, comparable to the 
9.4% of students who claimed to be regular cigarette smokers [77]. This perhaps suggests 
that young adults are being influenced by the fashionable and social Shisha water pipe 
smoking. Certainly many more Shisha bars have opened in the UK since 2008 to supply 
the demand for shisha smoking.  
It is well accepted that tobacco smoking causes many serious diseases resulting in 
significant health problems. It is therefore troubling that shisha smoking is considered to 
be socially acceptable. Disturbingly there is evidence to suggest that many smokers 
perceive that smoking shisha is less harmful to health compared with conventional 
cigarettes [78]. In a study by Jackson et al. [77], it was found that nearly all regular 
waterpipe smokers considered it to be less harmful than smoking cigarettes. It is possibly 
this erroneous belief that has given rise to the recent surge in the use of water pipe. This 
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is of concern owing to the major health effects associated with any form of tobacco 
smoking. Importantly, given the social nature of shisha smoking, participants are exposed 
to smoke for longer periods than they would be for cigarette smoking, and inhale larger 
quantities of smoke and hence harmful compounds than they would in comparison to 
smoking a cigarette. 
A typical Shisha water pipe consists of a clay head, metal body, a glass bottle 
filled with liquid (such as water), and a flexible connecting hose with a mouthpiece (figure 
4.1). Shisha smoking involves burning tobacco and molasses (Shisha paste) with the aid 
of charcoal. Typically 10-20 grams is encased in aluminium foil within which a few small 
holes has been made. The encased Shisha paste is placed in the head and burnt in a session 
of smoking [79]. A few pellets of charcoal are placed on top of the foil [80]. In the Shisha 
water pipe, tobacco undergoes a process of volatilization as it burns. Some researchers 
have claimed that using aluminium foil leads to less smoke with no odours, no ash fumes 
and a smoother smoke [81]. The burning produces tar, nicotine and carbon monoxide 
amongst other combustion products and two times more nicotine than that from smoking 
























Figure 4.1 “Shisha” . 1) Clay pot for tobacco, 2) Pipe stem connecting to the water 
container, 3) Water bowl, 4) Hose which connected to the mouth piece. 
It has been calculated that during a smoking session, a smoker inhales shisha 
smoke for periods of approximately anywhere between 20 and 80 minutes [75, 83] with 
a typical shisha smoking session involving approximately 200 puff inhalations compared 
to typically 20 puffs occurring during the smoking of a conventional cigarette [84]. This 
translates to a water pipe smoker inhaling about 90 L [85] or even more, whereas in 
comparison a conventional cigarette smoker inhales between 500-600 mL of smoke per 
cigarette [85]. Given the amount inhaled it is estimated that smoke from a smoking 
session of 45 minutes results in approximately 40 times more tar, 30 times more 





Chapter 4                 Volatiles Organic Compounds associated with shisha smoking 
70 
 
times more nicotine than received from smoking a single cigarette [78]. However, it is 
not just these compounds that are toxic. Studies using chromatography techniques have 
identified toxic volatiles including NO [86], formaldehyde [73], acetaldehyde [73, 86] , 
acetone [73, 86], propionaldehyde [73, 86], benzene [87], toluene and isoprene [87].  
All of these previous studies of volatiles associated with shisha have used labour 
intensive and time consuming offline analytical techniques. Also there are no previous 
studies done using PTR-MS to measure VOCs from any type of charcoal. However, there 
has been one study by Kabir et al., using GC-MS to investigated barbecue charcoal 
combustion as a potential source of aromatic volatile organic compounds and carbonyls 
[88]. They focused on a number of VOCs associated with the combustion, which are 
summarized in table 4.1, and for which concentrations in the surrounding air can be 
extremely high (hundreds of ppbv). The results from that investigation are used here to 
aid in the analysis of the volatiles resulting from the combustion of charcoal briquettes 
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Table 4.1 Common VOCs emitted from burning barbecue charcoal (adapted from the 













The advantage of the instantaneous analytical capabilities of PTR-MS analytical 
technique described in detail in section 2.1.11.1 of Chapter 2 has been put to good use in 
studies of e-cigarettes by Blair et al. [9] and Breiev et al [89]. In our study, we have gone 
beyond e-cigarettes and present the first PTR-MS investigations of shisha. This study 
involves not only analyzing the volatiles coming from the combustion of the shisha paste 
and charcoal and through the pipe, but also for comparison an analysis of the head space 
of shisha paste. This can be used, for example, to check the quality and constituents of 
the paste, but it is used here to ascertain any differences in volatile organic compounds 
(VOCs) resulting from combustion to those present in the paste. The key aim of this study 
is to identify the VOCs, and in particular toxic ones, that would be inhaled by a smoker. 
This highlights the advantages of real-time measurements, namely that PTR-MS can be 
used for puff-by-puff shisha measurements. A weakness of the PTR-MS method is its 
No Compound Molecular weight 
(g mole−1) 
 
1 Benzene 78.1 
2 Toluene 92.1 
3 Ethyl benzene 106 
4 Meta para 
xylene/Ortho 
xylene 106 
5 Styrene 104 
7 Formaldehyde 30 
8 Acetaldehyde 44.1 
9 Acrolein 56.1 
10 Acetone 58.1 
11 Propionaldehyde 58.1 
12 Crotonaldehyde 70.1 
13 Butylaldehyde 72.1 
14 Benzaldehyde 106 
15 Valeraldehyde 86.1 
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ambiguity in the identification of compounds in a complex chemical environment, 
because assignment is based solely on using m/z values of the mass spectral peaks 
observed. To aid in the VOC assignment, we have undertaken GC-MS measurements of 
the head space of shisha paste. Importantly, this study adds to the growing body of 
evidence showing that water pipe smoking is not a safe alternative to cigarette smoking.  
4.2 Experimental Methods 
4.2.1 Instrumentation 
4.2.1.1 Proton Transfer Reaction – Time of Flight - Mass Spectrometry (PTR-ToF-MS) 
The principles and operation of a PTR-ToF-MS have been extensively covered in this 
thesis in Chapter 2 and also in an in-depth review by Ellis and Mayhew [1], and hence 
only salient points of the instrument used for this study will be provided. For the 
measurements a KORE Technology Ltd. first generation instrument was used [90, 91].  
The smoke coming from burning charcoal without paste using the shisha water 
pipe was first investigated in order to separate VOC compounds coming from the 
charcoal alone, but of course it is the combined VOCs in the smoke that is relevant 
for smokers in terms of the toxic intake. Figure 4.2 shows the Shisha smoking 
measurement using the fume hood and figure 4.3 shows the schematic diagram of 
experimental set up for sampling the headspace of shisha paste. 
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To investigate the smoke coming from the water pipe we used a procedure we 
have used effectively for taking breath samples [2]. Smoke from the pipe was drawn 
into 100 ml glass syringes (Sigma Aldrich) using a 3-way luer-lock stopcock (Braun 
Medical Limited) at 3 minutes after the start of the burning. We noted that often ion 
signals were saturated when analysing the smoke directly. This indicates that the 
concentrations of VOCs were extremely high, and therefore to ensure we can give 
relative intensity values of the VOCs, it was necessary to dilute the smoke sample. In 
our studies, we diluted the smoke sample with clean air by a factor of ten. The luer 
stopcock was coupled to a Swagelok fitting and connected directly to the inlet of the 
PTR-ToF-MS. The syringes are gas tight and have minimal friction such that 
atmospheric pressure is sufficient to push the plunger in smoothly so that the smoke 
sample was drawn into the PTR-MS instrument with a constant flow rate. The syringes 
have a sufficient volume to ensure that a 60 second integration time was possible  [2]. 
Identical but different headspace bottles and syringes were used for each flavoured 
paste to avoid contamination. Background mass spectral measurements of empty 









Shortly before analysis approximately 40-70 mg (±10%) of a shisha sample was moved 
into a headspace vial (20 mL, Gerstel, Germany), which was subsequently sealed with a 
1.3 mm butyl/PTFE septum (Macherey-Nagel, Germany). Next, the samples were 
incubated at 40℃ for 30 minutes. Solid phase microextraction procedure was carried out 
automatically using a multipurpose sampler MPS (Gerstel, Germany) by inserting the 
SPME fibre coated with 75 μm CAR-PDMS (Supelco, Canada) into the vials and 
exposing the fibre to the sample head-space for 10 minutes. The sample temperature 
during the extraction was kept at 40 °C. Following the extraction, the fibre was introduced 
into the inlet of the gas chromatograph where VOCs were thermally desorbed at 290 °C. 
The fibre was conditioned at 290 °C for 5 minutes prior to each analysis. 
Chromatographic analyses were performed using an Agilent 7890A/5975C GC-
MS instrument (Agilent, USA). Separation of the volatiles was accomplished by using an 
Rt-Q-BOND column (30 m×0.25 mm, film thickness 8 μm, 100% divinylbenzene phase, 
Restek, USA) using a constant throughput of helium at a rate of 1 mL×min−1. The 
procedure for column temperature was as follows: increase the temperature from 60 °C 
to 260 °C at a rate of 5 °C minute−1, and then keep the temperature constant at 260 °C for 
20 minutes. The mass spectrometer worked in a SCAN mode with an associated range set 
from m/z 20 to m/z 200. The quadrupole mass spectrometer, ion source, and transfer line 
temperatures were kept at 150 °C, 230 °C, and 280 °C, respectively. The identification of 
compounds relied on the NIST mass spectral library matching. 




4.3.1 Shisha Pastes  
Commercially available flavoured shisha pastes, claimed to have been made from 
different types of fruits that were mixed with molasses, were purchased from shisha bars 
in Birmingham, UK. We restricted our investigations to some of the more popular 
flavoured pastes (table 4.2), namely strawberry, double apple, vanilla, and mint flavoured 
shisha pastes.  
Table 4.2 Type of shisha paste (brand Al-Fakher, taken from the shisha paste) 
 A packet 5 gram. 
 
Shisha paste Nicotine (%) Tar (%) 
Strawberry Flavour 0.05 0.0 
Double Apple Flavour 0.5 0.0 
Vanilla Flavour 0.05 0.0 
Mint Flavour 0.05 0.0 
 
4.3.2 Charcoal Briquettes 
The charcoal briquettes were purchased from a shisha shop in Birmingham. The make of 
the briquettes is Al-Fakher (a United Arab Emirates manufacturer, 
http://www.alfakher.com/). The briquettes are cylindrical with a diameter of 33 mm, a 
depth of 10 mm and a mass of 6.6 g. The typical burning time for these briquettes is 
approximately 15 minutes. Hence, during a Shisha smoking session, the charcoal is 
replaced several times. For the investigation of the smoke only coming from the Shisha 
pipe, we have recorded the intensities of the volatiles every 3 minutes for 9 minutes to 
ascertain changes in concentration as the charcoal is used up. 
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4.4 Results  
 
4.4.1 Headspace Analyses of Shisha Pastes 
 
Table 5.3 provides a summary of the PTR-MS analysis of the headspace of the various 
shisha pastes. In the following, the most intense peaks are defined as those with a relative 
intensity of 20 or higher.  
 
4.4.1.1 Double Apple Shisha Paste 
 
The most intense spectral peaks were observed at m/z 43, 61, 83, 85, 91 and 149. m/z 149 
has the largest intensity (100) and, based on the GC-MS analysis, is assigned to 
predominantly result from protonated p-propenyl anisole with a contribution from 
protonated methyl chavicol (estragol). The next most intense peak is found at m/z 91 
(relative intensity 40) is unassigned, m/z 83 (relative intensity of 27) results from 
protonated 2-methyl furan and a fragment ion from 1-hexanol. m/z 85 (relative intensity 
of 20) is also a product ion resulting from 1-hexanol. m/z 61 (relative intensity of 27) is 
from protonated acetic acid. 
Other product ions observed with lower relative intensities are at m/z 33 
(protonated methanol), m/z 41 (a fragment of 1-hexanol), m/z 45 (protonated 
acetaldehyde), m/z 57 (protonated acrolein with contribution from 1-hexanol), m/z 59 
(protonated 2-methyl furan and propanal), m/z 61 (protonated acetic acid), m/z 69 
protonated isoprene and 1,3-pentadiene), m/z 75 (protonated 1-hydroxy-2-propanone), 
m/z 79 (unassigned, because no benzene was found in the GC-MS measurements), m/z 81 
and 137 (from limonene), m/z 101 (protonated 3-Hexen-1-ol, (Z)) and from a product ion 
from 1-hexanol), and m/z 107 (protonated benzaldehyde).  
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4.4.1.2 Mint Shisha Paste 
The most abundant mass spectral peaks identified from the head space of mint shisha 
paste are found to be at m/z 33 (protonated methanol), m/z 61 (protonated acetic acid), 
m/z 81 (product ions coming from limonene, menthol and menthone), m/z 83 (protonated 
2-methyl furan), m/z 137 (protonated limonene and a product ion from menthone) and 
m/z 155 (predominantly protonated menthone). Besides these, mass spectral peaks with 
reasonable intensities were observed at m/z 41 and 43 (product ions from 1-hexanol), m/z 
45 (protonated acetaldehyde), m/z 55 (product ion from menthol), m/z 57 (contributions 
from protonated acrolein, and product ions from 1-hexanol and menthol), m/z 59 
(protonated acetone and propanal), m/z 69 (product ion from menthol), m/z 95 (product 
ion from menthone), m/z 97 and 139 (product ions from menthol), m/z 101 (protonated 3-
Hexen-1-ol, (Z)-), m/z 107 (protonated benzaldehyde), m/z 129 (protonated 3-octanone), 
m/z 135 (protonated o-cymene) and m/z 153 (protonated 2-cyclohexen-1-one, 3 methyl-
6(1-methylethyl)-).  
4.4.1.3 Strawberry Shisha paste 
 
The most intense product ions for strawberry shisha paste were observed at m/z 43 
(unassigned), m/z 45 (acetaldehyde and a product ion from ethanol), m/z 47 (protonated 
ethanol), m/z 59 (protonated acetone, propanal and oxirane, methyl-, (S)), m/z 83 
(protonated 2,4-hexadiene) and m/z 89 (protonated butanoic acid and ethyl acetate). Other 
product ions are observed at m/z 33 (protonated methanol), m/z 41 (unassigned), m/z 57 
(protonated acrolein), m/z 61 (protonated acetic acid), m/z 71 (product ion from butanoic 
acid), m/z 75 (protonated hydroxy-2-propanone (acetol)), m/z 79 (protonated benzene), 
m/z 87 (protonated 2,3-butanedione), m/z 91 (unassigned), m/z 99 (unassigned), m/z 101 
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(protonated 3-Hexen-1-ol, (Z)-), m/z 103 (protonated methyl isobutyrate), m/z 107 
(protonated benzaldehyde) and m/z 117 (protonated 1,3-dioxolane, 2,2,4-trimethyl-).  
4.4.1.4 Vanilla Shisha Paste 
From the vanilla flavoured Shisha paste, the most dominant peak is at m/z 59, which is 
predominantly protonated propanal with a contribution from oxirane, methyl-, (S). The 
second most intense mass spectral peak is at m/z 89 which is assigned to be protonated 
ethyl acetate. Other dominant peaks are at m/z 43 (unassigned), m/z 45 (protonated 
acetaldehyde with a contribution from a product ion associated with ethanol), m/z 71 
(unassigned), and m/z 87 (protonated 2, 3-butanedione with a contribution from 
protonated butyrolactone). Less intense peaks were found at m/z 33 (protonated 
methanol), m/z 41 (unassigned), m/z 47 (protonated ethanol), m/z 57 (protonated 
acrolein), m/z 61 (protonated acetic acid), m/z 73 (unassigned), m/z 75 (protonated 2-
Propanone, 1-hydroxy-), m/z 77 (protonated propylene glycol) and m/z 107 (protonated 
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Table 4.3 m/z of product ions resulting from the reaction of H3O
+ with the headspace of 
various shisha pastes using PTR- MS at 120 Td and possible VOC identification based 
on m/z of product ions and a GC-MS analysis of the shisha pastes.  
m/z (product ion) VOC Compound Relative intensity (%) 
 
Double apple flavour      
33 methanol 10 
41 1-hexanol (fragment) 12 
43 1-hexanol (fragment) 43 
45 acetaldehyde 3 
57 acrolein or 1-hexenol (fragment) 11 
59 oxirane, methyl-, (S)-/propanal 19 
61 acetic acid 27 
69 isoprene/1,3-pentadiene, (E)-/1,3-pentadiene, (Z)- 2 
75 2-Propanone, 1-hydroxy- 5 
79 unassigned 10 
81 limonene 2 
83 furan, 2-methyl-/1-hexanol fragments 27 
85 1-hexanol 20 
91 unassigned 40 
101 3-Hexen-1-ol, (Z)- 1 
107 benzaldeyde 3 
137 limonene 3 




33 methanol 55 
41 1-hexanol (fragment) 3 
43 1-hexanol (fragment) 18 
45 acetaldehyde 3 
55 menthol (fragment) 15 
57 acrolein and menthol (fragment) 13 
59 acetone/propanal 11 
61 acetic acid 24 
69 menthol (fragment) 5 
81 limonene, and menthol and menthone (fragments) 47 
83 furan, 2-methyl-  36 
95 menthone (fragment) 10 
97 menthol (fragment) 5 
101 3-Hexen-1-ol, (Z)- 1 
107 benzaldehyde 1 
129 3-octanone 1 
135 o-Cymene 1 
137 limonene and menthone (fragment) 37 
139 menthol (fragment) 12 
151 menthofuran 3 
153 2-Cyclohexen-1-one, 3-methyl-6-(1-methylethyl)- 13 




33 methanol 19 
41 unassigned 17 
43 unassigned  28 
45 acetaldehyde and product ion from ethanol 59 
47 ethanol 87 
57 acrolein 3 
             59 propanal/acetone/oxirane, methyl-, (S)- 100 
61 acetic acid 8 
71 butanoic acid fragment 15 
75 2-propanone, 1-hydroxy- 4 
79 benzene 2 
83 2,4-hexadiene 25 
87 2,3-butanedione 3 
89 ethyl acetate/butanoic acid 51 
91 unassigned 7 
99 unassigned 4 
101 3-Hexen-1-ol, (Z)- 2 
103 methyl isobutyrate 3 
107 benzaldehyde 1 


















117 1,3-dioxolane, 2,2,4-trimethyl- 18 
    
 Vanilla Flavour 
    
  
    
  
33 methanol 8 
41 unassigned 7 
43 unassigned 52 
45 acetaldehyde and product ion from ethanol 32 
47 ethanol 13 
57 acrolein (2-Propenal) 1 
59 propanal/oxirane, methyl-, (S)- 100 
61 acetic acid 1 
71 unassigned  49 
73 unassigned 1 
75 2-Propanone, 1-hydroxy- 3 
77 propylene glycol 3 
87 butyrolactone/2,3-butanedione 53 
89 ethyl acetate 90 
107 benzaldehyde 1 
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4.5 VOCs in mainstream smoke 
Figure 4.4 presents the mass spectrum of the VOCs from headspace of charcoal recorded 
whilst operating the drift tube at 120 Td. Figure 4.5 shows VOCS coming from the 
charcoal after exiting the shisha pipe after 3, 6 and 9 minutes of combustion. There 
appears to be no direct correlation of intensities with time. This could be the result of the 
shisha charcoal being not fully or evenly burned during the headspace sampling.  
Table 4.4 summarises the VOCs that were found in the smoke from a water pipe 
using a single pellet of charcoal without shisha being present. Assignment of the 
compounds is based on the m/z values of the product ions and using the results of a GC-
FID study of the volatiles emitted from burning barbecue charcoal by Kabir et al. [88] 
The most intense mass spectral peaks associated with the smoke from just burning 
charcoal using the water pipe are at m/z 43, 57, 79 and 93, assigned to be protonated 
propene, acrolein, benzene and toluene, respectively, with that associated with benzene 
being the most dominant. Less intense spectral peaks are observed at m/z 31 (protonated 
formaldehyde), 33 (protonated methanol), 42 (protonated acetonitrile), 45 (protonated 
acetaldehyde), 59 (protonated acetone and propionaldehyde), 61 (protonated acetic acid), 
69 (protonated isoprene or furan), 71 (protonated cronoaldehyde), 73 (protonated 
butylaldehyde), 85 (protonated pentanal), 87 (protonated valeraldehyde), 97 (protonated 
furfural), 101 (protonated 2,3-pentadione), 107 (protonated benzaldehyde). 
With the shisha paste the volatiles observed are identical to those obtained from 
the head space analysis and from the burning charcoal, with benzene being the most 
dominant compound, with the exception of strawberry, for which the most intense peak 
is observed at m/z 59. There are however some differences. For double apple additional 
peaks are observed at m/z 47 (protonated formic acid), 95 (protonated phenol), 103 
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(unassigned). For mint additional peaks were observed at m/z 47, 75 (protonated 2-
Propanone, 1-hydroxy-), and 149 (protonated benzene, 1-methoxy-4-(1- ). For 
strawberry, two additional peaks are observed at m/z 47 and 77 (protonated propanoic 
acid). 


















Figure 4.4 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of H3O
+) whilst operating the drift tube at a reduced electric field of 120 Td.  




Figure 4.5 Shows VOCS from headspace of charcoal via shisha pipe. 














31 formaldehyde 5 
33 methanol 12 
42 acetonitrile 6 
43 propene 92 
45 acetaldehyde 14 
57 acrolein/hexenal fragments 37 
59 acetone/ propionaldehyde 17 
61 acetic acid 16 
69 isoprene /furan 14 
71 crotonalaldehyde 8 
73 butylaldehyde 2 
79 benzene 100 
85 pentanal 4 
87 valeraldehyde 1 
93 toluene 39 
97 furfural 6 
101 2,3-pentadione 1 
107 benzaldehyde/meta para xylene/ortho xylene/Ethyl benzene 13 
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4.6. Discussion  
4.6.1 Key Findings  
In our study with double apple, a key compound identified anisole, p-propenyl also known 
as anethole. This is obviously used because it is an aromatic compound which is related 
to unsaturated ether and it is strongly linked with lignols. It has been used as flavouring 
substance to give a sweet flavour, because it is 13 times sweeter than sugar [92].  
Among these compounds, 1-hexenol is one of the alcohol compounds which have 
given a significant contribution to double apple shisha paste. 1-hexenol has an odour of 
fresh grass and is widely used in the perfume industry. It can cause irritation of the eyes 
and respiratory tract and possible [95]. 
Acrolein (m/z 57) is another toxic compound found in this study. It is an 
unsaturated aldehyde and this has been used widely as a biocide and also as a building 
blocker for other chemicals. It is a well known toxin which is strongly associated with 
skin, eyes, nasal passages [93] and has an impact on increasing the risk of cancer [94]. 
Another toxic compound is acetic acid. The concentrated acetic compound would 
potentially cause eye, nose and throat irritation if exposed to a prolong inhalation. 
For mint shisha paste, there were compounds corresponded to mint flavour 
detected. There were similar compounds as Saint et al., detected in our study too. For 
example, m/z 55, m/z 81, m/z 83, m/z 137, m/z 139 and m/z 155 were found as menthol 
fragments. Besides that, there were some menthone fragment ions found such as m/z 81, 
m/z 95, m/z 137 and m/z 155. Also there was some contribution from monoterpenes (m/z 
137 and m/z 81) which are related to limonene. We are uncertain about the type of mint 
used to prepare mint shisha paste and it is very difficult to confirm this because it 
indicated only an overall mint note intensity.  
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Some of the compounds are not really harmful if they are used carefully and 
safely. However, some “safe” compounds can still be toxic if exposed to them for too 
long or too frequently. For instance, one main compound in this study menthone has 
significant human health effects if exposed to large concentrations, according to 
Toxicology Data Network report [28], According to the report, over exposure to 
menthone causes ataxia, confusion, coma, nausea, and vomiting [95].  
Methanol is also one of the significant compounds found in the mint shisha paste 
which is far more toxic than menthone and can cause blindness if more than 10 mL is 
taken. 30 mL, can lead to death [96]. Another “safe” compound found in mint shisha is 
1-hexenol which has a reasonable contribution to mint shisha paste where the possible 
side effects already have been explained. 
This study confirms that mint shisha paste is associated with menthol and 
menthone. Hence, this study also shows that there were additional chemicals used to 
prepare the mint shisha paste. 
The key compounds from the strawberry are propanal, acetone and oxirane, 
methyl-, (S)-. Propanal also known as propionaldehyde and it has a fruity odour. It is 
widely used in manufacturing of plastics [97]. There is no evidence on acute effects and 
chronic effects. However, it has some health effects such as eye, nose, skin and throat 
irritation and also pulmonary edema if overexposed [97]. Meanwhile, acetone is a ketone 
compound and mainly use for laboratory purposes. There is no strong evidence on chronic 
health effects of acetone if safety precautions are taken [98]. Generally, exposure to 
acetone could cause skin and eye irritation, while severe exposure could cause 
unconsciousness and potentially can be harmful to the nervous system [98]. Acetone also 
could lead to hepatotoxic effects which can damage the liver [97]. Oxirane, methyl-, (S)-
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, also another source of toxicity and the level of health effect depends on the concentration 
and period of exposure and it may cause cancer (Carcinogeneic) [97].  
Also, the contribution from ethanol is also relatively high from strawberry shisha paste. 
High concentration of ethanol is a risk for health and eventually long term usage would 
cause liver damage [99]. Strawberry shisha paste also has high concentration of 
acetaldehyde. It is toxic and carcinogenic in humans [100]. 
There was no vanillin (protonated m/z 153) compound or any fragment ions of 
vanillin compound found from the headspace of vanilla flavour Shisha paste in our studies 
[101].  
The most obvious compounds from vanilla shisha paste were propanal and 
oxirane, methyl-, (S)-, where the possible health effects have already been discussed in 
earlier discussion. In addition to that, we also already discussed about toxicity of 
methanol, acetalaldeyhde, propanal, ethanol and acrolein in the previous shisha paste 
discussion which can be associated with similar compounds found from the vanilla shisha 
paste.  
4.6.2 VOCs from combustion of shisha paste and charcoal 
There were many VOCs produced from the combustion of the combination of shisha paste 
and charcoal. The main contributions were from the burning of charcoal.  
Shockingly, there were a lot of VOCs produced just from the burning charcoal itself. 
Kabir reported that, the main contribution from barbecue charcoal was toluene and then 
benzene [88]. In our study, the main contribution was from benzene, and then followed 
by propene and toluene. Benzene is the main source of carcinogenic which [97]. Exposure 
to benzene is a also known as factor for leukaemia. Propene (m/z 43) is another main 
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compound from the burning charcoal and excess exposure and intentional inhalation of 
propene could damage the central nervous system which sometimes can be life 
threatening via asphyxiation [97]. Inhalation of toluene in the modest levels can cause 
lethargy, memory loss, confusion, nausea and loss of appetite [97]. The extreme 
inhalation level could cause a lot of side effects such as nausea and headache, and in the 
case of high inhalation would cause death [97]. The other intense VOCs emitted by 
charcoal are acrolein and hexenal. In addition to that, there were some carbonyl emissions 
especially formaldehyde, acetaldehyde, propionaldehyde and acetone. These carbonyl 
compounds potentially cause a threat to health [88] because it is an electrophilic 
compound which is highly toxic and which can causes skin, eye and nasal passages 
irritation and also possibly increase the risk of cancer [97].  
The other toxic compounds coming from the combustion of charcoal are 
methanol, acetonitrile, acetic acid, isoprene and furan, fragments of C6/8 compounds 
benzaldehyde, meta para xylene, ortho xylene and ethyl benzene. Acetonitrile can cause 
acute toxicity such as cyanosis, cardiac and respiratory arrest if exposed for some period.  
Another important finding for some shisha samples was that, certain VOCs were 
only being produced during combustion because some compounds only become volatile 









The aim of the study was to analyse which VOCs are resulting from Shisha smoking. 
There were many VOCS from the head paste of shisha paste, conclusively identified using 
GC-MS and which could be identified by the mass spectral peaks observed in our PTR-
MS measurements. However, a number of spectral peaks could not be assigned to any 
compound detected with GC-MS.  
  This work, as the first PTR-MS study of Shisha, has shown that many VOCs are 
inhaled when smoking Shisha including aldehydes, esters, ketones, acids, alcohols, C6/8 
aromatic compounds, and esters. We also found that harmful chemicals come directly 
from the combustion of charcoal e.g., methanol, acetonitrile, acrolein, acetic acid or 
propionaldehyde, furan, propene, acetonitrile, benzene and toluene.  
     It is important to highlight that our samples were diluted as compared to the real 
shisha smoke particularly to measure the VOCs from charcoal burning and combination 
of shisha paste with charcoal burning in order to avoid signal saturation in the PTR-MS 
system, and hence no quantitative measurements of concentrations are given here. The 
main focus was to identify the compounds in shisha smoke.  
Based on the available evidence, in a real scenario, the health effects would be 
expected to be more severe for shisha especially when inhaling shisha smoke directly 
from a shisha water pipe. A session of shisha involves many hours and it could ultimately 
result in a huge intake of harmful VOCs. In addition to exposure to toxicants and 
carcinogens, which are to be found in the smoke, by shisha smokers, non-smokers who 
socialize with the smokers will also inhale large quantities of these harmful volatiles 
through passive smoking.  
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Further work on shisha is needed to monitor public and occupational exposure in 
Shisha bars under the COSHH Regulations (Control of Substances hazardous to health 
regulations). This may indicate a need for guidelines to improve the ventilation in local 
Shisha bars. Such guidelines and regulations must be implemented to inform workers and 
customers of shisha bars of the effects that are potentially hazardous to human health. 
Nakkest et al., report that a detailed labelling system is required on the shisha paste or 
related accessories for health awareness of the potential risk of Shisha smoking [102].  
     This study suggests that, future epidemiological studies on potential diseases 
associated with VOCs produced by shisha smoking are required to investigate the damage 
caused by shisha smoking. In addition to that, investigations of shisha smokers’ breath 
could be done using pre and post hookah smoke session to investigate the uptake of 
VOCs. 
     In summary, our research has shown that shisha pipe smoking results in the 
exposure to a large variety of VOCs some of which are toxic and/or carcinogenic. The 
findings of this study have a number of important implications to the health of shisha 
smokers. At the very least we have shown that shisha smoking is not risk free.  




5 INVESTIGATION OF THE PRODUCT IONS 
RESULTING FROM THE REACTIONS OF H3O+ WITH 
VANILLIN, MENTHOL AND ASSOCIATED COMPOUNDS 
(CYCLOHEXANOL, PHENOL, ANISOLE, 
BENZALDEHYDE AND GUAIACOL) 
5.1 Introduction  
This chapter is a direct follow-up from the previous one dealing with shisha. Flavour 
compounds are often used in shisha paste and this chapter deals with two expected 
flavour compounds (vanillin and menthol) in the vanilla and mint flavoured shishas. 
Originally this work was intended to be part of Chapter 4 to identify the product ions 
resulting from the reactions of H3O
+ with vanillin (C8H8O3) and menthol (C10H20O) and 
then to compare those to the shisha results. However, owing to the interesting product 
ions found for the two flavour compounds, we expanded the original study to include 
an investigation as to what happens to related compounds in the PTR-MS, namely 
cyclohexanol for comparison with menthol, and phenol, anisole, benzaldehyde and 
guaiacol for comparison with vanillin. Basically, we are systematically investigating how 
the proton transfer reaction changes as functional groups are changed.  
 Although the shisha study was undertaken at 120 Td, for completeness, we 
investigated the intensity of the product ions as a function of the reduced electric field 
(E/N) from 80 to 220 Td. 
The two compounds being investigated are also of interest to food sciences owing 
to their common use as food flavouring. Vanillin (4-hydroxy-3 methoxybenzaldehyde) is 
an organic natural compound which is widely used as a common flavouring compound 
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in foods, drinks and fragrances [103]. It is the key compound of vanilla flavour with 1-
2% in cured vanilla pods [104] . Vanillin can be extracted from vanilla beans, but the 
process is labour intensive and hence expensive. To reduce production costs there are a 
number of different biotechnical synthesis routes to produce vanillin flavoured products, 
which have been on the market for more than a decade. The synthesis involves different 
types of chemical and microorganisms’ processes to produce the familiar vanilla flavour. 
Menthol is also commonly used to flavour foods, but it also finds use as an active 
decongestant in drugs. Menthol is readily available as an extract from peppermint, mint 
oils and corn mint. Cigarette companies use menthol flavouring to attract young adults to 
smoking, in part because of the misconception by young people that smoking menthol 
cigarettes reduces the tar consumed and is less harmful [105], and we can assume that 
this follows for shisha. 
To our knowledge this is the first PTR-MS study of vanillin. In comparison there 
have been two PTR-MS studies investigating menthol [106, 107]. The first by Saint-Eve 
et al. reported product ions at a fixed E/N of 140 Td. The second, by Gordon et al. present 
an E/N study over the range of approximately 90-140 Td involving L-menthol powder. 
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5.2 Experimental Details 
Table 5.1 shows the details (Chemical formula, CAS number, vapour pressure and 
chemical structure) for menthol, vanillin and the associated compounds. With the 
exception of benzaldehyde and guaiacol, the chemicals used in this study were purchased 
from Sigma Aldrich (UK). Benzaldehyde and guaiacol were purchased from Alfa Aesar. 
All chemicals were used without further purifying.  
For each compound (menthol and vanillin), 1 mg samples were placed into 20 ml 
glass vials. The motive of using vials is because the samples were in crystal form. The 
inlet of a vial containing the compound was connected to a hydrocarbon filter via a 1/8th 
inch peek tube and nitrogen gas was then flowed through the trap. (Nitrogen was used 
rather than laboratory air to avoid any possible background contamination from the 
environment that is not trapped by the filter.) The outlet of the vial was connected to the 
PTR-ToF-MS (Kore Technology, Ltd) inlet using peek and Teflon tubes (see figure 5.1). 
A tee piece was used to exhaust any excess gas in order to maintain a constant drift tube 
pressure. For the vanillin sample, the vials were wrapped with a heating tape to increase 
their temperature to 80 o C. This was needed because vanillin has a low vapour pressure 
at room temperature. The concentrations of menthol and vanillin in the drift tube were 
sufficiently low to ensure that there was no depletion of the reagent ion signal or pulse 
counting saturation. For the associate compounds, tedlar bags were filled with nitrogen 
gas flow using a teflon tube with similar settings. 
A background mass spectrum for each reduced electric field was taken before the 
measurements with any compound were done, which was then subtracted from that 
obtained from the vial containing the sample.  
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Table 5.1 Information on compounds in this experiment, including vapour pressure and 
purity. 
Molecular 













































































 0.103 at 20 °C  
 
 






Figure 5.1 Experimental set up for headspace measurement of menthol, vanillin and 
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5.3 Results and Discussion 
5.3.1 Headspace of associated compounds (Cyclohexanol, Phenol, Anisole, 
Benzaldehyde, Guaiacol) 
 
5.3.1.1 The reaction of cyclohexanol with H3O+ 
The proton affinity of cyclohexanol is unkown. However, in this investigation we have 
not only observed the protonated parent, indicating that the proton affinity of 
cyclohexanol is greater than water, but that the proton transfer can be non-dissociative 
and dissociative. This is illustrated in figure 5.3 which shows a mass spectrum resulting 
from the reaction of H3O
+ with cyclohexanol at 120 Td. Table 5.2 provides the details of 
product ion branching ratio as a percentage for cyclohexanol also at 120 Td. Seven 
product ions are identified as C4H7
+ (m/z 55), C3H5O
+ (m/z 57), C5H7 (m/z 67), C6H9
+ (m/z 
81), C6H11
+ (m/z 83), C6H11O
+ (m/z 99) and C6H13O
+ (m/z 101). At 120 Td, C6H11
+ (m/z 
83) is found to be the major product ion resulting from the loss of a water molecule (H2O) 
from the protonated parent. Hence, using high resolution KORE PTR-ToF-MS, it could 
be resulting from C5H7O
+ with loss of CH4 and H2 but the measured peak position was 
83.086 which is close to C6H11
+. This agrees with a PTR-Quad-MS study reported by 
Brown [72]. In agreement with this Jürschik et al., observed m/z 83 as a main product ion 
at 130 Td [108]. At 115 Td he reported that the product ion branching ratio is 76%. In 
addition to this product ion, he reports C6H11O
+ (m/z 99) (corresponding to a loss of H2 
from the protonated parent), where we found the similar measured value of 99.08, thus 
no ambiguity in that assignment and C4H7
+ (3%) (resulting from a sequential loss of H2O 
and C2H4 from the protonated parent) [109], where it can be also assigned as C3H3O
+ 
(55.02). However, the measured value was close to C4H7
+. m/z 57 can be assigned as 
C3H5O
+ (57.034) or C4H9
+ (57.070) but we found that the measured mass was close to 




+ (57.03). Meanwhile for m/z 67 (C5H7
+, 67.05), 81 (81.070) and 101 (101.096), 
there is no uncertainty on that assignments because their exact masses are close to the 
measured value. 
Figure 5.4 illustrates how the product ion distributions vary as a function of the 
reduced electric field. m/z 83 (C6H11
+) is the dominant ion from 80-150 Td. Meanwhile, 
m/z 55 (C4H7
+) is the dominant ion from 160-220 Td. m/z 81 is only observed from 130 
Td–220 Td.                              
In our study we observed the protonated parent (m/z 101) for all of E/N (180-220 
Td), but with a low intensity. Brown reported no protonated monomer [109]. 
Winterhalter has mentioned that the protonated parent at m/z 101 is unstable and decays 
to protonated cyclohexene [C6H11]
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m/z 55 (water cluster)
 
Figure 5.3 A mass spectrum illustrating the product ions from the reaction of H3O
+ with 
cyclohexanol whilst operating the drift tube at reduced electric field of 120 Td for 10 
second integration time.  
 
 
Table 5.2 m/z values of the product ions and neutral species and their branching ratio 
percentages resulting from the reaction of cyclohexanol with H3O
+ at a reduced electric 

















+ C2H4+H2O 7 
57 C3H5O
+ C2H4+ CH4  3 
 67 C5H7
+ CH4+ H2O  3 
 81 C6H9
+ H2+H2O  1 
 83 C6H11
+ H2O  74 
 99 C6H11O
+ H2  10 
 101 C6H13O
+ - 2 
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Figure 5.4 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of H3O
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5.3.1.2 The reaction of phenol with H3O+ 
The proton affinity of phenol is high, at 817 kJ mol-1 [24]. Therefore, we could expect 
substantial dissociative transfer resulting from the reaction with H3O
+. However, that is 
not the case. Instead the dominant product ion is the protonated parent, as illustrated in 
figure 5.5, which shows the mass spectrum taken at 120 Td. Figure 5.6 presents the 
product ion branching ratio in percentages as a function of the reduced electric field and 
Table 5.3 provides the information about the branching ratio contribution for each of the 
product ions at 120 Td. Only two product ions were observed. In addition to the 
protonated parent, an ion at m/z 77 (C6H5
+) corresponding to the loss of H2O from the 
protonated parent, but only is observed for reduced electric fields above 160 Td. m/z 77 
could be assigned as C6H5
+ (77.04) or C5HO
+ (77.003). However, using high resolution 
KORE-ToF-MS, the measured value was close to the exact mass of C6H5
+. 
In agreement with our study, in a previous study looking at phenol by Feilberg et 
al., they reported only the protonated parent ion m/z 95 at 138 Td [111], . In another more 
recent PTR-MS study covering the rage 48-144 Td, Romano et al., also only observed the 
protonated parent at all reduced electric field values except at 48 Td where association of 
the protonated parent with water was observed [112]. This agrees with our observations.  
Figure 5.6 shows how the product ion distributions vary as a function of the 
reduced electric field. m/z 95 (C6H7O
+) is the dominant ion from 80-220 Td. Its branching 
ratio decreases as the channel resulting from the loss of water opens. 
 






















Figure 5.5 A mass spectrum illustrating the product ions from the reaction of H3O
+ with 
phenol whilst operating the drift tube at reduced electric field of a) 120 Td b) 220 Td for 
10 second integration time. There are some impurities recorded from the sample. m/z 77 
can be seen at 220 Td. 
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Figure 5.6 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of H3O
+ with phenol (C6H12O) from 150-220 Td.  
 
Table 5.3 m/z values of the product ions and neutral species and their branching ratio 
percentages resulting from the reaction of phenol with H3O
+ at a reduced electric field 
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5.3.1.3 The reaction of anisole with H3O+ 
To our knowledge, this is the first PTR-MS study of anisole. As for phenol, anisole has a 
large proton affinity. Its value is 840 kJ mol-1 [24]. This means that proton transfer is not 
only efficient, but it is highly exothermic. So again we could expect dissociative proton 
transfer to dominate. But in fact that again is not the case. 
 Figure 5.7 shows the overview of the whole spectrum reaction of anisole with 
H3O
+. Figure 5.8 shows the branching ratio in percentages as the function of reduced 
electric field (80-200Td). Only two product ions are found. One of them is the protonated 
parent at m/z 109 (C7H9O
+). The other is at m/z 94 and is assigned to be C6H6O
+. 
Unusually this means a loss of a radical, CH3 from the protonated parent. The branching 
ratios for m/z 109 (C7H9O
+) and m/z 94 (C6H6O
+) at 120 Td are 97 % and 3%, respectively 
(table 5.4). There is no uncertainty on assigning the product ion. 
Figure 5.8 illustrates how the product ions distributions vary as a function of the 
reduced electric field. For all values of E/N the dominant ion is C7H9O
+. Its branching 
ratio decreases owing to more fragmentation as the collisional energies of both the reagent 
ions and product ions increase with increasing E/N.  
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Figure 5.7 A mass spectrum illustrating the product ions resulting from the reaction of 
H3O
+ with anisole whilst operating the drift tube at reduced electric field of 120 Td. An 
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Figure 5.8 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of H3O
+ with anisole (C7H8O) using PTR-ToF-MS (8000). 
 
Table 5.4 m/z values of the product ions and neutral species and their branching ratio 
percentages resulting from the reaction of anisole with H3O
+ at a reduced electric field 
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5.3.1.4 The reaction of benzaldehyde with H3O+ 
The proton affinity of benzaldehyde is 834 kJ mol-1[ [24]]. Like the previous two 
molecules the protonated parent is a prominent product ion. However, unlike the previous 
two molecules, it does not dominate for all of the reduced electric fields investigated. 
Instead after about 170 Td, dissociative proton transfer processes dominate. Figure 5.9 
represents the mass spectrum of benzaldehyde at 120 Td. Figure 5.10 shows the branching 
ratio of benzaldehyde as a function of reduced electric field from 80 Td - 220 Td and table 
5.5 provides the details of product ions and their branching ratios at 120 Td. 
Four product ions are observed at m/z 77 (C6H5
+), m/z 79 (C6H7
+), m/z 105 
(C7H5O
+), m/z 107 (C7H7O
+). With the high resolution KORE-ToF-MS, m/z 77 could be 
assigned either as C6H5
+ (77.04) or C5HO
+ (77.003). In this study, m/z 77 was close to 
(C6H5
+) with loss of CO and H2. Similarly, the ion at a nominal m/z 79 could be assigned 
to be C6H7
+ (79.06) which was close to the exact mass of 79.06 with loss of CO and H2O. 
There was no other ambiguity in the assignment of other product ions. 
Among these ions, m/z 107 is the dominant ion at 120 Td where it contributes 91 
% to the branching ratio. The second most abundant ion at 120 Td is m/z 105 (6 %) 
followed by m/z 79 (3 %). m/z 77 only is significant above 180 Td.  
There has only been one other PTR-MS study of benzaldehyde by Maleknia et al. 
[12] who reports the product ions at an unspecified reduced electric field. They reported 
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Figure 5.9 A mass spectrum illustrating the product ions from the reaction of H3O
+ with 
benzaldehyde whilst operating the drift tube at reduced electric field of 120 Td. An ion 
resulting from an impurity is highlighted. 
 
Figure 5.10 shows how the product ion distributions vary as a function of the reduced 
electric field. m/z 107 (C7H7O
+) is the dominant ion from 80-160 Td. Its branching ratio 
decreases as more fragmentation occurs as the collisional energies of both the reagent 
ions and product ions increase with increasing E/N. For example m/z 79 (C6H7
+) and m/z 
77 (C6H5
+) branching ratios start to increase from 140 Td and 180 Td respectively. 
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Figure 5.10 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of H3O
+ with benzaldehyde (C7H6O). 
 
Table 5.5 m/z values of the product ions and neutral species and their branching ratio 
percentages resulting from the reaction of benzaldehyde with H3O
+ at a reduced electric 


















+ CO+H2 0 
79 C6H7
+ CO          3 
 105 C7H5O
+ H2  6 
 107 C7H7O
+ - 91 
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5.3.1.5 Guaiacol reaction with H3O+ 
This study represents the first PTR-MS study of guaiacol. The proton affinity of guaiacol 
is unknown. However, it must be higher than water, given the observed efficiency of the 
reaction and the formation of various product ions. Figure 5.11 shows the mass spectrum 
of guaicol at 120 Td and figure 5.12 shows the product ion branching ratios in percentages 
as a function of reduced electric field. There are eight product ions observed resulting 
from the reaction of guaiacol with H3O
+ at m/z 65 (C5H5
+), m/z 77 (C6H5
+ ), m/z 79 
(C6H7
+), m/z 81 (C5H5O
+), m/z 93 (C6H5O
+), m/z 107 (C6H3O2
+), m/z 110 (C6H6O2
+) and 
m/z 125 (C7H9O2
+) (table 5.6). m/z 110 represents a loss of CH3 from the protonated 
parent. The loss of a free radical is unusual in proton transfer reactions. This will have to 
be investigated with quantum mechanical calculations to help in the interpretation as to 
how that can occur. The ion at a nominal m/z 107 could result from a loss of H2O or CH4 
and H2. However, using the high resolution capabilities of the KORE PTR-ToF-MS, the 
peak position can be measured accurately, and that comes to m/z 107.012. C7H7O
+ has an 
exact m/z of 107.050, whereas that for C6H3O2
+ is at the exact value of 107.013. Thus we 
can assign the product ion at a measured m/z of 107.012 as C6H3O2
+. There is thus no 
ambiguity in that assignment. Similarly the ion at the nominal m/z 93 has a measured 
value of 93.03, which means it is C6H5O
+ and not C7H9
+, which has an exact m/z of 
93.070. Similarly, the ion at a nominal m/z 79 could be assigned to be C5H5O
+, but that 
would lead to an exact m/z of 79.02, whereas the measured value is 79.05 in good 
agreement with the exact m/z for C6H7
+. The ion at nominally m/z 65 could either C5H5
+ 
or C2H9O2
+, but the measured value is closer to the exact m/z for C5H5
+. 
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The most abundant product ion at 120 Td is m/z 125 (99 %), which is the 
protonated parent). The branching ratio of the protonated parent decreases gradually when 
the reduced electric field is greater than 130 Td.  
 



































          a) 
Chapter 5                                              Vanillin, menthol and associate compounds 
111 
 



































        b) 
Figure 5.11 A mass spectrum illustrating the product ions from the reaction of H3O
+ with 
guaiacol whilst operating the drift tube at reduced electric field of a) 120 Td b) 220 Td. 
Some impurities from the sample are recorded. 
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Figure 5.12 Product ion branching ratios in percentages as a function of E/N resulting  
 from the reaction of H3O
+ with guaiacol (C7H8O2). 
 
Table 5. 6 m/z values of the product ions and neutral species and their branching ratio 
percentages resulting from the reaction of guaiacol with H3O
+ at a reduced electric field 





















+ C2H4+O2 0 13 
77 C6H5
+ CH4+O2  0 3 
 79 C6H7
+ H2O+CO  0 10 
 81 C5H5O
+ CH4+CO  0 5 
 93 C6H5O
+ CO+H2O+H2  0 3 
 107 C6H3O2
+ CH4 + H2 0 2 
 110 C6H6O2
+ CH3  1 60 
 125 C7H9O2
+ -  99 13 
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5.3.2 The reaction of menthol with H3O+ 
For the E/N range investigated, no protonated parent was observed. Instead 
extensive fragmentation occurs following proton transfer from H3O
+ to menthol, as 
summarised in table 5.7, which presents the relative branching ratios for the product ions 
at 120 Td. Figure 6.13 presents the product ion branching percentages as a function of 
E/N. Meanwhile, figure 6.14 represents the mass spectrum of menthol at 120 Td. 
At 120 Td C5H7O
+ is found to be the major product ion observed. In comparison, 
a SIFT-MS study only observed one product ion, C10H19
+, which results from the 
elimination of H2O from the protonated parent [113]. That considerable fragmentation 
observed with the PTR-MS is a result of the increased collisional energies associated with 
reactions in the drift tube compared to the thermal collisional energies that occur in a 
SIFT. Substantial fragmentation in the drift tube of a PTR-MS was also observed in two 
previous PTR-MS studies of pure menthol [106, 107]. The first by Saint-Eve et al. used 
a PTR-Quad-MS system at a fixed E/N of 140 Td and reported product ions at m/z 81 
(100), 55 (62), 83 (42), 137 (22), and 139 (4) (relative intensities given in brackets, which 
are considerably different from those we recorded). The second investigation, by Gordon 
et al. presented E/N measurements over the range of approximately 90-140 Td identifying 
four product ions at m/z values of 55, 81, 83 and 139, with m/z 83 being the dominant one 
at 120 Td. The relative abundance of the product ions identified by Gordon et al. are in 
reasonable agreement with our values. However, we mention here that direct comparisons 
of relative intensities between different PTR-MS instruments have to be done with care 
owing to differences in the operating conditions for fixed E/N (e.g. temperature and 
humidity) and the differences in the transmission of ions from the drift tube to the transfer 
optics and then through the mass spectrometer, followed by any m/z detection efficiency 
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of the detector [114]. The key point of branching percentages is that they inform the user 
what should be detected for their own instrument under given operating conditions. 
From figure 5.13 it can be seen that at reduced electric fields higher than 120 Td, 
additional product ions are observed at nominal m/z values of 41, 53 and 79 corresponding 
to the product ions C3H5
+, C4H5
+ and C6H7
+, respectively. As the reduced electric field is 
reduced below about 100 Td, the dominant product ion is C10H19
+, which agrees with the 
thermal SIFT-MS observation. 


























































Figure 5.13 Product ion branching ratios in percentages as a function of E/N resulting 
from the reactions of menthol (C10H20O) in the reaction region of the PTR-MS as a 
function of E/N. 
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Figure 5.14 An illustrative mass spectrum illustrating the product ions resulting reactions 
with menthol in the drift tube of the PTR-MS at a reduced electric field of 120 Td. 
Table 5.7 m/z values of the product ions and their branching ratio percentages resulting 
from the reaction of menthol (C10H20O) with H3O






Neutral product Branching 
ratio % at 120 
Td 
55 C4H7
+ C6H14O 3 
57 C4H9
+ C6H12O 16 
69 C4H5O
+ C6H16 3  
81 C5H5O
+ C5H16 8 
83 C5H7O
+ C5H14 50  
97 C6H9O
+ C4H12 5  
139 C10H19
+ H2O 14 
155 C10H19O
+ H2 1 
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5.3.3 The reaction of vanillin with H3O+ 
Figure 5.15 represents the branching ratio of the product ions of vanillin at 120 Td and 
figure 5.16 represents the mass spectrum of vanillin at 120 Td. In comparison to menthol, 
vanillin shows little fragmentation from reactions in the drift tube of the PTR-MS. The 
protonated parent at the nominal m/z of 153 dominates throughout the E/N range 
investigated, as illustrated in figure 5.15 which provides the product ion branching 
percentages as a function of E/N. For all values of the reduced electric field another 
product ion is observed at m/z 125, the measured peak position of which indicates it to be 
C7H9O2
+, which results from the loss of CO from the protonated parent. Only for E/N 
values greater than about 160 Td is a third product ion observed, which is assigned to be 
C5H5
+. That the protonated parent is the dominant product ion agrees with an earlier study 
by Heenan et al., who report m/z 153 as the only product ion resulting from the reaction 
of H3O
+ with vanillin in their vanilla food flavour studies [101]. 
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Figure 5.15 Product ion branching ratios in percentages as a function of E/N resulting 
from the reactions in the drift tube of the PTR-MS with vanillin (C8H8O3).  
 
Figure 5.16 A mass spectrum resulting from the reaction of H3O
+ with vanillin at 
reduced electric field of 120 Td. 
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Table 5.8 Proposed product ions, neutral products and relative intensities resulting from  
the reaction of vanillin with H3O
+ at 120 Td. 
 
5.3.4 Comparisons of vanillin and menthol with other compounds – similarities  
An aim of the studies associated with vanillin and menthol was to see if these compounds 
are used in the shisha paste for vanilla and mint flavours, respectively. 
5.3.4.1 Menthol with cyclohexanol 
All of the product ions identified with menthol have been observed in the shisha paste 
such as m/z 55, m/z 57, m/z 69, m/z 81, m/z 83, m/z 139, m/z  97, m/z 155. 
5.3.4.2 Vanillin with phenol, anisole, benazaldeyhde and guaicol 
However, for vanillin no product ions associated with this compound were observed. 
These results agree with the GC-MS studies, which were undertaken after that of the 








Product ion  
molecular 
formula 
Neutral product Relative intensity 
at 120 Td (%) 
 
65 C5H5
+ C3H4O3 - 
125 C7H9O2
+ CO 7  
153 C8H9O3
+                                 93  




One of the more significant findings to emerge from this study is that of identifying the 
product ions from menthol and vanillin. For mint shisha paste, we found some similar 
product ions which were associated with menthol such as m/z 57, 69, 83, and 139 and 
suggested that menthol was used in mint shisha paste. Whereas, for vanilla shisha paste, 
there were no associated product ions monitored from vanillin. In addition to that, also 
some associate compounds to menthol and vanillin were measured using a different 
functional group such as cyclohexanol, phenol, anisole, benzalaldehyde and guaiacol 
which have a benzene ring. The finding from the headspace of cyclohexanol has shown 
that it has a very strong link with menthol. Meanwhile for vanillin, guaicol was the only 
compound which produced associate ions. Guaiacol is an artificial vanillin. However, 
guaiacol was not found from the GC-MS measurement. This needs further investigation.




6 PTR-TOF-MS STUDIES OF THE REACTIONS OF H3O+ 
AND O2+ WITH THE GENERAL ANAESTHETIC GASES 
HALOTHANE, ISOFLURANE, ENFLURANE, 




Halogenated anaesthetics have been used in surgical procedures for decades so that 
patients do not feel pain. But interestingly, there is little information as to how long these 
anaesthetics stay in the body post-surgery. 
To our knowledge there are only two studies associated with the retention of 
general anaesthetics in the body. The first by Yasuda et al. investigated the kinetics of 
isoflurane and sevoflurane administered to healthy young men. According to their 
investigation, there was a fast elimination of isoflurane from the body of the volunteers 
[6]. A later study by Fernández del Río et. al. (2015), but actually dealing with severely 
ill patients undergoing liver transplants, showed that the anaesthetic being used during 
surgery, isoflurane, remained in their bodies for weeks after this major operation [5]. 
If correct, the study by Fernández del Río et. al. [5] could have consequences in 
terms of when cognitive function is fully restored to a patient, and hence further studies 
are required to investigate elimination characteristics.  
Studies are therefore currently being planned in the Molecular Physics Group, 
University of Birmingham, and at the Breath Research Institute in Austria to continue the 
work of Fernández del Río et al. by undertaking longitudinal studies to determine the loss 
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of inhaled anaesthetics from the body following surgery. Concentrations of the 
anaesthetics and their metabolites in exhaled in breath will be determined as a function 
of time. The objective of those studies is to determine the factors which affect washout, 
such as the health, sex and age of the patient, the ASA (American Society of 
Anaesthesiologists) classification of the patient (1-4), the timing and dose of anaesthetics, 
and the type and length of the surgery.  
Previously published studies by Wang et al. have used a selected ion flow tube 
(SIFT) to analyse the reactions of H3O
+, NO+ and O2
+ with anaesthetic gases e.g. 
halothane, isoflurane and sevoflurane by observing these gases via on-line breath 
monitoring [115]. In this study, the PTR-MS was used in all the experiments. 
Comparisons between the SIFT-MS and PTR-MS results will be presented here. IMS and 
PTR-MS analytical instruments are being proposed to measure the concentrations of these 
compounds in the breath. However, before any of those studies can be undertaken, 
specific knowledge of reduced ion mobilities (IMS) and product ions (PTR-MS) are 
required. Furthermore, for applications of PTR-MS, it is important to determine what is 
the best operational reduced electric field to use to maximise sensitivity and specificity. 
A key aim of the study presented in this chapter is to determine the product ions 
resulting from the reactions of H3O
+ and O2
+ with a number of volatile halogenated 
anaesthetics, namely halothane, isoflurane, enflurane, sevoflurane, desflurane and 
methoxyflurane, with a major focus on the most commonly used ones, isoflurane and 
sevoflurane, as a function of reduced electric field for use in the later studies being 
planned.  
In Birmingham the key apparatus used was a KORE PTR-ToF-MS and in Austria 
an IONICON PTR-TOF 8000. It is important to ascertain the product ions separately, 
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because studies undertaken within the Molecular Physics Group have shown that the 
product ion branching ratios are very much instrument dependent. A full investigation as 
to why these differences occur is outside the goals of this PhD, but they are related to 
differences in ion production (e.g. internal energy of the reagent ion) and ion transmission 
properties, in the drift tube, the transfer optics to the mass spectrometer, and mass 
spectrometer.  
Here, the results from these investigations were reported and hence provided a 
library of product ions that can be used to determine the concentrations of inhaled 
anaesthetics in the breath of patients for two types of PTR-MS systems (the most 
commonly used ones).  
We will also show that the isomeric compounds isoflurane and enflurane can be 
distinguished.  
Finally, density function calculations for isoflurane and enflurane, undertaken by 
Dr Peter Watts of the Molecular Physics Group as part of this study, are also included to 
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6.2 Anaesthetics Details  
The details about the anaesthetic compounds purchased from Sigma Aldrich (UK) and 
for one compound (Methoxyflurane), from Alfa Aesar are listed in table 6.1 and used 
without further purification. 
1 μl samples were taken and placed into a 100 ml glass bottle. A sample of the 
headspaces was then taken (10 ml) using a 100 ml glass syringe which was coupled to the 
top part of the bottle using a luer-lock stopcock. The withdrawn samples were then diluted 
with 90 ml of clean air. The concentration of the anaesthetics was monitored closely to 
avoid depletion of H3O
+ and O2
+. Background spectra for each reduced electric field were 
obtained which were subtracted from the compound spectra. The drift tube pressure was 
set at 1 mbar and the glow discharge pressure set at 1.3 mbar. The drift tube and hollow 
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Table 6.1 Details of the anaesthetic compounds investigated in this thesis.  
Anaesthetic 
Molecuar weight in 
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6.3 Results and Discussion 
6.3.1 Halothane  
6.3.1.1 Reaction with H3O+ 
An early SIFT-MS study by Wang et al. [115] has shown that there is no bimolecular 
reaction of H3O
+ with halothane. Hence the proton affinity of halothane must be less than 
that of water and when proton transfer does occur the protonated species does not 
fragment within the lifetime between collisions with the water molecules. Instead these 
authors observed that the reaction proceeds through a three body process leading to 
H3O
+.CFCHClBr as the product ion. With PTR-MS, endothermic bimolecular processes 
may be driven by the electric field. However, there were no such interactions with 
halothane observed, nor association processes observed owing to the collisional effects 
in the PTR-MS.  
6.3.1.2 Reaction with O2+ 
The ionization energies of O2 and halothane are 12.07 eV and 11.2 eV, respectively [116]. 
Therefore, charge transfer is exothermic by about 0.9 eV. Table 6.2 summaries the results 
of the charge transfer reactions of halothane with O2
+ at 140 Td for measurements taken 
on the KORE PTR-ToF-MS in comparison to those obtained in the SIFT-MS studies by 
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Table 6.2 m/z values of the product ions and their branching ratio percentages resulting 
from the reaction of halothane with O2
+ at a reduced electric field of 140 Td using the 


















+ CFClBr 4 - 
67+69 CHFCl+ CF2Br  18 - 
69 CF3
+ CHClBr  5 - 
117+119 C2HF3Cl 
+ Br  9 20 
127+129+131 CHClBr+ CF3  3 5 
161+163 C2HF3Br
+ Cl  - 5 
 176+178+180 C2F2ClBr
+ HF 58 10 
 196+198+200 C2HF3ClBr
+ - 3 60 
 
The O2
+ reactions occur via charge (electron) transfer producing an excited parent 
cation, (M+)*. The majority of these fragments produce seven product ions, and only a 
small signal is observed for the non-dissociative charge transfer channel, even at the 
lowest E/N. These seven product ions were observed in order of increasing m/z (using the 
lightest isotopomer) at m/z 51 (CHF2




+) and 196 (C2HF3ClBr
+). The most abundant product ion at 
140 Td was found to be at m/z 176 (58%). Figure 6.1 provides an overview of the 
complete spectrum recorded, including the product ions and other ions present in the drift 
tube and figure 6.2 (a)-(e) shows the product ions in more detail.   
Unsurprisingly, our product ion distributions and types of ions differ from those 





+). According to them, 
the most abundant ion is the protonated parent ion m/z 196 (C2HF3ClBr
+). In PTR-MS at 
140 Td, m/z 176 is the dominant ion corresponding to the loss of HF from C2HF3ClBr
+. 
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With the exception of m/z 161, the same ions were observed as the SIFT, but some 
additional ones too, and with different branching percentages. These differences are 
simply a result of the differences in the techniques; namely, because SIFT-MS reactions 
are at thermal energies, whereas the PTR-MS reactions are not. Some other ions also were 
observed in low intensities less than 1% such as m/z 79 (Impurity), m/z 85 (Unknown), 
m/z 95 (Unknown), m/z 97 (Unknown) and m/z 99 (Unknown) after the sample was 
introduced, but that they could not be associated to halothane, and hence are considered 
to result from an impurity. Also, the intensities of the peaks were not overlapping with 
the expected isotope peaks and agree with the isotope ratios. 












































Figure 6.1 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of O2
+ with halothane (C2HClF3Br) whilst operating the drift tube at a reduced 
electric field of 140 Td. Other ions such as the reagent ion O2
+ and an impurity ion (NO2
+) 
coming from the ion source are also highlighted. Note that the recombination energy of 
NO2
+ is 9.6 eV, and hence cannot charge transfer to halothane given that the (adiabatic) 
ionisation potential for halothane is 11.0 eV, and hence is not of concern to us. 






































































































































































































Figure 6.2 Spectra illustrating the complete set of product ions (including isotopes) 
observed following the reaction of O2
+ with halothane, and in order if increasing m/z a) 
m/z 67(CHF35Cl+) and m/z 69 (CHF37Cl+/ CF3
+) b) m/z 117 (C2HF3
35Cl +) and m/z 119 
(C2HF3
37Cl+) c) m/z 127(CH35Cl79Br+) , m/z 129 (CH35Cl81Br+/CH37Cl79Br) and m/z 
131(CH37Cl81Br+) e) m/z 176 (C2 F2
35Cl79Br+), m/z 178 (C2 F2
35Cl81Br+/ C2 F2
37Cl79Br+) 
and m/z 180 (C2 F2
37Cl81Br+) and f) m/z 196 (C2HF3
35Cl79Br+), m/z 198 (C2HF3
35Cl81Br+/ 
C2HF3
37Cl79Br+) and m/z 200 (C2HF3
37Cl81Br+). 
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Figure 6.3 illustrates how the product ion distributions vary as a function of the reduced 
electric field. For all values of E/N the dominant ion is C2F2ClBr
+, but its branching ratio 
decreases owing to more fragmentation as the collisional energies of both the reagent ions 
and product ions increase with increasing E/N. 









+(69) CHFCl+(67+69)  C2HF3Cl
+
(117+119)
























E/N (Td)  
Figure 6.3 Product ion branching percentages as a function of E/N resulting from the 
reaction of O2











6.3.2.1 Reaction with H3O+  
Figure 6.4 shows the full mass spectrum of isoflurane and figure 6.5 shows the mass 
spectrum of each product ion in more detail at 140 Td. The product ion branching 
percentages at 140 Td are presented in table 6.3 for measurements undertaken on the 
Birmingham KORE PTR-ToF-MS and an IONICON PTR-TOF 8000. The values 
displayed took into account isotopic abundances. Also presented in table 6.3 are published 
values of product ion percentages recorded using an IONICON PTR-Quad-MS 
(Fernandez del Rio et al. [2]), unpublished results from a PTR-TOF 8000 (kindly recorded 
by Michaela Malásková from the Institute of Breath research, University of Innsbruck, 
Austria, for reasons given below) and results from a SIFT-MS study [117]. 
 Seven product ions resulting from the reaction of isoflurane with H3O
+; 
namely (using the lightest isotopomer) m/z 51 (CHF2
+), m/z 67 (CHFCl+), m/z 115 
(C2H2F2ClO
+), m/z 117 (C2HF3Cl
+), m/z 145 (C3HF3ClO
+), m/z 163(C3F4ClO
+) and m/z 
165 (C3H2F4ClO
+). The most intense product ion observed at 140 Td is m/z 67 (40 %) and 
this is followed by m/z 51 (31%) and m/z 117 (16%). The full product ion branching 
percentages over an E/N range of 80 to 220 Td are provided in figure 6.6. The product 
ion branching ratios for CHF2
+ and CHFCl+ increase as the reduced electric field 
increases. However, the branching ratios for other product ions decrease as the reduced 
electric field increases as the result of more fragmentation occurring as the collisional 
energies of both the reagent ions and product ions increase with increasing E/N. 
 The only other published PTR-MS study is by Fernandez del Rio et al. [72], who 
used an Ionicon PTR-Quad-MS, and covered the range of reduced electric fields from 95 
to 140 Td, finding identical ions to ours, other than C3HF3ClO
+ which was not observed 
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by them. This is surprising given its relatively good branching percentage at low E/N. 
However, at an E/N of 140 Td the branching percentage associated with this channel is 
small, and hence the branching percentages of the ions measured by the PTR-Quad-MS 
and KORE PTR-ToF-MS at 140 Td should be similar. Certainly, there are some 
similarities. For example, the most abundant ion at 140 Td in Fernandez del Rio et al. 
study is at m/z 67 (CHFCl+) (50%), which is consistent with our results, although with a 
lower percentage at 40%. The rest of the ion branching percentages are, however, 
significantly different. This is illustrated at 140 Td in table 6.3, which compares the results 
of our measurements with those of Fernandez del Rio et al. These disparities in the 
branching percentages between the two studies must result from differences in the 
transmission properties of the mass spectrometers (quadrupole versus ToF), the efficiency 
of the detectors and the transfer optics of the two instruments as a function of m/z.  
 This significant difference in product ions between PTR-MS instruments is an 
important issue and has only recently been raised as an issue in the literature [118]. To 
ascertain whether there is a difference between different PTR-ToF-MS instruments, 
isoflurane measurements at 140 Td on an IONICON PTR-ToF-8000 was undertaken. 
The results are presented in table 6.3. From that table, it can be seen that the 
branching percentages qualitatively agree with each other, but quantitatively they 
are different. This must be a result again of differences in transmission and detection 
efficiencies between the two instruments. Another issue to consider is that little is 
known about the internal energy of the reagent ion. Owing to differences in its 
formation in the hollow cathode, it could enter the drift tube with different internal 
energies. Only one study so far has tried to investigate this [109] and in that study, 
it was found that product ion distributions change according to hollow cathode 
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current. The key message here is that the product ion branching percentages must 
be measured for individual instruments in order to determine their sensitivities for 
analytical purposes. 
No protonated parent ion was detected in this study or the earlier PTR-MS study 
for any value of the reduced electric field. That no protonated parent was observed is in 
agreement with that found in the SIFT-MS studies by Wang et al., in which they found 
six product fragment ions at m/z 67 (CHF2O
+), m/z 99 (C2H2F3O
+), m/z 117 (C2HF3Cl
+) 
and m/z 119 (C2H3F4O
+), m/z 147 (C3H3F3ClO
+) and m/z 165 (C3H2F4ClO
+) [115]. That 
no protonated parent is observed is important, because our DFT (Density functional 
theory) calculations show that the proton affinity of isoflurane is close to that of water 
(Appendix 2). According to Dr Peter Watts’, DFT calculation (please see appendix 2), 
there are three sites for protonation on the isoflurane molecule. He also has shown the 
possible formation and fragmentation. 
These calculations are in agreement with the measurements of Wang et al.[115] 
who obtained a reaction rate coefficient (3.4 ×10-9 cm3 s-1) which is only slightly less than 
the collisional value (3.5 ×10-9 cm3 s-1). The difference implies that the reaction of H3O
+ 
with isoflurane is marginally endothermic, meaning that the proton affinity of isoflurane 
must be slightly less than that of water (by a few kJ/mol). Thus if the protonated parent 
did not fragment instantaneously then it would back react with the high concentrations of 
water in the PTR-MS drift tube, resulting in a lower observed signal (as found for example 
with protonated formaldehyde in a PTR-MS [1]), resulting in less sensitivity for its 
detection.  
In this study, there were no product ions associated with CHF2O
+(nominal m/z 
67), m/z 99, m/z 119 and m/z 147 (C3H3F3ClO
+) observed, with the latter confirmed from 
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the lack of any m/z 149 and the correct isotope abundance of our m/z 147 relative to m/z 
145 in our measurements. For m/z 67 (nominally) is not assigned to CHF2O
+ because m/z 
69 is seen in the correct isotope ratio expected for chlorine. Differences between SIFT-
MS and PTR-MS results can again be explained by the nature of the collisional energies 
involved in the two techniques and the types of detection mass spectrometers used (SIFT-
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Table 6.3 m/z values of the product ions and neutral species and their branching 
percentages resulting from the reaction of isoflurane with H3O
+ at a reduced electric field 
of 140 Td for a KORE PTR-ToF-MS, an IONICON PTR-Quad-MS, and an IONICON 
PTR-TOF 800 (Michaela Malásková, Institute of Breath research, University of 






























+ C2H2F3ClO 31 12 - 16 
 67 CHF2O
+ C2H2F3Cl
  - - 15 - 
184 67+69 CHFCl+ C2H2F4O 40 50 - 47 
 99 C2H2F3O
+ CHF2Cl  - - 10 - 
                                                                                                                                                                                                                                                                                        115+117 C2H2F2ClO
+ CF3 2 - - -
 117+119 C2HF3Cl
+ CH2F2O  16 6 30 28 
 119 C2H3F4O
+ CClF  - - 25 - 
 145+147 C3HF3ClO
+ C2F2Cl  1 - - - 
 147+149 C3H3F3ClO
+ F2  - - 10 - 
 163+165 C3F4ClO
+ HF + H2  2 24 - 7 
 165+167 C3H2F4ClO
+ HF 8 8 10 2 
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Figure 6.4 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of H3O
+ with isoflurane (C3H2F5ClO) whilst operating the drift tube at a reduced 
electric field of 140 Td. Other ions such as the protonated water dimer, m/z 37, and an 
impurity ion (NO2
+) coming from the ion source are also highlighted. (That observation 
shown there is no change in the NO2
+ signal with and without isoflurane, indicates that 
the ionisation energy of isoflurane is greater than that of NO2 (9.6 eV).) The ionisation 
energy of isoflurane is not available in the literature, but that for an isomeric form, 
enflurane, is, which is at 11.7 eV.  
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Figure 6.5 Expanded figure of the product ions resulting from the reactions of H3O
+ 
with isoflurane to illustrate their isotopic abundances for a) m/z 67 (CHF35Cl+ ) and m/z 
69 (CHF37Cl+) b) m/z 99 (C2H2F3O
+), m/z 115 (C2H2F2
35ClO+), m/z 117 
(C2HF3
35Cl+/C2H2F2
37ClO+) and m/z 119 (C2HF3
37Cl+) c) m/z 145 (C3HF3
35ClO+), m/z 
147(C3HF3
37ClO+ ), m/z 149 (Impurity), m/z 163 (C3F4
35ClO+), m/z 165 
(C3H2F4
35ClO+/C3F4
37ClO+) and m/z 167 (C3H2F4
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CHF2+(51) CHFCl+ (67+69) C2H2F2ClO+(115+117) 
C2HF3Cl
+(117+119) C3HF3ClO+(145+147) C3F4ClO+(163+165)  C3H2F4ClO+(165+167)
 
Figure 6.6 Product ion branching ratios in percentages as a function of reduced electric 
field (E/N) resulting from the reaction of H3O
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6.3.2.2 Reaction with O2+ 
Figure 6.7 presents the mass spectrum resulting from the reaction isoflurane with O2
+. 
The details of the product ions branching percentages at a reduced electric field of 140 
Td are presented in table 6.4. All the results take into account isotopic abundance. For 
comparison the results from the (Thermal) SIFT-MS study are also provided [117]. 
Eleven product ions were observed resulting from charge transfer; namely (and 
using the lightest isotopomer) m/z 51 (CHF2
+), m/z 67 (CHFCl+), m/z 99 (C2F3H2O
+), m/z 
115(C2H2F2ClO
+), m/z 117 (C2HF3Cl
+), m/z 145 (C3HF3ClO
+), m/z 149 (C3H2F5O
+), m/z 
163 (C3F4ClO
+), m/z 165 (C3H2F4ClO
+), m/z 181 (C3H2F4ClO2
+) and m/z 183 
(C3HF5ClO
+). All of these ions can be seen at 140 Td except C3H2F4ClO2
+. That is only 
observed at low E/N with a relatively low intensity. The most abundant product ions from 
this study at 140 Td are m/z 67 (CHFCl+) (36%), m/z 51 (CHF2
+) (23%) followed by m/z 
117 (C2HF3Cl
+) (11%). The details of the complete spectrum of isoflurane reaction with 
O2
+ is presented in figure 6.8 (a)-(d). 
In comparison to our observations, Wang et al. only report four product ions using 
SIFT. Their product ions are m/z 69 (CF3
+), m/z 99 (C2F3H2O
+), m/z 115 (C2H2F2ClO
+) 
and m/z 149 (C3H2F5O
+). The common ions found between Wang’s study and ours are at 
m/z 99 (C2F3H2O
+), m/z 115 (C2H2F2ClO
+) and m/z 149 (C3H2F5O
+), however with 
significantly different branching percentages. This is because ion-molecule reactions in 
the flow tube of a SIFT-MS are at thermal energies as has been mentioned in section 
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Table 6.4 m/z values of the product ions and their branching ratio percentages resulting 
from the reaction of isoflurane with O2
+ at a reduced electric field of 140 Td using the 




















+ C2HF3ClO  23 - 
C3H2F5ClO 67+69 CHFCl
+ C2HF4O  36 - 
m/z 184 69 CF3
+ C2H2F2ClO  - 10 
 99 C2F3H2O
+ CF2Cl  2 20 
 115+117 C2H2F2ClO
+ CF3  7 45 
 117+119 C2HF3Cl
+ CHF2  11 - 
 145+147 C3HF3ClO
+ HF2  2 - 
 149 C3H2F5O
+ Cl  6 25 
 163+165 C3F4ClO
+ H2F  6 - 
 165+167 C3H2F4ClO
+ F  6 - 
 181+183 C3H2F4ClO2
+ FO  0 - 
 183+185 C3HF5ClO
+ H  1 - 
 
 Also, in the study by Wang et al., the dominant ion was found to be C2H2F2ClO
+ (45 %) 
corresponding to a loss of CF3 from the charged parent, whereby in this study this product 
ion only has a branching percentage of 7 %.  
According to PubChem Chemistry database [119], the most dominant peak from 
70 eV electron impact (EI) technique is m/z 51 (CHF2
+) (100), followed by m/z 149 
(C3H2F5O
+) (~25) and m/z 117 (C2HF3Cl
+) (~20). Similar product ions were found from 
this stdy for isoflurane but the abundance of each ion are different. Then there are a large 
number of fragment ions (intensities less than 20) in the EI mass spectrum, which are not 
observed in our PTR-MS study owing to its softer ionisation process. EI which has been 
used in mass spectrometry leads to excess energy and extensive fragmentation. However, 
excessive fragmentation will cause difficulty in finding a peak which can be associated 
to the molecule especially for the parent ion.  
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Figure 6.7 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of O2
+ with isoflurane (C3H2F5ClO) whilst operating the drift tube at a reduced 
electric field of 140 Td. Other ions such as an impurity ion (NO2
+) coming from the ion 
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Figure 6.8 Expanded figure of the product ions resulting from the reactions of O2
+ with 
isoflurane to illustrate their isotopic abundances a) m/z 51 (CHF2
+), m/z 67 (CHF35Cl+) 
and m/z 69 (CHF37Cl+/ CF3
+) b) m/z 99 (C2H2F3O
+), m/z 115 (C2H2F2
35ClO+), m/z 117 
(C2HF3
35ClO+/C2H2F2
37ClO+) and m/z 119 (CHF3C
37Cl) c) m/z 145 (C3HF3
35ClO +), m/z 
147 (C3HF3
37ClO+) and m/z 149 (C3H2F5O
+) d) m/z 163 (C3F4
35ClO+), m/z 165 
(C3F4
37ClO+/C3H2F4
35ClO+), m/z 167 (C3H2F4
37ClO+), m/z 181 (C3H2F4ClO2
+) m/z 183 
(C3HF5
35ClO+) and m/z 185 (C3HF5
37ClO+). 
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Figure 6.9 represents how the product ion distributions vary as a function of the reduced 
electric field. CHF2
+ is the dominant ion from 110 Td-220 Td. The branching ratios for 
CHF2




+ decrease owing to increased fragmentation as the 
collisional energies of both the reagent ions and product ions increase with increasing 
E/N. 
 












































Figure 6.9 Product ion branching ratios in percentages as a function of E/N resulting from 
the reaction of O2
+ with isoflurane (C3H2F5ClO).  
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6.3.3 Enflurane  
Enflurane is a structural isomer of isoflurane, and therefore it is of interest to investigate 
if there are any changes in the ion-chemistry as a result of this, that could provide a 
method to distinguish one isomer from another.  
6.3.3.1 Reaction with O2+  
This is the first reported PTR-MS study of the reactions of enflurane, an isomer of 
isoflurane, with O2
+. The ionization energy of enflurane is 11.7 eV [4] whereas the 
recombination energy of O2
+ is 12.07 eV. Therefore, charge transfer is exothermic by 
only about 0.37 eV. In our study no parent ion was observed, instead there is enough 
energy in the reaction for dissociative charge transfer to occur. Figure 6.10 presents the 
mass spectrum resulting from the reaction of enflurane with O2
+ at 140 Td. Figure 6.11 
(a)-(e) shows the product ions at this reduced electric field in more detail.   
Table 6.5 summaries the results of the enflurane reactions with O2
+ at 140 Td for 
measurements taken on the KORE PTR-ToF-MS. Nevertheless, substantial dissociative 
charge transfer is observed, as highlighted in the table below (table 6.5). Seven product 
ions were observed, namely (and using the lightest isotopomer) m/z 51 (CHF2
+), m/z 67 
(CHFCl+), m/z 69 (CF3
+), m/z 98 (C2HF2Cl
+), m/z 113 (C2F2ClO
+), m/z 115 (C2H2F2ClO
+) 
and m/z 117 (C2HF3Cl
+). The most abundant ion at 140 Td is m/z 67 (CHFCl+) (table 6.5 
and figure 6.11) which contributes 32 % to the branching ratio. This is followed by CHF2
+ 
(27 %), C2HF2Cl
+ (26 %), and then the rest of the product ions contribute less than 5 %. 
Isoflurane reactions with O2
+ produced eleven product ions. Some identical ions 
from both measurement are m/z 51 CHF2
+, m/z 67 CHFCl+, m/z 115 C2H2F2ClO
+ and m/z 
117 C2HF3Cl
+. Also, some additional ions were found from isoflurane reactions with O2
+ 
compared to enflurane such as m/z 99 (C2F3H2O
+), m/z 145 (C3HF3ClO
+), m/z 149 




+, m/z 163 (C3F4ClO
+), m/z 165 C3H2F4ClO
+, m/z 181 C3H2F4ClO2






Table 6.5 m/z values of the product ions and their branching ratio percentages resulting 
from the reaction of enflurane with O2






















  27 
67+69 CHFCl+ C2HF4O  32 
69 CF3
+ C2F2OCl  4 
98+100 C2HF2Cl
+ CHF3O  26 
113+115 C2F2ClO
+ CH2F3  4 
 115+117 C2H2F2ClO
+ CF3 3 
 117+119 C2HF3Cl
+ CHF2O  4 
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Figure 6.10 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of O2
+ with enflurane (C3H2F5ClO) whilst operating the drift tube at a reduced 
electric field of 140 Td. Other ions present, such as an impurity ion coming from the 








Figure 6.11 Expanded figure of the product ions resulting from the reactions of O2
+ with enflurane to illustrate their isotopic 
abundances for a) m/z 51 (CHF2
+), m/z 67 (CHF35Cl+), m/z 69 (CHF37Cl+/CF3
+) and m/z 82 (Impurity) b) m/z 98 (C2HF2
35Cl+) and 
m/z 100 (C2HF2
37Cl+) c) m/z 113 (C2F2
35ClO+), m/z 115 (C2F2
37ClO+/C2H2F2
35ClO+), m/z 117 (C2HF3
35Cl+/C2H2F2
37ClO+) and m/z 
119 (C2HF3
37Cl+) d) m/z 131 (C3H3
35ClF3




+), m/z 135 (C2F4
35Cl+/C2H3
37ClF3O
+) and m/z 137 
(C2F4
37Cl+) e) m/z 145(C3HF3
35ClO+), m/z 147 (C3HF3
37ClO+), m/z 163 (C3F4
35ClO+), m/z 165 (C3H2F4
35ClO+/C3F4
37ClO+) and m/z 
167 (C3H2F4
37ClO+). 
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Figure 6.12 illustrates how the product ion distributions vary as a function of the reduced 
electric field. m/z 51 (CHF2
+) and m/z 67 (CHFCl+) are dominant ions from 150 Td to 220 
Td and their branching ratio increase owing to more fragmentation as the collisional 
energies of both the reagent ions and product ions increase with increasing E/N. 
 










































Figure 6.12 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of O2
+ with enflurane (C3H2F5ClO).
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6.3.3.2 Reaction with of H3O+  
This is the first reported PTR-MS study of the reactions of enflurane with H3O
+. Figure 
6.13 presents an overview of the mass spectrum resulting from the reaction of enflurane 
with H3O
+ at 140 Td including other ions present in the drift tube. Figure 6.14 shows the 
details of product ions. Figure 6.15 represents the product ion branching ratios in 
percentages as a function of E/N resulting from the reaction of H3O
+ with enflurane 
(C3H2ClF5O).  
Table 6.6 illustrates the main product ions of enflurane reactions with H3O
+. The 
results of this study show that there were nine product ions. The observed product ions 
are identified as (using the lightest isotopomer), m/z 51 (CHF2
+), m/z 67 (CHFCl+), m/z 
98 (C2HF2Cl
+), m/z 113 (C2F2ClO
+), m/z 115 (C2H2F2ClO
+), m/z 117 (C2HF3Cl
+), m/z 131 
(C3H3F3Cl
+), m/z 133 (C2HF3ClO
+) and m/z 163 (C3F4ClO
+) at 140 Td. The most intense 
product ion which has contributed 61 % at 140 Td is m/z 113. This is followed by m/z 131 
(12 %) and m/z 115 (11 %). The other product ions contributed less than 10 % of the 
branching ratios are m/z 67 and 163. The m/z 51(CHF2
+) branching ratio increased with 
the reduced electric field strength as the collisional energy increased. No protonated 
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Table 6.6 m/z values of the product ions and their branching ratio percentages resulting 
from the reaction of enflurane with H3O
+ at a reduced electric field of 140 Td using a 
KORE PTR-ToF-MS. The IONICON PTR-ToF-MS results are presented for comparison 























+ C2H2F3ClO  1 8 
67+69 CHFCl+ C2H2F4O  7 66 
98+100 C2HF2Cl
+ CH2F3O  <1 - 
113+115 C2F2ClO
+ CH3F3  61 11 
115+117 C2H2F2ClO
+ CHF3  11 1 
117+119 C2HF3Cl
+ CH2F2O  1 12 
131+133 C3H3F3Cl
+  F2O  12 - 
133+135 C2HF3ClO
+ CH2F2  2 - 
 163+165 C3F4ClO
+ H2 +HF  5 1 
      
 
In comparison to the KORE PTR-ToF-MS results, enflurane measurements with 
an IONICON PTR_TOF 8000 resulted in completely different branching ratios. 
Furthermore, no product ions were detected on the IONICON instrument at m/z 98 
(C2HF2Cl
+) m/z 131 (C3H3F3Cl
+), and m/z 133(C2HF3ClO
+) for any reduced electric field.  
However, it did not produce identical product ions. The similarities between these 
two compounds are m/z 51 (CHF2
+), m/z 67 (CHFCl+), m/z 115 (C2H2F2ClO), m/z 117 
(C2H2F2ClO) and m/z 163 (C3F4ClO
+). In comparison to isoflurane, enflurane has two 
additional product ions which are C2HF2Cl
+ and C2F2ClO
+.  
The density molecular calculation by Dr Peter Watts has given as some details 
about the possible four protonation sites for enflurane (please see Appendix 2 chapter 6).  
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Figure 6.13 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of H3O
+ with enflurane (C3H2F5ClO) whilst operating the drift tube at a reduced 
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Figure 6.14 Expanded figure of the product ions resulting from the reactions of H3O
+ 
with enflurane to illustrate their isotopic abundances a) m/z 67 (CHF35Cl+) and m/z 69 
(CHF37Cl+) b) m/z 98 (C2HF2
35Cl+) and m/z 100 (C2HF2




35ClO+), m/z 117 (C2H2F2
37ClO+/C2HF3
35Cl+) and m/z 119 
(C2HF3
37Cl+) d) m/z 131(C3H3F3
35Cl+), m/z 133 (C3H3F3
37Cl+/C2HF3
35ClO+) and m/z 
135 (C2HF3
37ClO+) e) m/z 163 (C3F4
35ClO+) and m/z 165 (C3F4
37ClO+) f) m/z 183 
(C3HF5
35ClO+) and m/z 185 (C3HF5
37ClO+). 
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Figure 6.15 illustrates how the product ion distributions vary as a function of the reduced 
electric field. m/z 113 (C2F2ClO
+) is the prominent ion from 110-180 Td but its branching 
ratio decreases owing to more fragmentation as the collisional energies of both the reagent 
ions and product ions increase with increasing E/N. 
 
 









CHF2+(51) CHFCl+ (67+69) C2HF2Cl+(98+100) C2F2ClO+(113+115)
C2H2F2ClO+(115+117) C2HF3Cl+ (117+119)  C3H3F3Cl+(131+133)  
























 Figure 6.15 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of H3O
+ with enflurane (C3H2ClF5O).  
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6.3.4 Sevoflurane  
6.3.4.1 Reaction with O2+  
Figure 6.16 shows the mass spectrum resulting from the reaction of sevoflurane with O2+ 
at 140 Td, and figures 6.17 (a)-(c) shows product ions in more detail to illustrate the 
isotopes.  
Table 6.7 gives the m/z values of the product ions, molecular formula and their 
branching ratio percentages at a reduced electric field of 140 Td. Four product ions were 
observed which are assigned (using the lightest isotopomer) to be m/z 51 (CHF2
+), m/z 
131 (C3H3 F4O
+), m/z 181 (C4H3F6O
+) and m/z 199 (C4H2F7O
+). Among these ions, the 
dominant product ion at 140 Td, which contributes 35 % to the branching ratio, is m/z 
131. The m/z 199, m/z 181 and m/z 51 contribute 28 %, 27 % and 10 %, respectively. m/z 
51(CHF2
+) branching ratio increases as the collisional energy increases. However, for m/z 
131 (C3H3 F4O
+), m/z 181 (C4H3F6O
+) and m/z 199 the branching ratios decrease as the 
collisional energy increase. The branching ratio for CF3
+ increases after 170 Td.  
To our knowledge there has been no other PTR-MS study of sevoflurane with 
using O2
+ as the reagent ion. However, Wang et al. report the reactions of sevoflurane 
with O2
+ using a SIFT-MS [117]. They observed five product ions. The assignments of 
ions are; m/z 49 (CH2FO
+), m/z 129 (C3HF4O
+), m/z 131 (C3H3 F4O
+), m/z 181 (C4H3F6O
+) 
and m/z 199 (C4H2F7O
+) (table 6.7). The most dominant product ion in their study is m/z 
131, the branching percentage of which varies by 70-50 % (the first number indicates 
shortest reaction length of 3 cm and the second one indicates long reaction length, 40 cm). 
This was followed by m/z 49 (5-30 %), m/z 181 (15-2 %), m/z 199 (11-4 %) and m/z 129 
(5-10 %) [115]. Also, m/z 131 is the dominant product ion in our study. m/z 69 is only 
observed at high E/N in this study (180 Td). 
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There are similarities between our PTR-MS and the SIFT-MS studies. However, 
m/z 49 was not detected in the PTR-MS study. Hence, Wang et al. claimed that m/z 49 is 
relatively abundant when the reaction length is increased in the SIFT-MS but the 
dominant product ion remains as CH2FOCH (CF3)
+ (m/z 131) [115].  
The ionization energy of sevoflurane (11 eV) is less than the recombination 
energy of O2
+ (12.07 eV). The difference in the energies is 1.07 eV [120]. Probably, this 
could be the reason for lesser fragmentation being obsreved. 
Table 6.7 m/z values of the product ions and neutral species and their branching ratio 
percentages resulting from the reaction sevoflurane with O2
+ at a reduced electric field of 
140 Td using the KORE PTR-ToF-MS in comparison to SIFT-MS results published by 






















+ C3HF6  - 5-30 
51 CHF2
+ C3H2F5O  10 - 
69 CF3
+ C3H3F4O  - - 
129 C3HF4O
+ CH2F3  - 5-10 
131 C3H3 F4O
+ CF3  35 70-55 
181 C4H3F6O
+ F  27 15-2 
 199 C4H2F7O
+ H  28 11-4 
 
The reason for the difference in branching ratio and product ions between PTR-MS and 
SIFT technology has already been explained in the earlier discussion stressing the 
differences in the collisional energies.  
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Figure 6.16 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of O2
+ with sevoflurane (C4H3F7O) whilst operating the drift tube at a reduced 
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Figure 6.17 Expanded figure of the product ions resulting from the reactions of O2
+ with 
sevoflurane to illustrate their isotopic abundances for a) m/z 79 (C2F2OH
+/impurity), m/z 
91(Impurity), b) m/z 129 (C3HF4O
+) and m/z 131 (C3H3 F4O
+) c) m/z 181(C4H3F6O
+), m/z 
183 (C4HF7
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Figure 6.18 illustrates how the product ion distributions vary as a function of the reduced 




+ but their branching ratios decrease owing to more fragmentation as the 
collisional energies of both the reagent ions and product ions increase with increasing 
E/N. 






































Figure 6.18 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of O2
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6.3.4.2 Reaction with H3O+  
Figure 6.19 shows the mass spectrum of sevoflurane reaction with H3O
+ at 140 Td. The 
details of the product ions and the branching ratio as a function of reduced electric field 
are presented in the table 6.8. In this study, there were six product ions observed as a 
result of reaction with H3O
+. The corresponding ions (using the lightest isotopomer) are 
at m/z 51 (CHF2
+), m/z 69 (CF3
+), m/z 181 (C4H3 F6O
+), m/z 182 (C4H4F6O
+) and m/z 199 
(C4H2F7O
+). It is apparent from table 6.6 (also figure 6.19 and figure 6.20) that the most 
intense product ion at 140 Td is m/z 181 (C3H3 F4O
+) with 69% of the branching ratio. 
The next most intense ion is at m/z 182 (C4H4F6O
+) (18 %). Measurements using the PTR-
TOF-8000 (Ionicon Analytik GmbH) in Innsbruck, show similar product ions, with 
branching ratios in good agreement (table 6.8).  
In their SIFT-MS study, Wang et al. found four product ions [115]: with the 
dominant ion being m/z 49 (CH2FO
+) (20-80 %) (the first number indicates shortest 
reaction length of 3 cm where sevoflurane is introduced into the carrier gas, close to the 
mass spectrometer sampling orifice and the second one indicates the longer reaction 
length of 40 cm, where the sample is introduced much further upstream). This is followed 
by m/z 199 (80-20%) and m/z 181 (15-2 %). Apparently, they claimed that the branching 
ratio increases with increasing humidity [115]. m/z 49 (CH2FO
+) was in our studies, but 
by changing sevoflurane and water concentrations in the drift tube, our results indicate 
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Table 6.8 m/z values of the product ions and neutral species and their branching ratio 
percentages resulting from the reaction sevoflurane with H3O
+ at a reduced electric field 
of 140 Td. The IONICON PTR-ToF-MS were measured following a request to Michaela 
Malásková from the Institute of Breath research, University of Innsbruck, Austria. SIFT-


























+ C3H2F6  - 80-20  - 
51 CHF2
+ C3H3F5O  <1 - <1 
69 CF3
+ C3H4F4O  <1 - <1 
131 C3H3 F4O
+ CHF3  <1 70-55 - 
 181 C4H3F6O
+ HF  77 15-2 98 
 182 C4H4F6O
+ FO  20 - 2 
 199 C4H2F7O
+ H2  2 80-20 - 
 
There have been a couple of other PTR-MS studies investigating sevoflurane. 
Summer et al. investigated sevoflurane in the exhaled breath of operating room personnel 
and they used m/z 181(unassigned) to determine the sevoflurane concentration[121].  
Critchley et al. reported the headspace spectrum of sevoflurane using an 
IONICON PTR-Quad-MS [122]. According to them, there were three product ions using 
H3O
+ (140 Td) observed. They identified the ions as m/z 199 (C4H2F7O
+), m/z 181 
(C4H3F6O
+), m/z 49 (CH2FO
+) [122]. In comparison to our findings, their studies 
confirm that these three ions are the dominant product ions from sevoflurane. However, 
they did not report any observation of C4H4F6O
+ (m/z 182) in their investigation. They 
also mentioned that the dissociative proton transfer leading to m/z 199 (C4H2F7O
+) is the 
dominant reaction channel [122]. The dissociative reaction/channels result in H2 and/or 
CH4 loss especially in small hydrocarbons[123]. In our study, the dominant ions are m/z 
181 and m/z 182, and not m/z 199 as mentioned by Critchley.   












Figure 6.19 A mass spectrum illustrating the product ions resulting from the reaction of 
H3O
+ with sevoflurane whilst operating the drift tube at a reduced electric field of 140 
Td. Other ions such as m/z 49 which is produced via a secondary process and an impurity 
ion C3H7O
+ coming from the sample are also highlighted. 



































Figure 6.20 A Mass spectrum illustrating product ions m/z 181(C4H3F6O
+), m/z 182 
C4H4F6O
+/13CC3H3F6O
+, m/z 183 (13CC3H4F6O
+) and m/z 199 (C4H2F7O
+. 

















































Figure 6.21 illustrates how the product ion distributions vary as a function of the reduced 
electric field. For all values of E/N the dominant ion is C4H3F6O
+, but its branching ratio 
decreases with increasing E/N owing to increased fragmentation as the collisional 
energies of both the reagent ions and product ions increase with increasing E/N. C4H2F7O
+ 
was less than 3 % for all values of E/N. 
 














































E/N (Td)  
Figure 6.21 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of H3O
+ with sevoflurane (C4H3F7O). Product ions that contribute less 
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6.3.5 Methoxyflurane  
There has been no previous PTR-MS study of methoxyflurane.  
6.3.5.1 Reaction with O2+  
The ionisation potential of methoxyflurane is 11.0 eV [116]. Hence O2
+ can energetically 
charge transfer, with an exothermicity of about 1.1 eV. Figure 6.22 shows the mass 
spectrum of methoxyflurane reaction with O2
+ at 140 Td for which the product ions 
resulting from dissociative charge transfer are highlighted. Figure 6.23 (a)-(e) shows 
these product ions in more detail. Figure 6.24 presents the product ion branching ratio 
percentages resulting from the reaction of methoxyflurane with O2
+ as a function of the 
reduced electric field.  
       Six product ions were observed from the reaction of methoxyflurane with O2+. 
Following are the ions obtained via charge transfer (electron) process (using the lightest 
isotopomer); m/z 51 (CHF2
+), m/z 67 (CHFCl+), m/z 81 C2H3F2O
+, m/z 129 (C3H4F2ClO
+), 
m/z 143 (C3H2FCl2O
+) and m/z 145 (C3H4FCl2O
+). Among these, the most dominant 
product ion at 140 Td was m/z 81 which has contributed 58 % of the branching ratio. The 
next intense ion was m/z 145. The other product ions contributed less than 6% of the 
branching ratio. There was no parent ion detected in the measurement and therefore non-
dissociative charge transfer dominates the reaction of methoxyflurane with O2
+. There 
were some impurities from the sample which are not associated with methoxyflurane 
product ions. 
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Table 6.9 m/z values of the product ions and their branching ratio percentages resulting 
from the reaction of methoxyflurane with O2
+ at a reduced electric field of 140 Td using 






    

















+ C2H3Cl2O  2 
67+69 CHFCl+ C2H3FClO  5 
81 C2H3F2O
+ CHCl2  58 
 129+131 C3H4F2ClO
+ Cl  3 
 143+145+147 C3H2FCl2O
+ H2F  <1 
 145+147+149 C3H4FCl2O
+ F  32 
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Figure 6.22 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of O2
+ with methoxyflurane (C3H4F2Cl2O) whilst operating the drift tube at a 
reduced electric field of 140 Td. Other ions such as impurity ion (NO2
+) coming from the 
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Figure 6.23 Mass spectrum illustrating product ions resulting from the reactions of O2
+ 
to methoxyflurane with illustrate their isotopic abundances a) m/z 51 (CHF2
+), m/z 67 
(CHF35Cl+), m/z 69 (CHF37Cl+) b) m/z 81 (C2H3F2O
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Figure 6.24 illustrates how the product ion distributions vary as a function of the reduced 
electric field. The dominant ions from 80 Td-160 Td are m/z 81 (C2H3F2O
+) and m/z 145 
(C3H4FCl2O
+) but their branching ratios decrease with increasing E/N owing to more 
fragmentation as the collisional energies of both the reagent ions and product ions 
increase with increasing E/N.  
 



















































Figure 6.24 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of O2
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6.3.5.2 Reaction with H3O+ 
The proton affinity of methoxyflurane is unknown. However, H3O
+ does react with 
methoxyflurane via dissociative proton transfer.  
Figure 6.25 presents a mass spectrum resulting from the reaction of 
methoxyflurane with H3O
+ at 140 Td, and figure 6.26 presents a mass spectrum of each 
product ion in detail. Figure 6.27 provides the product ion branching ratios in percentages 
as a function of E/N.  
 Table 6.10 provides details of product ions together with their branching ratios. 
There were six product ions observed. The product ions assigned (using the lightest 
isotopomer) are at m/z 51 (CHF2
+), m/z 67 (CHFCl+), m/z 79 (C2HFCl
+), m/z 
81(C2H3FCl
+), m/z 143 (C3H2FCl2O
+) and m/z 145 (C3H4FCl2O
+). The most abundant 
product ion at 140 Td was m/z 145 (66 %) resulting from the loss of HF from the 
protonated parent, followed by m/z 143 (25 %), resulting from loss H2 and HF from the 
protonated parent.  
Table 6.10 m/z values of the product ions and their branching ratio percentages resulting 
from the reaction of methoxyflurane with H3O
+ at a reduced electric field of 140 Td using 
the KORE PTR-ToF-MS. 
 
Name/ Formula Product ion 
m/z 










+ C2H4Cl2O  1 
67+69 CHFCl+ C2H4FClO  2 
79+81 C2HFCl
+ CH4FClO  1 
 81+83 C2H3FCl
+ CH2FClO  5 
 143+145+147 C3H2FCl2O
+ HF+H2  25 
 145+147+149 C3H4FCl2O
+ HF  66 
 
Chapter 6                                                                                                      Anaesthetics 
168 
 





































Figure 6.25 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of H3O
+ with methoxyflurane whilst operating the drift tube at a reduced electric 
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Figure 6.26 Mass spectrum illustrating product ions resulting from the reactions of 
H3O
+ with methoxyflurane to illustrate their isotopic abundances a) m/z 67 (CHF35Cl+) 
and m/z 69 (CHF37Cl+) b) m/z 79 (C2HF
35Cl+), m/z 81 (C2H3F
35Cl+/ C2HF
37Cl+) and m/z 
83 (C2H3F
37Cl+) and c) m/z 143 (C3H2F
(35,35)Cl2O
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Figure 6.27 illustrates how the product ion distributions vary as a function of the reduced 
electric field. The dominant ion from 120 Td-180 Td is m/z 145 (C3H4FCl2O
+). The m/z 
67 branching ratio increases when the electric field increases. At the same time, m/z 143 
branching ratio decreases when the electric field increases. m/z 81 only shows low 
intensity throughout the E/N from 80 Td – 220 Td. 
 










































Figure 6.27 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of H3O
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6.3.6 Desflurane  
No previous PTR-MS study of desflurane has been reported. 
6.3.6.1 Reaction with O2+  
Figure 6.28 shows the mass spectrum resulting from the reaction of desflurane (C3H2F6O) 
with O2
+ at 140 Td, and figure 6.29 illustrates the product ions in more detail at 140 Td. 
Figure 6.30 represents product ion branching ratios in percentages as a function of E/N.  
Table 6.11 m/z values of the product ions and their branching ratio percentages resulting 
from the reaction of desflurane with O2
+ at a reduced electric field of 140 Td using the 



















  29 
69 CF3
+ C2H2F3O  8 
99 C2H2F3O
+ CF3  4 
101 C2F4H
+ CHF2O 2 
 147 C3F5O
+ FH2  21 
 149 C3H2F5O
+ F  34 
 167 C3HF6O
+ H  2 
  
Table 6.11 provides the detail of m/z values of the product ions, their molecular structure, 
and their branching ratio percentages resulting from the reaction of desflurane with O2
+ 
at a reduced electric field of 140 Td. There are seven product ions observed. The product 
ions (using the lightest isotopomer) are at m/z 51 (CHF2
+), m/z 69 (CF3
+), m/z 99 
(C2H2F3O
+), m/z 101 (C2F4H
+), m/z 147 (C3F5O
+), m/z 149 (C3H2F5O
+) and m/z 167 
(C3HF6O
+). 
It can be seen from table 6.11 that the most abundant product ion at 140 Td is m/z 
149 (C3H2F5O
+), followed by m/z 51 (29 %), m/z 147 (21 %) and m/z 69 (8 %). The 
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branching ratios from other product ions were less than 8 %. There was no protonated ion 
observed.  
   






































Figure 6.28 A mass spectrum illustrating the product ions resulting from the reaction of 
O2
+ with desflurane whilst operating the drift tube at a reduced electric field of 140 Td. 
An impurity ion is highlighted. 
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Figure 6.29 Mass spectrum illustrating product ions resulting from the reactions of O2
+ 
with desflurane to illustrate their isotopic abundances a) m/z 49 (CH2FO
+), m/z 
51(CHF2
+), m/z 69 (CF3




and m/z 119 (C2H3F4O
+) c) m/z 147 (C3F5O
+), m/z 149 (C3H2F5O
+) and m/z 167 
(C3HF6O
+) . 
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Figure 6.30 illustrates how the branching ratio changes with as a function of reduced 
electric field. The m/z 51 (CHF2
+) branching ratio increases as the reduced electric field 
increases, and the m/z 149 (C3H2F5O
+) branching ratio decreases owing to more 
fragmentation as the collisional energies of both the reagent ions and product ions 
increase with increasing E/N.  
 










































Figure 6.30 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of O2
+ with desflurane (C3H2F6O). 
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6.3.6.2 Desflurane reaction of with H3O+  
Figure 6.31 shows the mass spectrum resulting from the reaction of desflurane (C3H2F6O) 
with O2
+ at 140 Td, and figure 6.32 provides more detail of these product ions. Figure 
6.33 presents the product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of with desflurane H3O
+.  
 There are four product ions observed at 140 Td (table 6.12). They are 
assigned (using the lightest isotopomer) as m/z 51 (CHF2
+), m/z 147 (C3F5O
+), m/z 149 
(C3H2F5O
+) and m/z 167 (C3HF6O
+). Among these, the most abundant product ion at 140 
Td is at m/z 149, which contributes approximately 61 % to the branching ratio. The other 
obvious product ion is at m/z 147 which contributes 34 % to the branching ratio. The other 
product ions contributed less than 2 %.  
      Measurements using the IONICON PTR-TOF 8000 revealed four product ions. There 
are some similarities between our finding such as m/z 51 (CHF2
+), m/z 147 (C3F5O
+) and 
m/z 149 (C3H2F5O
+). However, an additional ion at m/z 101 (6 %) was also observed. No 
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Table 6.12 m/z values of the product ions and their branching ratio percentages resulting 
from the reaction of desflurane with H3O
+ at a reduced electric field of 140 Td using the 
KORE PTR-ToF-MS and The IONICON PTR-ToF 8000 instruments. The IONICON 
measurements were made by Michaela Malásková from the Institute of Breath research, 






















+ C2H2F4O  2 18 
 101 C2F4H
+ CHF2O - 6 
C3H2F6O 147 C3F5O
+ HF+H2  34 23 
168 149 C3H2F5O
+ HF  61 53 
 167 C3HF6O
+ H2  3 - 





































Figure 6.31 A mass spectrum illustrating the product ions resulting from the reaction of 
H3O
+ with desflurane (C3H2F6O) whilst operating the drift tube at a reduced electric field 
of 140 Td. Other impurites such as protonated acetone resulting from an impurity in the 
sample are also highlighted.  
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 c) d) 
Figure 6.32 Mass spectrum illustrating product ions resulting from the reactions of H3O
+ 
with desflurane to illustrate their isotopic abundances a) m/z 51 (CHF2
+), m/z 67(CHF2O
+) 
b) m/z 99 (C2H2F3O
+), m/z 101 (Impurity), m/z 117 (C2HF4O
+) and m/z 119 (C2H3F4O
+) 
c) m/z 127 (CHF6
+/Impurity), m/z 147 (C3F5O
+) and m/z 149 (C3H2F5O
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Figure 6.33 illustrates how the product ion distributions vary as a function of the reduced 
electric field. For all nearly all values of E/N the dominant ions are m/z 149 (C3H2F5O
+) 
and m/z 147 (C3F5O
+). Only at above about 210 Td, does the branching ratio for CHF2
+ 
become larger than that for C3F5O
+. The branching ratio for m/z 149 (C3H2F5O
+) (80 Td- 
220 Td) and m/z 147 (C3F5O
+) (160 Td-220 Td) decreases owing to more fragmentation 
as the collisional energies of both the reagent ions and product ions increase with 
increasing E/N. Meanwhile, m/z 147 (C3F5O
+) branching ratio decreases as the reduced 
electric field decreases. 
 






































Figure 6.33 Product ion branching ratios in percentages as a function of E/N resulting 
from the reaction of H3O
+ with desflurane (C3H2F6O). 
 
 





Although previous studies were based on a small number of studies and samples, 
the findings suggest that there is high potential of using exhaled breath to monitor and 
investigate the elimination characteristics of anaesthetics in the near future via PTR-MS 
biomonitoring of specific exhaled anaesthetics. A few studies performed by researchers 
have proved that it is possible to measure VOCs concentrations from common clinical 
specimens such as urine, blood and exhaled breath and they proposed to have more 
investigations via implementing longitudinal studies to have a better understanding. 
In this study, the PTR-MS headspace analysis of various general anaesthetics, 
halothane, isoflurane, enflurane, sevoflurane, methoxyflurane and desflurane, was 
presented for two reagent ions, H3O
+ and O2
+. The major aim of this study was to provide 
a database of the product ions that need to be recorded if these anaesthetics are going to 
be monitored for washout studies.  
Reported for the first time are PTR-MS studies of enflurane, methoxyflurane and 
desflurane. The Density Functional calculation by Dr Peter Watts has given us some clues 
about the possible formation and fragmentation of isoflurane and enflurane. However, 
there were some disparities on different branching ratios produced by different 
instruments. These need further investigation. 
The ion chemistry for H3O
+ and O2
+ with these compounds is very complex, 
because of the many product ions observed in each reaction. The detailed information of 
ion chemistry of each anaesthetic compound and specific monitored ion channels are 
identified and discussed. In most of the studies, the protonated parent (H3O
+ as reagent 
ion) and parent ion by charge transfer (for O2
+ as reagent ions) were not observed. 
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Certainly, most of these anaesthetic compounds react via non-collisional dissociation. 
However, the protonated parent ion using H3O
+ reagent ions, quickly dissociates into 
other product ions. This study will be useful for diagnostics purpose in future washout 
characteristics studies.  
Now, there is some concrete data of the potential ions provided from the 
anaesthetics gas either using H3O
+ or O2
+ as reagent ions to aid the investigation on 
washout characteristics of anaesthetics gases for patients who have undergone surgery 
and also possibly for staff who were exposed to these highly volatile anaesthetics, mainly 








7 BREATH ANALYSIS TO DETERMINE HUMAN 
WASHOUT CHARACTERISTICS OF KEY VOLATILE 




In general, pharmacokinetic (and hence washout) characteristics of ingested drugs and 
health supplements are usually determined using an analysis of serum, blood or urine 
[72]. But the drawing of blood is not preferred by the patients and sample handling 
requires a well-established lab and trained staff.  
Breath sampling and analysis provides a non-invasive method to investigate the 
washout characteristics of drugs and to detect their metabolites. Furthermore, there is an 
unlimited supply of the sample. One of the first PTR-MS studies to do this was by 
Harrison et al., who observed the washout of propofol from a patient who had been 
heavily sedated [4]. Another PTR-MS study was by Beauchamp et al., who undertook an 
investigation of the washout characteristics of eucalyptol (1, 8-cineol) via exhaled breath 
[124]. Ruzsanyi et al. followed-up the study by Beachamp, but with a more strict time 
schedule and using a multi capillary column IMS (Ion mobilty spectroemeter) in addition 
to PTR-MS[125]. The IMS results were found to be in good agreement with those 
obtained using PTR-MS, with time-concentration curves showing good reproducibility 
for each volunteer (but less so between volunteers). In addition to that, Fernandez del Rio 
at al. reported a PTR-MS study dealing with the elimination of isoflurane on patients 
following a liver transplant [5].  
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During the 2016 IABR Standardisation Focus Group Meeting in Zurich, Professor 
Paul Thomas (Loughborough University) proposed a pharmacokinetic benchmarking 
study, which would compare breath volatile data from different groups using different 
analytical techniques. This is to aid towards standardised breath analysis and 
measurement protocols. It was suggested that peppermint oil capsules (readily purchased 
as health supplements) could be used for this purpose. Dr. Simona Cristescu (Nijmegen 
University, The Netherlands) became the lead and driver for this programme. The 
Molecular Physics Group at the University of Birmingham, and the Institute for Breath 
Research, Austria applied to be part of this European consortium, which is being 
coordinated by Ben Henderson, University of Nijmegen. In this chapter, preliminary data 
taken in collaboration with a study at the Institute for Breath Research, University of 
Innsbruck are presented.  
An additional reason for the Molecular Physics Group to be involved was to obtain 
data for the metabolism of limonene contained in peppermint oil in order to get data 
through non-invasive breath sampling of liver function for healthy volunteers. This is of 
interest in relation to their studies on liver disease [2], [126]. 
Thus in summary the key aims of this study are:  
(i) To aid in the benchmarking endeavour to estimate the range of results between 
participating laboratories 
and  
(ii) To provide breath data for healthy volunteers which would then be followed-up in a 
separate study with patients who are suffering from liver disease (a separate ethics 
approval will be made for that). 
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The protocol for recruitment and ingestion of the capsules was prepared by Prof. 
P. Thomas, Dr. S Cristescu, Dr. J Beauchamp, and Dr. S Fowler.  
For the measurements reported here, ethical approvals were obtained at the University of 
Innsbruck and the University of Birmingham. Although ethical approval was gained to 
do this study in October 2017, in Birmingham, time constraints meant that there was 
insufficient time to do work there. Instead, the work presented here was done in 
collaboration with another PhD student, Ms. Michaela Malásková, in the Institute for 
Breath Research, in Dornbirn, University of Innsbruck in December 2017. Unfortunately, 
only four people were recruited during the period I was in Dornbirn. Nevertheless, the 
results are interesting and illustrate the complexity of the use of such measurements for 
standardization procedures. This work presented in this thesis will be added to those from 
other groups, leading to a significant database of pharmacokinetic information using 
breath analysis. 
In this study the breath profile of a participant was monitored after he/she 
swallowed a peppermint oil capsule. The details of the peppermint oil capsule and the 
protocol will be given in the experimental section below. Once swallowed, the 
peppermint capsule dissolved in the stomach and the compounds in the capsule were 
released and entered the blood stream through the stomach and small intestines. 
Following the absorption of the volatiles into the blood stream, they are distributed 
throughout the body via the circulatory system, and following this metabolism and 
excretion of the volatiles occur, which leads to the loss (washout) of the compounds.  
Volatiles in the blood stream can exchange in the lungs, and thus be monitored in 
the breath. Hence the decrease in concentration of the compounds in the blood stream as 
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a result of the metabolic and excretion processes can be monitored in the breath. Breath 
thus provides a non-invasive window to monitor these processes. 
In summary, the objective of this study is to monitor temporal changes in the body 
concentrations of key volatiles contained in peppermint oil after the ingestion of a 
peppermint capsule using PTR-MS. 
7.2 Experimental Details and Protocol 
All the work presented in this chapter was done in a collaborative programme at the 
Institute for Breath Research in Dornbirn Austria using a PTR-TOF 8000. Real-time 
breath samples were analysed using an IONICON buffered end-tidal device (BET) [127] 
connected to a PTR-TOF 8000 (figure 7.1), so that real time measurements, and hence 
individual breaths, could be obtained. Details of the BET are given below in Section 
7.5.The PTR-MS was operated at 130 Td with the drift tube pressure and temperature 
maintained at 2.2 mbar and 70 ºC, respectively.  
A full description of the standardised breath experiment has been prepared by Thomas et 
al. [private document for IABR]. In brief, a volunteer swallows a 200 mg peppermint 
food supplement capsule, which dissolves in the stomach. The volatile compounds enter 
the blood stream, and these and their metabolites are subsequently detected in their breath. 
Owing to elimination and metabolism the volatile compounds decrease in concentrations, 
and hence the washout characteristics can be recorded. Breath samples are not monitored 
continuously, but at set times, e.g. every 30 minutes. A baseline is first taken, however, 
before the ingestion of a capsule. Typical measurement times for our studies are -30 
minutes (background) followed by 0 hr (ingestion), and then every 30 minutes for 
approximately 6 hours. Samples of the air in the laboratory were also recorded. For each 
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measurement period, the volunteer supplied 5 breaths using BET. These measurements 
from these five breaths were then averaged in the subsequent analysis using only the 
alveolar phase of the breath. 
The purpose of the initial sample is to establish baseline levels of VOCS from 
peppermint oil in exhaled breath from potential dietary or environmental effects.  
In addition to the above general protocol, an additional breath measurement was acquired 
immediately when the volunteer (or his/her colleagues) noticed the taste/smell of 
peppermint in his/her exhaled breath usually at 15 min intervals until the signal of 
peppermint decrease gradually. This additional protocol was adopted to make allowances 
for the volatiles coming up from the gut to the mouth soon after the capsule begins to 
dissolve, so that we can ascertain when the “true” (blood) volatiles are present in the 
breath. A continuous observation during one set of breath tests was done until the breath 
peppermint concentrations rise continuously for each consecutive exhalation. This 
frequent sampling of exhalations continued until the VOCs from the peppermint 
concentration reached a peak and then decreased. Subsequently, the standard protocol 
was once again adapted to continue until reaching the end protocol time (360 minutes) 
[124]. The integration time was set to 1 Sec. 




Figure 7.1 A breath-volunteer exhaling smoothly through the BET which was coupled to 
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7.3 Peppermint Oil Capsules 
This investigation used Boots Pharmaceuticals Digestive Health Peppermint Oil 200 mg 
capsules. On the information sheet on the health supplement bottle, the main ingredients 
of the oil are listed only as peppermint and soya. The capsule itself is made from beef 
gelatine and glycerol. No other information on the ingredients of the peppermint oil is 
provided.  
As with any matrix, without any separation of compounds, it is impossible to 
ascertain which compounds in the peppermint oil would be contributing to a given m/z in 
the mass spectrum recorded using PTR-MS. However, from GC/FID and GC-MS studies 
of peppermint oil by Schmidt at al. [11], the main chemical composition of peppermint 
oil (summarised in table 7.1) can be identified. Using these results, the main compounds 
are menthol, menthone, menthyl acetate, 1, 8-cineole, limonene, β-pinene and β-
caryophyllene. Hence this gives us a good idea of what the key volatiles in peppermint 
oil. But some care needs to be taken here, because the concentrations of volatiles and 
even the actual volatiles can change owing to differences in manufacturer of the 
peppermint oil.  
A GC-MS study of the oil contained in the Boots’ capsules is currently being 
undertaken to determine this at the Institute for Breath Research in Dornbirn. 
Unfortunately, there was no time to do this during the breath measurements. Nevertheless, 
several of the major compounds identified in the work by Schmidt et al. were separately 
measured on the PTR-8000 at the reduced electric field of 130 Td in order to determine 
which compounds could be contributing to a mass spectral peak in the breath and 
peppermint oil headspace analyses. 
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Table 7.1 The principle chemical composition of peppermint oil adapted from the GC 
















α-pinene 136 137 C10H16 0.7 pine-like, warm, 
herbal 
β-pinene 136 137 C10H16 1.1 resinous-piney, 
dry 
limonene 136 137 C10H16 2.6 lemon-like, 
fresh 
menthofurane 150 151 C10H14O 3.7 fresh-minty, 
herbal, slightly 
cool 
pulegon 152 153 C10H16O 1.9 herbal-minty, 
campherous 
menthone 154 155 C10H18O 23.4 minty 
1,8-Cineole 154 155 C10H18O 5.3 eucalyptus-like, 
fresh 




menthol 156 157 C10H20O 40.7 cool-minty 
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Using table 7.1 we have selected menthone and menthol to investigate separately 
on a KORE PTR-ToF-MS. However, just because the concentrations are high in the oil 
that does not mean that the concentrations will be high in the breath, owing to differences 
in absorption, metabolism and excretion. (Hence it will therefore be extremely interesting 
to compare our PTR-MS results (real-time measurements) with those taken by the other 
groups involved in this study who are using GC-MS (not real-time) for their breath 
analysis.) Therefore, with this uncertainty some other compounds were selected to 
measure, namely menthol, menthone, α-pinene, β-pinene, 1, 8-cineole, and limonene. 1,8-
cineole in particular is not metabolised efficiently in the body, and is removed from the 
blood via gas exchange in the lungs, whereas menthol is metabolised into menthol 
glucuronide in the liver and urinated out of the body [128]. Table 7.2 provides pertinent 
details on these compounds (molecular weight, CAS number, vapour pressure and 
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Table 7.2 Details about standard compounds investigated in this study related to 
peppermint oil capsule in this experiment, including vapour pressure and purity. 
 
Molecular 
































































7.67 x 10-3 mm 












0.28 mm Hg at 
(25 °C) 
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Given that the pinenes and limonene are isomers, the similar product ions can be expected 
from these compounds, and hence for the analysis of the breath volatiles, we will be 
presenting the sum contribution of these for a particular m/z. 
To obtain the mass spectra, a 0.1 µl of each sample was taken using a microsyringe 
and placed in a 5 ml vial. The vial was connected to nitrogen gas flow using a Teflon tube 
and peek tube to the inlet line. Background spectra were taken for each vial at 130 Td 
prior to the sample measurements. The inlet and the drift tube temperature were fixed at 
100 °C.  
7.4 Participant information 
Every participant’s details about height (cm), weight (kg), age (years), BMI (Body Mass 
Index), as well as questions about diet, personal habits and lifestyle were recorded in the 
participant information form. These detailswill enable us to exclude possible dietary or 
lifestyle factors from influencing the results. 
        Unfortunately, owing to time constraints, only measurements taken of 2 males and 
2 females with an age range of 37-58 are reported here. But these illustrate the method 
and type of results. Details (Age, Sex and quantity of repeated measurement) of each 
volunteer are listed in table 7.3. 
  No dietary requirements were required. However, the volunteers were requested 
to fast for 10 hours prior to the measurements. To make this easier on the volunteer the 
measurements were started in the morning.  
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Table 7.3 Details of the age, sex and number of measurements of the volunteers who 
participated in this peppermint oil study. 
 
Volunteer Age Sex Number of 
measurements 
1 58 Male 1 
2 45 Male 1 
3 37 Female 4 (sequential 
days) 
4 28 Female 3 (sequential 
days) 
 
 All participants were provided with a volunteer information sheet upon recruitment 
and informed consent procedures were followed. Participants were asked to breathe 
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7.5 Buffered End Tidal (BET) 
Herbig J et al. introduced a real-time breath- gas sampling method known as buffered 
end-tidal (BET) on-line sampling. Figure 7.2 shows the BET system which can be easily 
coupled to a PTR-MS system. There are several advantages for using the BET method 
compared to conventional direct sampling. In this approach, the end-tidal portion of the 
breath-gas sample is buffered using a single exhalation of breath delivered via a tailored 
tube [127]. This helps to increase the sampling time by typically several seconds. 
Consequently, it improves the signal quality and reduces the total measurement time per 
participant. Besides that, the participant can maintain a normal breathing style, 
consequently limiting the risk of hyperventilation. Figure 7.2 shows the volunteer’s 
breath sampling method using BET. 
The BET sampling was tested by Herbig J et al. to compare the measurements 
with direct on-line sampling using PTR-MS. They found a good agreement between 
acetone and acetonitrile concentrations. The only variabilities observed were high 
differences in breath to breath isoprene concentrations. This variability could be from the 
different strength of exhalation and hyperventilation on end tidal concentrations [127].  
 




Figure 7.2 Schematic of the buffered end-tidal (BET) sampling apparatus (reproduced 
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Results and Discussion 
7.6 Headspace measurements of compounds associated with 
peppermint oil  
7.6.1 Headspace of α-pinene  
The proton affinity for α-pinene is < 854 kJ/mol [131]. Therefore, it efficiently reacts with 
H3O
+, either dissociatively or non-dissociatively [132]. Figure 7.3 presents an overview 
of the mass spectrum of α-pinene recorded at 130 Td. Table 7.4 provides the product ions 
resulting from the reaction of α-pinene with H3O
+ at 130 Td. Eleven product ions were 










+) and 137 (C10H17
+). The most dominant product 
ion from the headspace of α-pinene is at m/z 137 (protonated parent ion) (relative intensity 
100). Other ions were observed at m/z 81 contributing 98% to the relative intensity. This 
was followed by m/z 95 (12), m/z 67 (5), m/z 93 (4), m/z 135 (4), m/z 57 (3), m/z 109 (2), 
m/z 43 (1) and m/z 69 (1).  
Using a drift tube voltage of 580 V (corresponding to about 140 Td) Maleknia et 
al. observed the following product ions resulting from α-pinene (relative intensities in 
brackets) [133];  at m/z 81 (100), m/z 137 (44), m/z 93 (21.7), m/z 95 (7.2 ), m/z 135 (1.5), 
m/z 107 (1) and m/z 109 (0.9 ) [133]. We observed similar product ions except m/z 107 
but with a different relative abundance. In their measurement, the most dominant ion is 
at m/z 81, whereas in our study at 130 Td the dominant product ion is at m/z 137, followed 
by m/z 81, m/z 95 and m/z 67. The disparities of the relative intensity are simply because 
of different instruments were being used. Materic et al, reported m/z 81 and 137 are the 
two major fragments from α-pinene. However, Materic et al, have not reported on m/z 
135, 95, 93, 67,69, 57, 57 and 43 in their measurement using PTR-ToF-8000 [132]. This 
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is purely because two different instruments were used. The instruments have a different 
transmission factor and transfer optic factor (as mentioned in chapter 6 discussion that 
branching ratios are very much instrumental dependent). 
According to Tani et al. monoterpenes α-pinene produces fragmentation ions such 
as m/z 67, 81 (C6H8H
+), and m/z 95, and also protonated m/z 137 (C10H16H
+) [134]. These 
product ions agree with our study.  
 

















Figure 7.3 A mass spectrum illustrating the product ions (starred) resulting from the 
reaction of H3O
+ with α-pinene (C10H17) at a reduced electric field of 130 Td.  
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Table 7.4 Table m/z values of the product ions and their relative intensities (dominant ion 
given an intensity of 100) resulting from the reaction of α-pinene with H3O
+ at a reduced 
electric field of 130 Td. 
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7.6.2 Headspace of β-pinene 
The proton affinity of β-pinene is unknown. Nevertheless, we assume it will be similar to 
α-pinene because it is an isomer of α-pinene and hence will readily react with H3O
+ either 
dissociatively or non-dissociatively. Figure 7.4 shows an overview of a PTR-MS mass 
spectrum of β-pinene at 130 Td. Table 7.5 provides the product ions of β-pinene at 130 
Td. As shown in table 7.5, there were ten product ions observed as a result of β-pinene 
reactions with H3O
+.  










+) and 137 
(C10H17
+). We observed the m/z 137 protonated parent ion. α-pinene and β-pinene are 
isomers as pointed out earlier. Therefore, the observed product ions were similar in both 
compounds. However, the relative intensities for each ion is different although the 
product ions are similar. The most dominant product ion was m/z 137 (100) which is the 
protonated parent ion. This was followed by m/z 81 (99), 95 (16), m/z 135 (6), m/z 67 (6), 
m/z 79 (2), m/z 57 (2), m/z 109 (1), m/z 107 (1) and m/z 93 (1). 
Tani et al. mentioned that fragments ions from β-pinene were m/z 67, 81 and 95 
and the protonated molecular ion was 137 [134]. Similar ions were detected in our 
measurements but different relative intensities. Perhaps this also could be related to 
different instrumentation. 
Materic et al reported that the most abundant ions from β-pinene are m/z 137 and 
m/z 81 [132]. Our results also showed that the most abundant ions are m/z 137 and m/z 
81. However, Materic et al have not reported about other product ions related to β-pinene. 
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Figure 7.4 A mass spectrum illustrating the product ions (starred) from the reaction of 
H3O
+ with β-pinene (C10H17) whilst operating the drift tube at reduced electric field of 
130 Td for 10 second experiment time.  
 
 
Table 7.5 m/z values of the product ions and their relative intensities (dominant ion given 
an intensity of 100) resulting from the reaction of β-pinene with H3O
+ at a reduced electric 
field of 130 Td. 
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7.6.3 Headspace of 1,8-cineole 
The proton affinity of 1,8-cineole is unknown. However, it can react with water molecule 
either via dissociatively or non-dissociatively [124].Figure 7.5 presents the mass 
spectrum of 1,8-cineole at 130 Td. Table 7.6 summarises the product ions and the relative 
intensity of 1,8-cineole at 130 Td. The observed product ions are at m/z 81, 95, 137 and 
155. m/z 155 is the protonated parent. This indicates that H3O
+ reacts with 1,8-cineole in 
a PTR-MS dissociatively and non-dissociatively. The relative intensities of these ions are 
m/z 137 (C10H17
+) (100), m/z 81(C6H9
+) (63), m/z 155 (C10H19O
+) (11), and m/z 95 
(C7H11
+) (1) with the relative intensities are given in the brackets. 
According to Maleknia et al. the most abundant compound at 580 V from 1,8-
cineole is m/z 81 (100, relative intensity calculated on the basis of ion counts/s), at 480 V 
it has a relative intensity of 85, whilst at 380 V it has only a relative intensity of 4 [133]. 
This illustrates the effect of the reduced electric field on collision induced dissociation. 
The relative intensity for m/z 137 is different from Maleknia et al. compared to our study 
where we found the contribution from m/z 137 is 100 % at 130 Td. Maleknia et al., also 
detected m/z 155 with only a relative intensity of 0.3 at 580 V (140 Td), whereas we 
observe a higher relative intensity of 11 in this study. Moreover, Maleknia et al. have 
found an additional peak at m/z 95 (7.8), whereas in this study, only 1 was obtained. Tani 
reported m/z 81, 95, 137, 155 and 173 as fragment ions of 1,8-cineole using PTR-MS in 
terpenoids (cineole) study [135, 136]. Tani’s findings agree with our findings except for  
m/z 173. Besides that, Steegh et al. found m/z 81 and 137 from their investigation on 
metabolites emit from a plant (Arabidopsis) where 1,8 –cineole was identitified as one of the 
metabolite using PTR-MS [135]. We also found m/z 81 and m/z 137 as abundant product ions 
Chapter 7                                              Breath profile and washout characteristic                                                                      
201 
 
from 1,8-cineole. In addition to that, Beauchamp et al. refer m/z 81, 137 and 155 as the 
product ions detected from headspace of 1,8-Cineole (eucalyptol) [124].  
















Figure 7.5 A mass spectrum illustrating the product ions (starred) from the reaction of 
H3O
+ with 1,8-cineole (C10H19O) whilst operating the drift tube at reduced electric field 
of 130 Td. Other ion such as impurity ion coming from the drift tube is also highlighted. 
 
 
Table 7.6 m/z values of the product ions and their relative intensity resulting from the 
reaction of 1,8-cineole with H3O
+ at a reduced electric field of 130 Td. 
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7.6.4 Headspace of limonene 
The proton affinity of limonene is 875 kJ/mol [29, 137]. Figure 7.6 shows the mass 
spectrum of limonene, whilst table 7.7 provides the details of the product ions with 
relative intensity measured at 130 Td resulting from reactions with H3O
+. Four product 
ions are identified at m/z 67 (C4H9
+), 81 (C6H9
+), 95 (C7H11
+) and 137 (C10H17
+). The 
protonated parent ion is at m/z 137 (100). Dissociative proton transfer leads to the m/z 81 
(76), m/z 95 (11) and m/z 67 (1) product ions.  
Using a PTR-Quad-MS, Hewitt et al. reported product ions at m/z 67, 81, 95 and 
137 between 120-130 Td [138] . m/z 67 only contributed approximately 0.1 % of total 
abundance at 120 Td. In our study, m/z 67 has also contributed a small relative intensity 
of 1 at 130 Td, and hence can be ignored. Also, there was no ion at m/z 67 reported by 
Fernandez del Rio in her limonene study [2]. Meanwhile, Materic et al, have only found 
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Figure 7.6 A mass spectrum illustrating the product ions (starred) from the reaction of 
H3O
+ with limonene (C10H17)  whilst operating the drift tube at reduced electric field of 
130 Td. An ion resulting from an impurity of acetone in the drift tube is highlighted. and 
protonated water clusters (m/z 37 and m/z 55) were observed in this measurement. 
 
 
Table 7.7 m/z values of the product ions and their relative intensities (dominant ion given 
an intensity of 100) resulting from the reaction of limonene with H3O
+ at a reduced 
electric field of 130 Td. 
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7.6.5 Headspace of menthone 
The proton affinity of menthone is unknown. Hence, it reacts with H3O
+ either 
dissociatively or non-dissociatively [101]. From the results summarised in figure 7.7 and 
table 7.8 five product ions result from the reaction of H3O
+ with menthone at 130 Td. 
These product ions were observed at m/z 59 (C3H7O
+), m/z 81(C6H9
+), m/z 95 (C7H11
+), 
m/z 137 (C10H17
+) and m/z 155 (C10H19O
+). The dominant ion observed is at m/z 155, 
which is the protonated parent. This is followed by m/z 137 (29), m/z 81 (14), m/z 95 (3) 
and m/z 59 (3). 
In an earlier PTR-MS study by Tietz et al. at 140 Td, four product ions associated 
with menthone were observed at m/z 81 (100), 95 (31), 137 (26) and 155 (11) [139]. In 
our study, similar product ions are found at 130 Td but the calculated relative intensities 
are different. This could be due to different instruments being used.  
According to a PTR-Quad-MS study by Heenan et al. also at 140 Td, three product 
ions are associated with menthone, at m/z 81 (100 %,), m/z 137 (30 %), m/z 155 (10 %) 
[101], which are different from our result, again illustrating issues of transmission of ions 
in different instruments.  
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Figure 7.7 A mass spectrum illustrating the product ions (starred) from the reaction of 
H3O
+ with menthone (C10H19O) whilst operating the drift tube at reduced electric field 
of 130 Td. An ion resulting from an impurity in the drift tube is identified. 
 
Table 7.8 m/z values of the product ions and their relative intensities (dominant ion given 
an intensity of 100) resulting from the reaction of menthone with H3O
+ at a reduced 
electric field of 130 Td. 
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7.6.6 Headspace of menthol 
The headspace of menthol was reported in Chapter 5 section 5.3.2. However, that was 
done on a first generation KORE-PTR-ToF-MS. The plan for the breath analysis in 
Birmingham was to use a second generation KORE PTR-TOF-MS which has a different 
drift tube configuration and a smaller TOF tube [140].Therefore, the headspace analysis 
was repeated again for comparison with the first generation instrument. Figure 7.8 shows 
the mass spectrum of the headspace of menthol at 130 Td. Eight product ions are 








+) and 155 (C10H19O
+). m/z 155 (protonated parent 
ion) was detected via a non-dissociation process. This indicates that the reaction of 
menthol with H3O
+ is via dissociative proton transfer. The most abundant product ion is 
at m/z 83 (100 relative intensity). This is followed by m/z 139 (88), m/z 57 (48), m/z 81 
(34), 97 (25), m/z 69 (9), m/z 155 (1) and m/z 55 (1).  
 However, the study on headspace of menthol using the first generation KORE-
PTR-ToF-MS produced eight product ions with m/z 55, 57, 69, 81, 83, 97, 139 and 155. 
For the headspace measurement of menthol using the second generation KORE-PTR-
ToF-MS has produced seven product ions except m/z 55 which is less than 1. m/z 83 is 
the dominant ion in both measurement. Obviously, the reason for the difference in relative 
intensities is due to two different instruments were being used.  
A prior E/N study (90-133 Td) using PTR-MS at 133 Td identified four product 
ions at m/z 55, 81, 83 and 139 [107]. According to Gordon et al. the most abundance 
product ion (the branching percentage) at 133 Td is m/z 83 (approximately 43 %). This is 
followed by m/z 55 (approximately 33 %), m/z 81 (approximately 16 %) and m/z 139 
(approximately 8 %). Our measurements also find that the dominant product ion at 130 
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Td is m/z 83 (in relative intensity to 100). However, for the rest, there are significant 
discrepancies in the product ion intensities, which again relates to the difference in the 
mass discrimination of quadrupole compared to TOF mass spectrometers. There may also 
be differences in the transmission of the ions into the mass spectrometer and efficiencies 
of different ion detectors. Gordon et al. did not observe product ions at m/z 57, 69, and 
97.  
Similarly, differences are found in the relative intensities of product ions described in 
another PTR-Quad-MS study of menthol by Saint-Eve et al [106] at an E/N of 140 Td 
product ions were observed at m/z 81 (100), m/z 55 (62), m/z 83 (42), m/z 137 (22) and 
m/z 139 (4).  
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Figure 7.8 A mass spectrum illustrating the product ions from the reaction of H3O
+ with 
menthol (C10H20O) whilst operating the drift tube at reduced electric field of 130 Td e. 
Impurity ion was observed in this measurement. 
 
Table 7.9 m/z values of the product ions and their relative intensities (dominant ion given 
an intensity of 100) resulting from the reaction of menthol with H3O
+ at a reduced electric 
field of 130 Td. 
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7.6.7 Headspace of the oil contained in the Boots’ Peppermint Capsule 
Figure 7.9 presents the headspace mass spectrum of the oil contained in a Boots’ 
peppermint capsule at 130 Td. Table 7.10 provides the relative intensity of peppermint 
product ions at 130 Td together with an assignment of the compounds that produce these 
ions following a reaction with H3O
+ based on the headspace analysis of pure compounds 
presented in this chapter and upon the results of Schmidt et al [11].  
The most abundant product ion is at m/z 155 (which is assigned a relative intensity 
of 100), as assigned to result from a number of compounds in the peppermint oil, namely 
menthol (loss of H2 from the protonated parent), and protonated menthone, 1,8-cineole, 
and isomenthone. The next intense ion is at m/z 137 (33) which is assigned as to result 
from either a dissociative proton transfer reaction of H3O
+ with 1,8-cineole and menthone, 
or non-dissociative proton transfer which can be contributions from protonated α-pinene, 
β-pinene and limonene. These are followed by m/z 83 (24) resulting from product 
fragment ions of menthol and β-pinene. These tentative assignments are based on our 
headspace study on associated compounds to peppermint oil containing capsules (section 
7.6.1-7.6.6). m/z 81 (19) has contributions from α-pinene, β-pinene, limonene, menthol, 
menthone and 1,8-cineole. m/z 151 (11) most probably has contributions from 
menthofurane, menthol, methonane and α–pinene. m/z 57 is assigned to result from 
menthol, α-pinene and β-pinene. m/z 59 is protonated acetone which could be from the 
drift tube, (7), m/z 153 (5) comes from menthol, menthone fragmentation and pulegon. 
There were a few ions which have a relative intensity less than 5, including m/z 43 
(protonated acetic acid), m/z 45 (protonated acetaldehyde), m/z 69 (protonated isoprene), 
m/z 95 (fragment ion from menthone, α-pinene and β-pinene), m/z 97 (fragment ion from 
menthol), m/z 135 (fragment ion from α-pinene and β-pinene), m/z 157 (protonated 
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menthol) and m/z 205 (protonated sesquiterpene and protonated β-caryophyllene) [11] . 
If m/z 205 is assigned as a sesquiterpene, it also can produced fragment ions at m/z 137 
and 81 following a reaction with H3O
+, based on the results presented in a paper by Lee 
et al. [141]. 
 





























Figure 7.9 A mass spectrum illustrating the product ions and their intensities from the 
reaction of H3O
+ with peppermint oil contained capsule whilst operating the drift tube at 
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Table 7.10 m/z values (tentative identification) of the product ions and their relative 
intensities (dominant ion given an intensity of 100) resulting from the reaction of 
peppermint capsule with H3O
+ at a reduced electric field of 130 Td. 
 
m/z Compound/ fragment ion 
resulting from a reaction 
of H3O+ 
Relative intensity (%) 
43 protonated acetic acid  1 
45 protonated acetaldehyde 1 
57 Menthol, α-pinene, and β-
pinene  6 
71 unassigned 1 




83 menthol and β-pinene  24 
95 menthone, α-pinene and β-
pinene  1 
97 menthol  2 
135 of α-pinene and β-pinene  1 
137 α-pinene, β-pinene , 
limonene, menthone and 
1,8-cineole  
33 
139 menthol  16 
141 unassigned 2 
151 menthofurane, menthol, 
methonane and α –pinene  
11 
153 menthol, menthone and 
pulegon 
5 
155 protonated menthone, 
protonated 1,8-cineole and 
menthol  
100 
157 protonated menthol  1 
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7.6.8 VOCs in the exhaled breath after ingestion of a peppermint capsule  
Based on the results presented in the last section, it is clear that the ions to be monitored 
for the breath analysis are at m/z 81, 137 and 155. These result from a number of 
compounds in the peppermint oil, and as mentioned it will be interesting to see what the 
GC-MS study achieves.  
 
Figure 7.10 Shows five breaths for each measuring period by monitoring alveolar phase 
of m/z 59, 81, 137 and 155.  
Following the protocol described in section 7.2, five breaths were collected for each 
measuring period. An illustration of these breaths, whilst monitoring m/z 59, 81, 137 and 
155 is given in figure 7.10. The alveolar phase is clearly distinguishable, and from which 
the intensities of the signals were averaged and standard deviations determined. m/z 59 is 
a result of acetone which is always in high concentrations in the breath [124], and is used 
here to illustrate the concentrations of the volatiles from the peppermint oil.  
This study confirmed that the peppermint capsule ingestion resulted in VOCs 
present in exhaled breath, especially at m/z 155, 137 and which could be from menthol, 
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were found in the headspace study investigation which was on pertinent associate 
compounds. 
7.6.9 Washout characteristic of peppermint capsule.  Personal and inter-
individual variations 
Figure 7.12-7.20 shows the peppermint washout characteristics of volunteers who took 
part in this study using a PTR-TOF 8000 with BET. The decrease in the ion signals is 
related to the loss of volatiles in the blood. It can be expected that this loss follows an 
exponential decay where the concentration decreases as time. In figure 7.11 (a, b, c), ncps 
(normalised counts per second) for 81, 137 and 155 is presented for one of the studies. A 
exponential line plot through the data points show that this is in fact the case, and from 
this a pseudo excretion rate can be calculated. Table 7.12 provides the details about these 
pseudo excretion rate of volunteers and the excretion rates for the same for different days 










































Figure 7.11 Shows an example of an exponential decay graph of a volunteer for a) m/z 
81, b) m/z 137 and c) m/z 155 (normalised counts per second (ncps) versus time) which 
indicates it is possible to calculate pseudo excretion rate using natural log function. 
 
 Figure 7.12 represents the washout characteristics of peppermint capsule for a 
male age 58 (Volunteer 1). VOCs from the peppermint capsule were detected after 30 
minutes of ingestion of the peppermint capsule. The excretion rate for compounds is 
directly related to the pseudo rates determined form the product ions calculated. m/z 81 (-
0.014 cps min-1), 137 (-0.015 cps min-1) and 155 (-0.018 cps min-1) having almost similar 
excretion rates. The maximum concentration was monitored at 30 minutes. The 
concentration of the VOCs from the peppermint capsule gradually reduces to the 




















Figure 7.12 The washout characteristics of volatiles in breath recorded at m/z 81, 137, and 
155 following the ingestion of a capsule containing 200 mg of peppermint oil for 
volunteer 1. 
 
One unanticipated finding from volunteer 2 (figure 7.13) was that the result shows 
the fluctuation of VOCs from the exhaled breath before and after the ingestion of a 
peppermint capsule. No significant increase of VOCs in exhaled breath was detected. 
Perhaps, this could be the result of the compounds being metabolised by the volunteer 
quickly so we are only able to see the VOCs at are almost background levels. This result 
shows that the chemical reaction, especially the catabolic reaction of peppermint capsule 






































Figure 7.13 The washout characteristics of volatiles in breath recorded at m/z 81, 137, and 
155 following the ingestion of a capsule containing 200 mg of peppermint oil for 
volunteer 2. 
 
For volunteer 3 (female, 37), measurements for four sequential days were 
undertaken. Surprisingly, for the first measurement the VOCs from the peppermint 
capsule were only detected after approximately 105 minutes (figure 7.14). The maximum 
concentration was obtained at 120 minutes. The second measurement on the second day 
shows a similar trend, where the peppermint compounds were detected at 120 minutes 
and the maximum concentration was obtained at 150 minutes (figure 7.15). The 
measurement for the third day showed the maximum concentration at 165 minutes (figure 
7.16). From figure 7.15, it can be seen that, for the fourth day, the maximum concentration 



































Figure 7.14 The washout characteristics of volatiles in breath recorded at m/z 81, 137, and 
155 following the ingestion of a capsule containing 200 mg of peppermint oil for 
volunteer 3 (day 1). 
 
Figure 7.15 The washout characteristics of volatiles in breath recorded at m/z 81, 137, and 
155 following the ingestion of a capsule containing 200 mg of peppermint oil for 


































































Figure 7.16 The washout characteristics of volatiles in breath recorded at m/z 81, 137, and 
155 following the ingestion of a capsule containing 200 mg of peppermint oil for 
volunteer 3 (day 3) 
.
 
Figure 7.17 The washout characteristics of volatiles in breath recorded at m/z 81, 137, and 
155 following the ingestion of a capsule containing 200 mg of peppermint oil for 
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For volunteer number 4 (Female 28), three measurements were undertaken on 
different days (figure 7.18-7.20). The maximum concentration monitored from day one 
was at 90 minutes. For the following days, it was observed at 30 minutes and 60 minutes 
respectively. The maximum concentration time was not similar for all the measurements. 
The excretion rate also varies from day to day.  
 
Figure 7.18 The washout characteristics of volatiles in breath recorded at m/z 81, 137, and 
155 following the ingestion of a capsule containing 200 mg of peppermint oil for 






































Figure 7.19 The washout characteristics of volatiles in breath recorded at m/z 81, 137, and 
155 following the ingestion of a capsule containing 200 mg of peppermint oil for 
volunteer 4 (day 2). 
 
 Figure 7.20 The washout characteristics of volatiles in breath recorded at m/z 81, 137, 
and 155 following the ingestion of a capsule containing 200 mg of peppermint oil for 
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Table 7.11 Shows the pseudo excretion rate (decrease in the product ions) of volunteers 
for each product ion measured from the exhaled breath after ingestion of the peppermint 
capsule for each of the volunteers. 
 
Volunteer Day m/z 81 (cps 
min-1) 
m/z 137 (cps 
min-1) 
m/z 155 (cps 
min-1) 
Volunteer 1  Day 1 -0.014 -0.015 -0.018 
Volunteer 2  Day 1 -0.002 -0.003 -0.009 
Volunteer 3 Day 1 -0.004 -0.005 -0.01 
 
Day 2 -0.004 -0.004 -0.005 
Day 3 -0.005 -0.006 -0.007 
Day 4 -0.013 -0.017 -0.02 
Volunteer 4 
Day 1 -0.006 -0.007 -0.001 
Day 2 -0.002 -0.002 0.000 
Day 3 -0.017 -0.019 -0.023 
 
Thus, VOCs from the peppermint oil appeared in the exhaled air approximately 
30-60 minutes for some volunteers and for other volunteers it took more than an hour 
after administration of the capsule.  
Almost all the cps versus time bar charts for all the volunteers have shown good 
washout characteristics. In addition to that, due to the shape of the curves from the 
washout characteristics, the detected maximal concentration of the same volunteer for 
different days changed and failed to show a consistent trend. This indicates that the 
excretion rate for the particular volunteer changes day to day. This perhaps can be linked 
with their daily activities and food intake. In accordance with the present results, previous 
studies have also shown differences within individuals in their washout characteristic for 
1,8-cineol as reported by Ruzsanyi and Beauchamp [124, 125].  
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According to Ruzsanyi, this kinetic trend could be observed only with strict 
consistency to the protocol. She mentioned that when a volunteer was not holding to the 
8 hours of fasting prior to the breath sampling, the release of maximal cineol 
concentration could take up to 18 hours after swallowing the capsule [125]. However, in 
this peppermint washout study, all the volunteers fasted for a minimum 8-10 hours prior 
to the capsule ingestion and the maximal signal concentration of volunteers was able to 
be detected within two to three hours and some within an hour. Therefore, these results 
provide support for Ruzsanyi’s claim. 
There are many unknown factors which can have influences on the volatiles in 
exhaled breath such as physiological influences [124]. Also, it is therefore unlikely that 
such connections existing between onset time and sex, age or body mass index (BMI) 
were distinguishable. However, the eating patterns and digestion right after the capsule 
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7.6.10 Metabolites from Peppermint capsule 
In this experiment, there should be some volatile metabolites of the key compounds in 
peppermint oil in the breath. For examples, for menthol we may expect to observe 
glucuronide, and for limonene the metabolites are perillyl alcohol, trans-isopiperitenol 
and trans-carveol. Surprisingly, no metabolites associated with either menthol or 
limonene were found in this study. Certainly, the metabolites of limonene were observed 
in the study by Fernandez del Rio et al (this has not been published yet). At present, we 
have no explanation to this observation. However, we cannot draw any conclusion owing 
for the limited number of breath samples reported here in this proof-of-principle study.  
  Somerville et al. have claimed that peppermint (Colpermint) metabolites in  
spastic colon syndrome volunteers appeared to be glucuronide. Glucuronide is metabolite 
of menthol from peppermint which was found delayed in the urine [142]. Valente et al. 
reported that they found glucuronide after 1-2 hours [143]. 
Meanwhile, for 1,8-Cineole, it has been found that it is oxidized at high rates to 
2-exo-hydroxy-1,8-cineole by rat and human liver microsomal P450 enzymes [144]. 
However, there was no metabolites related to 1,8-Cineole found.  
According to Miyazawa et al. (-) menthone was metabolized to (þ) - neomenthol 
(2) (via 3-reduction) and 7-hydroxymenthone (3) by human liver microsomes [145]. Also, 
there were no metabolites detected related to menthone. 
Besides that, Sun J has stated that there were a few metabolites (oxygenated 
metabolites) produced from D-Limonene. The metabolites are perillic acid, 
dihydroperillic acid, and limonene-1-,2-diol (circulating metabolites) and also 
metabolites from plasma, such as limonene-8,9-diol and perillic acid isomer [146]. 
However, there were no metabolites related to limonene detected from the exhaled breath. 
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These findings raise intriguing questions regarding the nature and extent of 
production of metabolites from menthol, menthone, 1,8-cineole, limonene, α-pinene and 
β-pinene via exhaled breath. However, there were no metabolites associated with 
menthol, 1,8-Cineole, menthone and limonene found in this study. 
 There were no other breath studies claimed about the metabolites from these 
associate compounds with peppermint oil capsule. Therefore, detailed separate studies on 
the metabolisms of these compounds and its metabolites should be done in order to have 

















The main objective of the study was to provide a proof-of-principle study to show how 
PTR-MS can record the washout characteristics of some volatiles present in peppermint 
capsules via exhaled breath. Although only a small number of volunteers took part, the 
results are encouraging and will be continued further both in Birmingham and Innsbruck.  
In summary, we investigated the breath profiles of four healthy volunteers just 
prior to and after ingestion of a peppermint capsule. For two of the volunteers repeated 
measurements were obtained to check for intra-individual variations.  
For all studies, a noticeable smell of peppermint was obvious in the breath of all 
the volunteers shortly after the ingestion of the peppermint capsule, which soon 
disappeared, and is almost certainly related to the volatiles coming-up from the gut and 
not from the bloodstream. Thereafter, any volatiles recorded are considered to be from 
the blood.  
The measurement shows that the start of observing these volatiles in the breath 
coming from the blood varied both in the intra- individual and the inter-individual 
measurements.  
The onset and the peak concentration were typically for 35 minutes, although a 
broad range of times was involved. The limitations of sampling protocol could be one of 
the reasons for the maximum peppermint levels being widespread. For example, sampling 
protocol could lead to underestimation of transience of breath peppermint. 
The issue of washout characteristics can be sorted by frequent sampling and 
analysis using even shorter times (probably within minutes) with sufficient sampling 
intervals depending on target compounds. In this case, the target compounds were m/z 81, 
137 and 155. Also, m/z 137 and 81 are not just from one compound, and hence there may 
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be differences in washout owing to differences in metabolism of the compounds. It would 
be interesting to use GC-MS measurements in parallel with PTR-MS measurements for 
an individual to look for differences. 
 The concentration levels were different during the different measurement phases 
for each individual, hence illustrating a large uncertainty in exhaled concentrations. Also, 
exhaled peppermint concentration can be dependent on the dose rate/body weight [72]. It 
can be suggested that, probably the concentration of peppermint in each capsule could be 
different which lead to variations of maximum concentration time within inter- and intra 
personal. 
This study has illustrated how once volatiles enter the blood stream they are 
eliminated and decrease in concentration rapidly.  
In this study, the primary active product ions of the peppermint oil capsule, were 
observed rather than the metabolites. The immense variability in the breath of peppermint 
levels proves that there must be a further condition to be understood about the kinetics of 
this compound in the body after ingestion of peppermint capsule. 
Therefore, it can be said that each individual has their own metabolic rate towards 
the ingestion of peppermint capsule. Probably the metabolic rate for each individual 
changes day to day. If this is true, perhaps these changes depend on their daily activities 
and food intake. Besides that, age, sex and BMI factors might play important roles in 
determining their body metabolism even though we are uncertain about their correlation.  
  Further studies are required with a larger population and broader spectrum of 
participants.  
This study illustrates the application of breath analysis for investigating 
pharmacokinetics and washout characteristic studies, showing that on-line breath gas 
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analysis has advantages compared to blood or urine sampling. Moreover, with breath 
sampling it is possible to carry out uninterrupted sampling with unlimited samples.  
These real-time PTR-MS measurements with BET application have shown 
prominent and positive results for washout characteristics examination and will benefit 
future studies on liver diseases.  




8 Breath analysis of Rugby Players who had concussion 
(controls and injured) 
8.1 Introduction 
 
The National Health Service (NHS), has defined concussion as a sudden brain injury 
causing short-lived loss of mental function [147]. Generally, concussion causes a mixture 
of signs/symptoms. It does not show any loss of consciousness [147]. Concussion usually 
can be observed in the presence of one or more symptoms, physical signs, confusion and 
abnormal behaviour. Sometimes, it can be linked to a severe brain injury. The most 
common side effects include memory loss, confusion, blurry vision and a blank 
expression for a short period, although it can be much more serious [147] . The indication 
for emergency management of a severe brain injury is categorized when a Glasgow Coma 
Score of less than 15 is achieved with deteriorating mental status and potential spinal 
injury and also with deteriorating symptoms appearing [148]. Symptoms of a concussion 
may not be too obvious for several hours after injury. Therefore, most concussions are 
not identified until 24 hours or even more [149, 150]. Furthermore, most concussion 
diagnosis is evaluated based on self-reported symptoms [150]. 
The Standardized Assessment of Concussion (SAC) and Sport Concussion 
Assessment Tool (SCAT3) or Child SCAT3 is used as a standard protocol to assess 
injured athletes for concussion. It can be used for athletes from aged 13 years and above. 
This standardized tool is developed to be used only by a medical professional [148]. 
However, this evolutionary method to diagnose the concussion is not always effective 
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because not all concussed athletes will be identified within the expected period of injury 
[149, 150].  
There is no specific diagnostic test or biomarker for a concussion. Currently, the 
essential and key element of a concussion diagnosis is to confirm the existence of signs 
and symptoms after any person has experienced a sudden blow to the head or body. A 
fundamental diagnosis of concussion purely depends on an athlete’s self-report of signs 
and symptoms. This self-based report is made complicated due to insufficient information 
from the respected individual [151]. 
Later, multiple evaluation tools were developed such as symptom scales and 
checklists, balance testing, and neurocognitive assessments to increase the sensitivity and 
specificity of identification of the concussed athletes [152-155]. Following this, a few 
conventional neuro imaging techniques are used to diagnose the concussion. The common 
neuro-imaging techniques which have been used to diagnose the head and brain injuries 
are conventional computed tomography (CT) which uses ionizing radiation and magnetic 
resonance imaging (MRI) which uses radio frequency. CT and MRI scanning is usually 
used to scan severe head trauma injuries to locate the structural (bone and tissue) damages 
such as fractures and hematoma [156]. However, these techniques have limited diagnostic 
information on concussion per se because, in most of the cases, the structural imaging 
appeared to be normal [156]. Furthermore, these techniques involve ionizing and non-
ionizing radiation respectively, and are costly and time-consuming [149, 157].  
Generally, people who play contact sports such as rugby are at high risk of 
concussion and the ensuing side effects. This is supported by a recent systematic review 
on rugby union and rugby league in the UK [158]. Hence, researchers are trying various 
Chapter 8                                                                                                       Concussion                                                                      
230 
 
methods to diagnose and identify the concussion at an early stage, also taking into account 
that the blood-brain barrier (BBB) is one of the important components in the brain where 
it separates the circulating blood and extracellular fluid (indicates all body fluids) in the 
central nervous system) [159]. The disruption of the BBB (having a high possibility to 
happen) results from a concussion and traumatic brain injury. TBI, a crucial and still 
unsettled concern is the question of how best to detect possible breakdown in the BBB 
following neuro-trauma or concussion. Therefore, a new clinical trial was carried out to 
address this issue where the breath analysis technique has been used. This project is the 
first clinical trial using breath analysis for a concussion study.  
The motive for this study is to measure the alveolar breath from injured players to 
monitor VOCs from the exhaled breath to see whether there are any differences in exhaled 
VOCs concentration by comparing with the exhaled breath of healthy rugby players. 
Also, the common VOCs such as methanol, acetone and isoprene were monitored from 
exhaled breath of the injured rugby players and healthy rugby players. These compounds 
can be detected easily via exhaled breath which can be co-related with concentration of 
blood. Besides that, we wanted to monitor whether there is any biomarker produced 
associated to N-acetyl aspartate (NAA) (protonated m/z 176) from the exhaled breath due 
to the concussion. NAA is an amino acid that is present in the vertebrate brain which is 
primarily being stored in the neurons and secondly in the oligodendrocytes. NAA plays 
many important roles in the physiology and metabolic processes of the brain [12]. In 
addition to that, other potential VOCs were investigated. 
This project was a collaboration with the Neuro Trauma Department of Queen 
Elizabeth Hospital (QE), Birmingham and the School of Rehabilitation and Sport Science 
and School of Physics and Astronomy of the University of Birmingham. If this technique 
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is successful, it could lead to a development of a non-invasive method to diagnosis the 
concussion symptoms as early as possible. 
  The injured players also have undergone other medical tests at the Queen 
Elizabeth Hospital, Birmingham and the School of Rehabilitation and Sport Science of 
the University of Birmingham as listed below: 
• MRI (T1, T2, functional resting state, DTI, venous BOLD and MR spectroscopy) - 
no pre-season screening players have had this. 
• ImPACT computerised test- it is a standardized test to check the absorption of 
energy during the fracture in the head 
• WAIS-IV symbol search and digit span (reversed lists only)- this is a test to 
examine the association between intellectual function and memory 
• 9-hole peg test- it is a standardized test to check the upper extremity function by 
using a shallow container holding nine pegs and wood which has nine empty holes 
• SCAT-3 (Sport Concussion Assessment Tool)- it is a standardized method to 
evaluate players injury level 
• Balance assessment with the Tekscan force plate and Wii Balance Board, using the 
Modified Balance Error Scoring System protocol- it is a protocol to assess sports 
concussion 
• Neurological exam – it is a test to check the sensory neuron and motor responses 
• Transcranial magnetic stimulation- it is a procedure to stimulate the brain cells.  
• Blood, urine and saliva sampling for metabolomics and brain tissue damage markers 
 In this study, breath analysis of healthy rugby players is being utilized as a tool for the 
study of the physiological process which is mainly focussed on the brain [14].  
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8.2 Details of analytes measured from exhaled breath of rugby players 
(healthy and injured players) 
Philips et al. [46] stated that different compounds have been found in the exhaled breath. 
Isoprene, acetone and methanol [160] are the main compounds emitted in human breath 
which correlated with daily activities and metabolism. This is supported by a few other 
researchers, who mentioned that major compounds from the healthy individuals exhaled 
breath are, isoprene and acetone [161] and also methanol [162]. The results of this study 
encouraged us to do the investigation towards healthy rugby players and rugby players 
who suffered a concussion to understand whether their sports activities influence these 
common VOCs or not.  
The reasons for these molecules to be selected for this study are: 1) these 
molecules have been monitored to be existent in human breath and blood at predominant 
concentrations, and 2) these VOCs are important because they cover a broad range of 
solubilities where these VOCs concentrations are high in the exhaled breath, and they can 
be measured using a good signal to noise ratio [163]. Therefore, in this study, we have 
investigated acetone, isoprene and methanol in healthy and injured players (after 68 hours 
of injury) to monitor whether there is any difference in the concentration of these VOCs 
resulting from concussion. Table 8.1 shows the information about in-vitro blood/gas 
partition coefficients of acetone, isoprene and methanol and details about these molecules 
are described in section 8.1.  
In this study, PTR-MS was used to measure the exhaled breath of healthy rugby 
players and players who had suffered a concussion, to measure these common VOCs 
(methanol, acetone, and isoprene) and also other potential VOCs.  
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Table 8.1 Information about in-vitro blood/gas partition coefficients of the VOCS chosen 







Acetone (C3H6O) 59 341 
Isoprene (C5H8) 69 0.75 
Methanol (CH4O) 33 2700 


















Isoprene is a common organic compound also known as 2-methyl-1, 3-butadiene and the 
formula is C5H8 (protonated m/z 69). Isoprene can be produced by a biogenic process 
such as in trees and plants. Isoprene can be categorized as a prominent VOC from the 
human body as a result of the metabolic pathways. From literature, isoprene which 
excretes through the lungs has a low water solubility and low boiling point [13].  
Recent theory explains that isoprene has been produced by living organisms and 
is made from isopentenyl pyrophosphate (IPP) and its isomer dimethyl allyl 
pyrophosphate (DMAPP) [165, 166]. Two important metabolic pathways linked with 
DMAPP have been found: mevalonic acid pathway (MVA) and the 1-deoxy-D-xylulose-
4-phosphate/2-C-methylerythriol 5-phosphate (DOXP/MEP) pathway [13]. The 
production is related to the isoprenoid biosynthetic pathway. Deneris et al. has mentioned 
there is a possibility that breath isoprene may be linked to cholesterol genesis (DL-
mevalonate pathway) [165]. Besides that, Kennedy et al. reported that breath isoprene 
level depends on a number of clinical conditions, but the physiological definition of these 
changes has not been standardized yet [167]. He also mentioned based on some 
supportive evidence, that isoprene is related to cholesterol biosynthesis and the 
measurement could be used to monitor lipid disorders [167, 168].  
Isoprene concentration from the exhaled breath in the human body is determined 
by physical activities [166]. Lindinger W et al. and Karl et al. have reported that isoprene 
concentration from exhaled breath increases within a few seconds after exercise [13, 169]. 
Karl et al. also stated that increases in heart rate associated with body position such as 
standing, reclining and sleeping increases isoprene concentration in the breath [170]. His 
experiment which involved atorvastatin therapy has suggested that isoprene can be used 
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as a non-invasive marker for cholesterologenesis [170]. J.King et al. has proposed that 
isoprenoid deficiency linked to muscular dystrophy can be explained by the degeneration 
of not only skeletal muscle but also cardiac or diaphragmatic muscle which has been 
affected by Duchenne muscular dystrophy (DMD) [171]. 
8.2.2 Acetone 
 
Acetone (a type of ketone) also known as propanone is an organic compound with the 
formula (CH3)2CO (protonated m/z 59). Acetone could be produced by biogenic 
emissions e.g. naturally, in plants, forest, trees, fruits and flora and also by anthropogenic 
emission e.g. vehicles. It also could be found as a breakdown product of animal fat 
metabolism. 
There are three ketone bodies, acetone, acetoacetate, and β-hydroxybutyrate. 
Acetone in the body is produced via ketogenesis [32]. Ketone bodies are produced from 
acetyl-CoA, mainly from the mitochondrial matrix of liver cells during the fatty-acid 
metabolism [32]. Ketone bodies play an important role as a major energy source for brain, 
heart, and muscle when glucose is not available as a fuel source. Ketoacidosis happens 
when there is a large amount of accumulation of ketone bodies and acetone helps to 
maintain the pH buffering capacity [33].  
Acetone is produced via spontaneous de carboxylation of acetoacetate. It is 
produced by the non-enzymatic decarboxylation of acetoacetate or is catalysed by 
acetoacetate decarboxylase. It is highly volatile. Therefore, it could be found in the breath 
(because it has a high vapour pressure), urine and blood. Acetone is the most abundant 
compound in human breath. 
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 A high concentration of acetone is observed in fasting healthy people after a few 
hours (e.g. 10-15) or after extreme sports activities for 2-3 hours. This happens due to the 
metabolism of the reserved sugar in the blood and fat to acetone [13]. Wang Z et al. used 
acetone as a tool to test the breath of Type 1(T1D) and Type 2 (T2D) diabetic patients. 
He found that acetone could be used as a biomarker for T1D and as an observation tool 
for T2D. Smith D et al. undertook breath analysis using acetone and other metabolites as 
a disease marker [172]. This could be used in the future to give a non-invasive technique 
for glycemic control or for other potential diseases [172]. 
8.2.3 Methanol 
Methanol is the simplest alcohols also known as methyl alcohol. Its chemical formula is 
CH3OH (protonated m/z 33). It is a volatile compound which produces a characteristic 
flavour. Contrary to ethanol, methanol is highly toxic. Methanol is produced naturally via 
anaerobic metabolism from many types of bacteria. Pectin is a source of methanol [13]. 
Also, methanol could be considered as a multi-potential carcinogenic agent [173]. 
A previous study has shown that the concentration of methanol in the body will 
be increased after the consumption of fruits [35]. This is due to the lack of natural pectin, 
which is produced in the human colon by bacteria. Pectin is degraded by faecal bacteria 
and methanol is released by the degradation [35].  
According to Bajtarevic et.al., lung carcinoma patients have a lower concentration 
of methanol compared to healthy volunteers in which a lower concentration could be 
partially due to age factors and a lower exhalation force [36].  
In other studies, Turner C et al. has reported that breath methanol levels are not 
associated with age and breath ethanol or ethanol consumed [174]. However, he also has 
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mentioned that it could be probably inversely related to Body Mass Index (BMI). Fruit 
intake could be the reason for the inverse relation of methanol concentration with BMI 
[174].  
8.3 Experimental details  
 
For the concussion studies, nineteen healthy rugby players’ breath samples (Male: age 
20-24) were collected before the concussion (as control). Seven players who sustained a 
head injury had their breath samples collected 2-3 days (68 hours) after the injury to 
compare with the controls. The players were asked to complete a detailed questionnaire 
which included information about the home, diet (especially consumption of fruit, fruit 
juices or any flavoured drinks), smoking status, health condition, and medications. A 
glass syringe (100 ml, Sigma-Aldrich) was connected to the breath sampling tubing using 
a stopcock (Braun Medical Limited) to take the breath sample. The volunteers were calm 
and in a relaxed condition during the breath sampling. Also, they were requested to breath 
in and breath out normally using a gas-tight respiratory system with an in-line CO2 
mainstream sensor connected to a fast-time response capnometer (Capnogard 1265 
Novametrix Medical Systems Inc) [2]. The breath samples were taken using syringes 
during the alveolar plateau on the capnograph. 3 to 4 breath samples were collected as 
replicates to increase the statistical power (precision) of the study and to reduce the 
statistical errors. In addition, more samples were taken, in case the instrument failed or in 
case problems arose during handling of the syringes. Also, these samples were served to 
check the repeatability. For each sample, 3 mass scan cycles were taken. The glass 
syringes were used in this experiment because they do not contain any volatiles and are 
easy to clean using an autoclave. The breath samples were sealed in the syringes using a 
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luer lock fitting. All the samples were kept in an incubator for 30 min at 40 oC to reduce 
condensation effects. Syringes were covered with a heating bag maintained at 45 oC 
(figure 3.12). The mass range analysed was from an m/z 20 to 200. The inlet flow was set 
to 10-15 ml/min and the drift tube voltage was set to 600 V (E/N of 140 Td) to reduce the 
water clustering. The data were analysed and signal intensities were normalised to H3O
+ 
signal of 50 million counts because H3O
+ can change over the course of a day or may 
differ from one day to another in the instrument. The room air samples were collected 
and measured in the same condition as breath. The reason to do this protocol is purely to 
check any background contamination or contribution to the subject’s breath [2].  
In addition to that, the headspace of NAA was performed at 140 Td to identify the 
product ions. NAA was purchased from Sigma Aldrich (CAS Number: 997-55-7). 0.1 mg 
of NAA was placed in a 20 ml vial. The inlet of a vial containing the compound was 
connected to a hydrocarbon filter via a 1/8th inch peek tube and nitrogen gas was then 
flowed through the trap. The vial was wrapped with a heating tape to increase the sample 
temperature to 80 o C. This was needed because the sample was in the solid form and has 
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8.3.1 Details of the players who took part in this breath analysis of 
concussion study 
Nineteen rugby players (male) took part in this study as controls and 7 rugby players who 
had a concussion during the rugby tournament have taken part as patients. There were 
two players (see table 8.2) who had given breath samples as controls (RCP13 and RCA23) 
and also as injured players (RCP22 and RCP23). The rest of the injured players (5 injured 
players) had not given breath samples as controls. The players and patients were given 
specific ID (identification code) by the Neuro-trauma Department of QE Hospital, 
Birmingham.  
Table 8.2 Details on healthy male rugby players (controls) and injured male rugby 
players. This table includes details about age, weight, height, ID (identification code) and 










*- RCP31 18 99 190 
*- RCP33 23 95 183 
*- RCP24 25 90 184 
RCA09 - 28 94 182 
RCA10 - 33 109 201 
RCA11 - 26 97 185 
RCA12 - 24 99 187 
RCA13 RCP22 25 122 187 
RCA14 - 27 106 118 
RCA15 - 27 114 178 
RCA 17 - 27 122 190 
RCA18 - 21 87 187 
RCA19 - 25 124 185 
RCA20 - 27 126 178 
RCA21 - 26 92 188 
RCA22 - 32 106 183 
RCA23 RCP23 21 100 183 
RCA24 - 25 117 200 
RCA25 - 20 118 189 
RCA26 - 18 71 155 
RCA27 - 21 126 204 
RCA28 - 21 82 175 
* RCP26 21 100 200 
*- RCP18 21 76 187 
* The injured rugby players who don’t have samples as controls 
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8.3.2 Data analysis  
 
For breath analysis, the contribution from the room air and surrounding places would 
influence the concentration of exhaled breath and could lead to confounding variables 
[16]. For example, in the case of food intake, such as garlic [39] or the intake of orange 
or citrus juices and also citrus fragrances [175], it can be found in the exhaled breath 
which could lead to multiple variables. 
 Besides that, if the analysis produced a significant amount of productions from 
the surrounding factors such as room air (background), food intake and smoking, strict 
and extra cautious action should be implemented when using it to find any biomarkers.  
 The statistical analysis was done using  MINITAB version 18. For this study, the 
Ryan-Joiner test was used to identify the data classification. It assesses the strength of the 
correlation and found that the data set was not normally distributed. This suggested to use 
non-parametric tests and therefore, Mann Whitney U-tests were used to determine the m/z 
values between the healthy players and injured players. There were two volunteers in the 
group of injured players (RCP13 and RCP23) who had also given breath samples as 
healthy players. The pre-breath samples (before injury) from these healthy players were 
collected six months before the collection of their samples as injured players. Therefore, 
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8.4 Isoprene calibration 
Isoprene, having a boiling point of 34.07ºC (307.22K), can be considered as a very 
volatile organic compound and is emitted in significant quantities into the atmosphere by 
many species of trees and plays a major role in atmospheric chemistry. It is also an 
important trace component of human breath as mentioned previously and is involved in 
many biosynthetic pathways. It is also produced in large quantities by industry.  
It is useful to be able to dynamically generate trace vapour standard mixtures of 
isoprene over a wide range of concentrations for use in calibrating analytical instruments 
used in the direct analysis in such diverse applications as end-tidal breath analysis and 
monitoring of atmospheric environments, both outdoors and indoors (occupational and 
domestic). Static trace gas/vapour standards in cylinders are expensive and limited to just 
one concentration, unless mixed with an adjustable flow of diluent gas. There is a range 
of methods for the dynamic generation of standard atmospheres of gas mixtures, 
especially at trace concentrations.  
Isoprene is readily photo-oxidisable and likely to decompose when stored in 
permeation tubes. Refillable diffusion tubes can be filled freshly just prior to any use in 
darkened conditions, thus reducing the degradation by such photo-oxidation. Here, the 
use of refillable diffusion tubes in a tube holder thermostatted at 0ºC (273.15K) in a bath 
containing an ice/water mixture for gravimetric calibration and subsequently in the 
calibration of Ionicon quadrupole proton transfer reaction mass spectrometer is reported. 
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8.4.1 Materials and methods 
Section 8.4.1, 8.6 and 8.7 were partially elaborated from a draft paper for future 
publication on isoprene calibration titled, ‘Dynamically generating trace standard 
atmospheres of isoprene vapour in air using refillable diffusion tubes and their use in 
calibrating Proton Transfer Reaction Mass Spectrometers’ (Authors D.J Blenkhorn, P.D 
Chellayah and J.M Thompson). 
Isoprene 99 % purity from Sigma Aldrich was used using oxygen-free nitrogen (99.998% 
purity) as a carrier gas. 
Tracer Cert® refillable diffusion tubes (supplied by Tracer Measurement Systems 
Ltd.) were used to generate the trace vapour standards of isoprene for gravimetric 
calibration [176]. The calibration was done over about a 5 hour period with a refillable 
diffusion tube with a precision bore section of length 2cm and 0.5mm bore (figure 8.1). 
The refillable diffusion tubes were weighed periodically using a Cole Palmer Symmetry 
PA120 digital balance (120g x 0.0001mg), recording weight to 0.1mg. Figure 8.3 shows 
the setup of a diffusion tube using PTR-MS quadrupole. 
A diffusion tube with a precision bore section of length 2cm and 0.2mm bore in 
the calibration of an early version of the Ionicon quadrupole Proton Transfer Reaction 
mass spectrometer (Ionicon Analytik GmbH, Innsbruck, Austria) was used for breath 
analysis of isoprene of healthy rugby players and rugby players who suffered concussion. 
Carrier gas (nitrogen) flows of 150 to 800 ml min-1 produced isoprene concentrations 
ranging from 0.036 to 0.192 mg l-1. 
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Figure 8.1 Different sizes of diffusion tubes. This picture was reprinted from J.Thompson 
, 2009, Journal of environmental monitoring [176]. 
 




    Figure 8.2 The experimental set up of isoprene calibration for Ionicon quadrupole    
    PTR-MS using a diffusion tube (precision bore section of length 2 cm and 0.5mm  








Chapter 8                                                                                                       Concussion                                                                      
245 
 
8.5 Results  
8.5.1 Pre and post injured samples from the same players  
Figure 8.3 represents a full mass spectrum of an injured rugby player’s exhaled breath 
using 140 Td. The mass spectrum was the average of three breath cycles. 
 
Figure 8.3 An example of a mass spectrum which shows an average of three breath cycle 
of an injured rugby player measured using Ionicon quadrupole PTR-MS.  
 
There were two samples taken from the same players who had given the breath sample 
before and after the concussion and also the respective background. Therefore, there was 
no statistical analysis performed due to the small number of samples. However, an 
exploratory study was done for these two players by looking for obvious differences 
between pre and post-VOCs from the exhaled breath. The first player was given 
identification as RCA23 for pre- breath sample and RCP23 for the post breath sample. 
Meanwhile, the second player was given identification as RCP13 for pre-breath sample 
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 Figure 8.4 a) and b) show the prominent VOCs which are different in concentration from 
the exhaled breath of healthy and injured players. There was an increase in the 
concentration for some VOCs of injured player samples compared to healthy samples 
such as m/z 45, 47, 51, 57, 59, 69, 75, 77, 79, 89, 93, 97, 107, 109, 124, 125 and 126. 
Also, there was a decrease in concentration of some VOCs observed for injured player’s 
samples compared to healthy samples. For instance, m/z 33, 41, 61, 63, 71, 73 and 81 
were observed to decrease in the concentration in the injured player’s breath sample. 
Figure 8.5 a) and b) show the obvious difference in exhaled VOCs obtained from 
the same rugby player before the injury (RCB13) and after injury (RCB 22) and also the 
respective background measurements. For example, a decrease in the concentration for 
some VOCs for the injured player compared to healthy players such as m/z 51, 57, 59, 63, 
71,73, 75, 77, 79, 81 and 101. There was some increase in some of the VOCs such as m/z 
41, 47, 69, 89, 93, 95, 107, 109, 124 and 126. 
Besides that, there were some common VOCs decreased in the concentration in 
both injured rugby players obtained when compared to healthy samples. For example, m/z 
33, 61,63,71,73,81,101 and 103. 
In both injured rugby players’ samples, there were some common VOCs observed 
from the exhaled breath as increasing in concentration. The observed common VOCs are 
m/z 47, 59, 69, 89, 93, 95, 107, 109, 124 and 126. 
 






 8.4 b)  
Figure 8.4 a) and b) Show the differences of obvious VOCs (starred) from the exhaled 
breath of healthy rugby player (RCA23) and injured rugby players (RCP23) which the 

































































 8.5 a) 
8.5 b) 
Figure 8.5 a) and b) Show the differences of obvious VOCs (starred) from the exhaled 
breath of healthy rugby player (RCB13) and injured rugby players (RCB22) which the 
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8.5.2 Comparison of methanol, acetone and isoprene of healthy players and 
injured players 
Figures 8.6 - 8.8 show the box plots (Origin Software) of methanol, acetone and isoprene 
respectively for healthy rugby and injured players which summarises the results for 
healthy rugby players and injured rugby players. The box plot was used to show the 
median, mean, lower quartile (LQ), and upper quartile (UQ) for respective volatiles. 
For the statistical analysis of isoprene and acetone, Minitab software (version 18) was 
used. The Mann Whitney test was applied to determine whether isoprene and acetone 
showed a statistical difference between healthy rugby players and injured rugby players. 
Two product ions have shown significant differences in intensities between healthy rugby 
players and injured rugby players. The significant p-values for acetone and isoprene are 
explained in detail later. 
For methanol (m/z 33) (figure 8.6) there was no statistical test performed for both 
healthy and injured players because the methanol concentration in the room air for the 
injured players were considerably high compared to the healthy players’ room air sample. 
From the box plot, it is clear that the presence of the volatiles in the room air is not 
negligible. Taking into account the confounding variables, the data for methanol was 
presented using a box-plot which included room air to show that there was methanol 
contamination during the injured player breath sampling. Meanwhile, for acetone and 
isoprene, the room air contribution was subtracted for the box plot presentation because 
it has the negligible effect on the concentration in the breath samples of healthy and 
injured rugby players.  
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For acetone results, the null hypothesis states that the difference in the median for 
two groups of rugby players is 0. The achieved confidence level was 95.08 % and the 
median for acetone scores was higher for healthy rugby players compared to injured rugby 
players. The p-value is 0.014, which is less than 0.05, where the decision is to the null 
hypothesis and concludes that there is a statistical difference in median engagement 
between two independent groups which consist of healthy players and injured players. 
Meanwhile, the median engagement for isoprene (m/z 69) scores is higher for 
injured rugby players compared to healthy rugby players (controls). The achieved 
confidence level for isoprene is 95.06 % .The P value is 0.015 which is less than 0.05 (i.e 
p < 0.05), where the decision is to the null hypothesis and it can be concluded that there 
is a statically difference in median engagement between two groups. 
The box plot presentation clearly shows the presence of the volatiles are negligible 
either in the room air of the School of Sports Science, University of Birmingham or the 
Brain Imaging centre of the QE Hospital. In addition to that, this analysis is based on 
comparisons of the injured players and healthy players affected similarly by the room air 
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Figure 8.6 Boxplot showing lower quartile (LQ), median, mean and upper quartile (UQ) 
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Figure 8.7 Boxplot (acetone) showing lower quartile (LQ), median, mean and upper 
quartile (UQ) normalised counts per second for exhaled acetone from a healthy rugby 
player and an injured player. 
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Figure 8.8 Boxplot (isoprene) showing lower quartile (LQ), median, mean and upper 
quartile (UQ) normalised counts per second for exhaled isoprene from healthy rugby 
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8.6 Gravimetric calibration and the use of scaling for using different 
sized Tracer Cert® diffusion tubes 
Figure 8.9 represents a weight loss of isoprene versus time (min), figure 8.10 shows 
isoprene calibration (normalised data) and figure 8.11 shows isoprene calibration (un-
normalised data) using the Ionicon quadrupole instrument.  
By applying a statistical design of regression experiments, better estimation on 
the rate of emission of any vapour trace was achieved from diffusion tubes. Figure 8.9 
shows the excellent robust rank regression method of Hettmansperger and McKean is 
available in Minitab® 18 [177]. In this graph, weight changes were monitored from the 
start of the experiment. For the first reading, we obtained a larger change compared to 
other points because of the initial loss of more volatile impurities. This might influence 
and leverage the fitted line. However, estimating emission rates by applying a fitted line 
just for five points would give a straight line and the influence and leverage of the first 
point in the plot will be “down-weighted” using robust and resistant linear regression. 
This has produced good and close fits between weight loss versus time concentration. On 
this fitted line plot [177], the points generally follow the regression line. The points 
adequately cover the entire range of weight (mg) values and the confidence envelope 
[177]. There was no curvature in the data and also there was no appearance of outlier 
except the contribution from the impurities on the surface of the diffusion tube which 















































Isoprene in tracer refillable diffusion tube, bore 1mm 2cm long 273K
cumulative weight loss mg vs cumulative time (min)
robust regression fits (mg) vs cumulative time (min)
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8.7 Using calibrated diffusion tubes and other Tracer Cert® diffusion 
tubes with scaling for calibration for of PTR-MS quadrupole  
The same principles and considerations as the gravimetric calibration were applied in 
designing experiments for the calibration of analytical measurement using the refillable 
diffusion tubes.  
For the isoprene calibration of PTR-MS using a diffusion tube, we used robust 
regression statics and a linear regression plot (fitted linear model). From the results, we 
were 95 % confident that the confidence interval contains the population where the p-
value is less than 0.05 for both normalised and non-normalised data (figure 8.10 and 
figure 8.11). Besides that, for prediction interval, we achieved 95 % confidence that 
observations fall within the interval indicated by the green line. However, this is only true 
for the concentration values that are within the range included in the analysis. The 
regression equation for normalised data is cps = 21420 +1468320 mg/l and for not 
normalised data is cps = 23784 + 1460648 mg/l. As you can see from both graphs 
(normalised and not normalised), the regression plot shapes are very similar, except that 
the vertical scale (cps or normalised cps) is different by a factor of four. 
 





Figure 8.10 Isoprene calibration (normalised data) of PTR-MS (Ionicon) using 0.2   
 mm bore 2 cm long diffusion tube 
 
 
Figure 8.11 Isoprene calibration of PTR-MS Ionicon for non-normalised data (robust rank 
regression) using refillable diffusion tube 
. 




It should be taken into account that the number of days collecting the injured players’ 
breath samples is variable because it is impossible to determine when the concussion 
would happen and when the subjects would be available to do further medical tests and 
give their breath samples. There were no product ions found from the headspace of NAA. 
Therefore, the fragmentation pattern of NAA was unknown. Perhaps, it could be possible 
that NAA does not fragment. 
         For the comparison of pre and post breath samples of the same rugby players, 
(RCA23(pre)-RCP23(post)) and (RCB13(pre)-RCB22(post)), there were some VOCs 
found to increase in concentration and some VOCs were found to decrease in 
concentration from the injured players VOCs compared to healthy players. Unfortunately, 
these findings may be somewhat limited by the number of players who had given pre and 
post samples. Although there were some differences in the VOCs concentration of two of 
the healthy players and injured players, the precise causes of these changes remain 
unclear. This needs further investigation by taking more samples of pre and post injury 
of the same player to monitor the correlation and consistency of difference in 
concentration of VOCs from the exhaled breath. 
        From figure 8.7, the methanol (m/z 33) concentration in the room air was higher for 
the injured rugby players’ room air compared to the healthy rugby players’ room air. 
Therefore, it was complicated to do any statistical analysis. Methanol has been used in a 
variety of commercial products, especially as cleaning and purification materials [178]. 
Besides that, methanol also has been used to prepare some medicines [178]. Possibly, 
methanol would have been used in the cleaning or purification material in the Brain 
Imaging centre or places nearby the MRI room. This would have contributed to high 
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concentrations in the room air of the Brain Imaging Centre. It clearly shows that there 
was a high possibility that the players’ breath was contaminated with this room air 
condition during the MRI imaging and the biological half-life of the methanol is unknown 
[160]. Therefore, methanol is pointless to be used as an indicator to evaluate any 
physiological condition of the players who had concussion.  
     According to the Mann Whitney statistical analysis for isoprene, there is a 
significant difference between the healthy and injured players. The isoprene 
concentration of the injured players is higher compared to the healthy rugby players. The 
healthy rugby players have a lower concentration of isoprene most probably because they 
were engaged with the exercise and training program for the rugby matches. Also, they 
were on a strict diet schedule.  
         However, due to concussion, the players had undergone some cognitive symptoms. 
These would have caused the players to be unfit to perform their normal activities such 
as training, exercise and also diet. Also, some evidence has linked isoprene levels to 
different physiological states [25]. According to King et al, isoprene tends to react 
sensitively associated to an increase in ventilation during the exercise session (isoprene 
is strongly lipophilic) [168]. For example, isoprene level is low during sleep [179] and 
increases when there is change in body posture. Also, during the physical exercise, a 
drastic increase in isoprene level was reported [169]. Hence, in our study, the injured 
players were in the calm state and did not perform any activities before and during breath 
sampling.  
         Dahl et al, have reported that non-metabolic isoprene clearance occurs through the 
lungs [180]. This perhaps can be linked to the abnormal health condition and abnormal 
metabolic activities in injured players. The high excretion of isoprene via breath from the 
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injured players could be due to the accumulation of non-metabolic isoprene after the 
concussion.      
        Acetone in the human body depends on biological variability, diet and natural daily 
activity of an individual [181]. In addition to that, the concentration of acetone is 
influenced by fasting or performing strong exercise for a few hours [13]. Therefore, these 
factors have to be taken into account in order to determine the correlation of the 
differences in the concentration of acetone from the exhaled breath of healthy players and 
injured players. From the statistical analysis, the results show that there is a significant 
difference between healthy players and injured players. The concentration of acetone of 
the injured players was significantly lower compared to healthy rugby players. Due to 
concussion, injured players potentially tend to have abnormal metabolism, especially an 
abnormality in the conversion of acetoacetate or isopropanol to acetone [182]. However, 
since diet is one of the important factors which affects the concentration of acetone, this 
concerns an uncertainty in the use of breath acetone as an indicator to monitor the 
concussion. 
     The Tracer Cert® Diffusion Tube has provided a significant advantage with the ease 
and quickness of calibration. A significant weight loss can be measured easily using a 
wide bore capillary of short length in a shorter period (few hours or days) using an 
electronic balance weighing to 0.1mg. The isoprene calibration result shows that 
calibration using diffusional tubes was in good agreement with the gravimetrical method. 
 
 




This study has shown the non-invasive application of PTR-MS by detecting 
significant differences of acetone and isoprene produced by healthy and injured rugby 
players via exhaled breath. For those rugby players with the concussion, the 
measurements were taken after 2-4 days of the injury.  
  Whilst the breath sampling was carried out, the players were healthy and 
conscious after the concussion. Although a significant difference was obtained for healthy 
and injured rugby players, it is crucial to understand about a low concentration of acetone 
in exhaled breath. Acetone concentration in humans depends on variable factors. 
Therefore, it will be challenging to use it for concussion monitoring purposes. 
For isoprene, although this current study is based on a small number of injured 
rugby players, it gives some clue that it could have an impact on injured players. This is 
essentially a Phase 1 clinical trial of a potentially interesting new medical diagnostic test. 
Therefore, further investigations by doing longitudinal studies are compulsory as this 
result is sufficiently encouraging to go onto a Phase 2 clinical trial. This longitudinal 
study also will aid the interpretation of other VOCs which can be correlated with the 
concentration of VOCs before and after the concussion in order to obtain concrete and 
conclusive results. Also, these VOCs can be potential indicators of concussion in the near 
future.  
For future work, it’s been suggested to get the breath samples of the injured player 
immediately after the concussion to monitor the immediate effects on VOCs from exhaled 
breath. 
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CHAPTER 9  
9 CONCLUSIONS AND FURTHER DISCUSSION 
The research work reported in this thesis has highlighted the potential of applying Proton 
Transfer Mass Spectrometry in the health sciences. The main aims of this chapter are to 
summarise the key outcomes and to discuss future directions. 
9.1 Key Conclusions and Summary of Chapters 
9.1.1 Volatile Organic Compounds Associated with Shisha Paste and Shisha 
Smoking 
This thesis presented the first PTR-MS study of shisha. Many VOCs were detected, either 
from the headspace of shisha paste, or from the volatiles coming out of the water pipe 
following the combustion of charcoal and shisha paste. Many harmful VOCs were found, 
predominantly from the headspace of the burning charcoal, namely benzene, toluene, 
propene and acetaldehyde.  
9.1.2 Investigation of the product ions resulting from the reactions of H3O+ 
with menthol and vanillin and associated compounds (cyclohexanol, phenol, 
anisole, benzaldehyde and guaiacol). 
The main objective of this investigation was to identify the vanillin and menthol product 
ions as a continuation investigation of Chapter 4 (VOCs from shisha smoking) where 
VOCs emitted from vanilla and mint flavoured shisha paste were measured. The key 
compound for vanilla is vanillin and menthol for mint. Vanillin and menthol product ions 
were investigated as a function of the important PTR-MS parameter E/N. The 
investigations on vanillin and menthol product ions have led us to investigate the reactions 
of H3O
+ with associated compounds which have differences in the functional groups, 
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namely, cyclohexanol, phenol, anisole, benzaldehyde and guiacol. Some similar ions 
associated to menthol were identified from cyclohexanol such as m/z 55, 57, 67, 81 and 
83.  
Of relevance to the shisha investigation, our results have shown that menthol has 
been used to prepare mint flavoured shisha paste but no vanillin was used in vanilla 
flavoured shisha paste. 
9.1.3 PTR-ToF-MS studies of the reactions of H3O+ and O2+ with the 
anaesthetic gases halothane, isoflurane, enflurane, sevoflurane, desflurane 
and methoxyflurane 
This study on anaesthetics has identified product ions from the reactions of H3O
+ and O2
+ 
as a function of reduced electric field for a number of commonly used (isoflurane and 
sevoflurane) and less commonly used (halothane, enflurane, sevoflurane, desflurane and 
methoxyflurane) anaesthetics. All the details on possible channels were described and 
identified. Although this study focuses on identifying the product ions resulting from the 
anaesthetics, the findings will have a bearing on a further investigation of on-line 
monitoring by applying mass spectrometry techniques to investigate changes of 
anaesthesia in breath post-surgery via longitudinal studies. Moreover, this study can 
provide supporting data which can be used to improve guidance on occupational safety 
and health for personnel who work in the operating theatres. This is important because 
the personnel working in operating theatres and intensive care units are exposed to toxic 
agents particularly volatile anaesthetics which can cause adverse effects.  
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9.1.4 Washout Characteristics of the Peppermint capsule 
 
In this study, the data indicated that there is a great variability in breath VOCs released 
from peppermint oil which contains various volatiles (namely 1,8-cineole, menthol, 
menthone, limonene, with α-pinene and β-pinene) between inter-individual and intra-
individual after ingestion of the peppermint capsule. The reason for these great 
differences could be the way the capsule is dissolved in the gut and the effect of diet. 
Perhaps metabolism is different for different people due to different BMI (Body Mass 
Index). Also, potentially, each peppermint oil capsule would have different 
concentrations of peppermint oil in the capsule. This probably would have an influence 
on the peppermint washout characteristics result of each individual who took part in this 
study. 
Further studies, which involve correlation measurements of expected VOCs in 
exhaled breath and blood, will need to be undertaken to monitor the variability of 
concentration between blood and breath washout characteristics. This could lead to in 
vivo studies in which in future breath sampling can be used to illuminate the 
pharmacokinetics of peppermint oil containing capsules which contains many volatile 
compounds.  
This study has identified that, m/z 155 is associated with menthol, menthone and 
1,8-cineole, whereas, m/z 137 associated with α-pinene, β-pinene, limonene, fragments 
of menthone and fragments of 1,8-cineole, and m/z 81 is associated with α-pinene, β-
pinene, limonene, menthone and 1,8-cineole. 
 Although VOCs from exhaled breath after ingestion of the peppermint oil capsule 
were identified using PTR-MS, further parallel monitoring of the breath washout 
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characteristics of the peppermint oil containing capsule using GC-MS is needed. This will 
aid the investigation to confirm and support the identification of VOCs and washout 
characteristics of the peppermint capsule from exhaled breath.  
9.1.5 Breath analysis of Rugby Players who have had concussion (control 
and injured) 
 
This study is purely an exploratory study using breath analysis for healthy and 
injured rugby players (after suffering a concussion). Methanol, acetone and isoprene were 
used to investigate the healthy and injured rugby players. One source of weakness in this 
study, which has affected the measurements of methanol from the exhaled breath, was 
the contamination of the room air where the background level of methanol was higher 
than the exhaled breath of injured players. This was probably due to the use of cleaning 
materials in the MRI room. Therefore, methanol was not considered to be used as an 
indicator in this study. However, this contamination does not affect acetone and isoprene 
as the background level of acetone and isoprene were low in comparison to the exhaled 
breath of the injured player. 
For acetone and isoprene, the results have shown a significant difference between 
the healthy and injured rugby players. Although acetone has shown a significant 
difference between healthy and injured players, this has thrown up many questions, as the 
concentrations of acetone from exhaled breath are influenced by many known factors 
such as diet, metabolism activities and routine physiological activities.  
The result of isoprene following concussion of rugby players’ research, supports 
the idea that isoprene can be used as a potential indicator to evaluate protocols for 
monitoring the condition of the injured player for the next level of a clinical trial by doing 
a longitudinal study.  
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Also, this longitudinal study would provide some clues on the consistency of other 
VOCs’ concentration which can be correlated with concentration of VOCs before and 
after suffering a concussion. 
9.2 Limitations of the Investigations 
 
For the shisha smoking investigation, the only limitation was in identifying the VOCs 
being emitted from the headspace of the shisha paste and also headspace of shisha paste 
and charcoal. Although, we used GC-MS to aid in identifying many of the compounds, 
some product ions observed with PTR-MS could not be assigned to any compound. 
Therefore, certain compounds were recorded as unassigned. 
The main limitation of breath analysis (regarding the rugby player concussion 
study and the peppermint washout characteristics study) was the difficulty in recruitment 
where only a limited number of participants took part. For example, only two players had 
breath samples taken for pre and post-concussion. Besides that, the exhaled breath of 
injured rugby players was collected and measured after a few days of concussion. More 
importantly, we need to investigate the instant effects of concussion, i.e. taking the breath 
samples immediately after the concussion. This may provide stronger evidence of 
biochemical changes in the brain due to injury.  
Similarly, in this case, the samples were only allowed to be taken with the 
collaboration of the Neuro-trauma Department, Queen Elizabeth Hospital, Birmingham 
with limited permitted time following the ethical guidelines.  
Also it has to be noted that it was difficult to recruit more volunteers for 
peppermint washout characteristics because the measurement took more than 6 hours and 
required a volunteer to fast for approximately 10 hours prior to the measurement.  
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Despite promising results from concussion and peppermint washout characteristic 
studies, a larger sample size study is required to provide more conclusive results. 
However, the proof-of-principle studies presented in this thesis clearly demonstrate the 
usefulness and potential of using PTR-MS for medical purposes/assessment. In light of 
that, multi clinical research centres are involved in an EU (European Union) funded 
project which this project is being coordinated by Dr Simona Cristescu and Professor Paul 
Thomas. This project should provide more samples from multiple ethnic, gender and age 
groups in order to get a better understanding. Owing to having a larger number of samples, 
the confounding factors from the investigations can be limited. 
 
9.3 Future work related to current studies 
 
In this section, some suggestions and recommendations are proposed to improve the 
methodology, sampling, and also the importance of findings. 
 For future work, the existing current studies need to be extended. For example, 
further investigation of shisha smoking can be done using breath analysis of shisha 
smokers by taking pre and post shisha smokers breath samples to monitor the VOCs 
before shisha smoking and breath after shisha smoking. This combination of findings 
provides some support for the conceptualization of shisha smoking by taking into account 
VOCs being produced and being absorbed in the body, especially the lungs. It will be 
more prominent and accurate if we used online breath sampling rather than off line 
sampling which can be influenced by a lot of environmental factors such as exposure to 
sun light and extreme weather conditions. 
Meanwhile, for anaesthetics investigation, based on the data base of product ions 
from this work, it is possible to carry out further work to monitor the washout 
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characteristics of each anaesthetic compound and the metabolites using the PTR-MS 
technique.  
For the peppermint oil containing capsules washout study, a larger scale European 
study is being carried out (coordinated by Prof. P. Thomas and Dr. S Cristescu) to 
establish a standardized breath protocol. Also, given that limonene is an ingredient in 
peppermint oil, its washout characteristics from a large number of healthy volunteers will 
be extremely useful for comparison with the limonene washout characteristics from 
patients who are suffering from liver disease [2]. 
 For concussion studies, it has been suggested to get immediate breath sample after 
the concussion and also, the significant difference of exhaled isoprene between two 
groups (healthy and injured) suggests that this is worth investigating further in a Phase 2 
trial.  
9.4 Summary  
This thesis provides fundamental groundwork on PTR-MS applications in the health 
sciences and the evaluation of breath samples. This research work has contributed 
significantly to showing how PTR-MS can be used in the medical sciences. More intense 
clinical trials using PTR-MS relating to the screening and diagnoses of early stage disease 
are required.  
In this thesis it has been shown how the analysis of shisha smoke extends our 
knowledge of the volatiles being emitted and their threat to health. For the flavour 
compound, Vanillin, expected to be the main flavour compound in vanilla shisha paste, 
was investigated using PTR-MS for the first time. This led to original PTR-MS studies 
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on guaiacol and anisole to aid in the understanding of the reactions of H3O
+ with vanillin 
owing to changes in the functional groups.  
The investigation of product ions from the reactions of anaesthetics with H3O
+ 
and O2
+ has provided a large data base of product ions for halothane, isoflurane, enflurane, 
sevoflurane, methoxyflurane, and desflurane. This will be used in a future investigation 
of the elimination of anaesthetics from the body; which surprisingly is lacking. This has 
consequences to possible cognitive awareness after an operation and could be used to 
determine liver function. For the first time product ions of halothane, enflurane, 
methoxyflurane and desflurane are presented. 
The study of washout characteristics of peppermint oil via exhaled breath results 
showed that there were inter-personnel and intra-personal variation. The VOCs from the 
peppermint oil contained in the capsule and the exhaled VOCs after the peppermint 
capsule ingestion were tentatively identified using PTR-MS. GC-MS is needed to 
conclusively assign the compounds.   
For the concussion clinical trial, breath sampling and analysis were used for the 
first time to investigate the VOCs in the breath of healthy and head-injured rugby players.   
To summarize, the large amount of work presented in this thesis has highlighted 
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APPENDIX 1- GC-MS measurements of various shisha pastes 
Supplementary Table 1. GC-MS measurements of various shisha pastes 









Methanol 67-56-1  32 6.7 x x x x x 
Acetaldehyde 75-07-0  44 7.6 x x x x x 
Ethanol 64-17-5 46 11.42 H 
   
HH 





2-Propenal 107-02-8 56 13.65 x x x x x 
Propanal 67-64-1 58 14.21 x x x x H 




Ethyl formate 109-94-4 74 15.92 x 
    












Furan, 2-methyl- 534-22-5 82 20.29 x x x x x 
2,3-Butanedione 431-03-8 86 20.6 H 
  
x HH 
Ethyl Acetate 141-78-6  88 21.44 x 
   
x 
Acetic acid 64-19-7  60 22.74 H HH HH H HH 
2-Propanone, 1-
hydroxy- 
116-09-6  74 22.98 H x x 
 
x 
3-Hexene, (Z)- 03/09/7642 84 23.02 x 
    
Benzene 71-43-2 78 23.44 x 
    
2,4-Hexadiene 592-46-1 82 23.75 x 
    
2,3-Pentanedione 600-14-6 100 26.11 x 
    





Propylene Glycol 57-55-6  76 27 
 
H 
   














Furfural 98-01-1  96 29.69 x x x x x 
Butanoic acid 107-92-6  88 30.8 HH 
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Butyrolactone 96-48-0  86 32.08 
 
x x x x 
3-Octene, (E)- 14919-01-8 112 32.35 
   
x 
 
3-Hexen-1-ol, (Z)- 928-96-1 100 32.94 HH x x H 
 













2051-78-7 128 34.46 x 
    
Furan, 2,5-
diethyltetrahydro- 
41239-48-9 128 35.66 
   
x 
 
Benzaldehyde 100-52-7  106 35.94 HH x HH x x 
Cyclohexanone, 3-
methyl- 















   
Butanoic acid, 2-
methyl-, methyl ester 







765-70-8  112 38 




1193-11-9 116 38.37 x 












3-Octanone 106-68-3 128 38.59 
   
x 
 
beta-pinene 127-91-3  136 38.63 
 
x 
   
Benzyl Alcohol 100-51-6  108 38.88 HH 
    




3-Octanol?? 589-98-0 130 39.45 






500-00-5  138 39.48 
 
x 
   
o-Cymene 527-84-4 134 40.14 x x x x x 
Limonene 138-86-3 136 40.34 
 
H x H 
 
 Pentanoic acid, 4-oxo-
, ethyl ester 
539-88-8 144 40.33 H 
    
Pyrazine, tetramethyl- 1124-11-4 136 40.62 
    
x 
Propanoic acid, 2-
methyl-, methyl ester 
547-63-7 102 41 HH x 
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5113-66-6 152 46.8 
 
x 
   











DL-Menthol 15356-70-4 156 49 
 
HH x HH x 
Benzene, 1-methoxy-
4-(1-propenyl)- 
104-46-1  148 48.62 





104-50-7 142 50 x 
    




Piperonal 120-57-0  150 52.48 











γ-Decanolactone 706-14-9  170 56.28 





dimethyl-, ethyl ester 
5413-49-0  202 58.17 x x 
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APPENDIX 2 - Chapter 6 
Ion Molecule Density Functional Calculation for isoflurane and enflurane (PTR-
MS)  
6.3.2.1 Isoflurane reaction with H3O+ 
There are three sites for protonation on the ISOF molecule. These are shown below with 
the sites being labelled in decreasing proton affinity – see Table 1. 
It is important to note that no protonated Isoflurane is observed as is to be expected from 
the calculated PA’s (proton affinities) and GBs. But if sufficient energy (probably from 
the field) is introduced into the system, the traces of protonated Isoflurane, which must 
be formed, will fragment. Rather than consider the formation of the fragment ions in 
isolation, the possible fragmentations occurring from each of the three protonation sites 
will be explored. 
 
 
Figure 1 Shows the possible protonated sites 
 
Table 1 Possible protonation of isoflurane. 
Site PA kJ mol-1 GB kJ mol-1 
1 670 655 
2 637 608 
3 573 552 
 
Table 2 The energetics for the proton transfers. 
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Reaction Product ∆H kJ mol-1 ∆G kJ mol-1 
ISOF + H3O
+ ISOF1H+ + H2O +15 -2 
ISOF2H+ + H2O +47 +45 
ISOF3H+ + H2O +112 +101 
 
a) ISOF1H+ 
Scheme 1 shows the formation and fragmentation of ISOF1H+. It can be seen that 
following proton transfer a major change in bond lengths (given in Å) has occurred and 
the formation of m/z 165a is well underway and proceeds to completion without going 
through a Transition State (TS). The suffix in m/z 165a should be noted as the ion with 
m/z165b formed via ISOF3H+ has a different structure. Further fragmentation to m/z 117 
is also a barrierless process i.e. no TS. A pathway for an alternative fragmentation via a 
Transition State (TS1) has been found and leads to the ion with m/z 67. The energetics 
for these processes is given in Table 3.  
Table 3 Shows the formation and fragmentations of ISOF1H+. All energies are relative to 
ISOF + H3O
+. 
Products ∆H kJ mol-1 ∆G kJ mol-1 
ISOF1H+ + H2O +15 -2 
m/z165a + HF + H2O +54 +8 
m/z117 + HFCO + HF + H2O +167 +68 
TS1 + HF + H2O +182 +143 
m/z67 + CF3CHO + HF + H2O +174 +77 
 
 















Scheme 2 shows the formation and fragmentation of ISOF2H+. 
 
Scheme 2 Fragmentations of ISOF2H+ 
 
Table 4 Formation and fragmentations of all energies which are relative to ISOF2H+. 
Products ∆H kJ mol-1 ∆G kJ mol-1 
ISOF2H+ + H2O +47 +45 









Scheme 3 shows the formation and fragmentation of ISOF3H+. Loss of HF following 
protonation occurs without TS which is perhaps surprising as there is a concomitant 
migration of the Cl to the carbon from which HF is lost. Concurrently, there is a 




Scheme 3 Formation and fragmentations of ISOF3H+. 
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Table 5 Formation and fragmentations of all energies which are relative of ISOF3H+. 
Products ∆H kJ mol-1 ∆G kJ mol-1 
ISOF3H+ + H2O +112 +101 
m/z165b + HF + H2O +82 +36 




d) m/z163 C3F4OCl+ 
Before a mechanism for the formation of this fragment ion it is necessary to explore its 
possible structures. There are two likely candidates as shown in Figure 2. The cyclic 
structure is the more stable with ∆H (cyclic – linear) -34 kJ mol-1 and ∆G (cyclic – linear) 
-37 kJ mol-1. The overall reaction thermodynamics assuming the neutral products are H2 
and HF are given in Table 6. The most likely mechanism of formation is a concerted loss 
of HF and H2 from ISOF3H
+ as a sequential loss would not yield either of the two 
proposed structures.  
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Table 6 All energies are relative to ISOF + H3O
+. 
Products ∆H kJ mol-1 ∆G kJ mol-1 
m/z163(cyclic) + H2 + HF + 
H2O 
+221 +146 




Whilst these calculations (DFT B3LYP 6-31+G9d,p) have given some insight into the 
feasibility, both mechanistically and thermodynamically, of the various fragmentations, 
they have failed to throw much light on the branching ratios. This is probably because the 
majority of the fragmentations occur via barrierless processes i.e. no transition states, that 
proceed via multiple conformations the probability distribution being unknown. Also, it 
should be noted that even at the lowest values of E/N the ions must have considerable 
excess energy as formation two of the three dominant ions require additional energies of 
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Table 7 Summary of thermodynamics for the various fragmentations. 
Ions Dominance ∆H kJ mol-1 ∆G kJ mol-1 Notes 
m/z165a 
m/z165b 
Major +54 +8 formed via 
ISOF1H + 
+82 +36 formed via 
ISOF3H+ 
m/z163 Major +221 +146 formed via 
ISOF3H+ 








m/z51 Minor +172 +121 formed via 
ISOF2H+ 
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6.3.4.2.1 Enflurane reaction with H3O+ 
There are four sites for protonation on the ENF molecule. These are shown in the table 1 
below. It is important to note that no protonated ENF is observed as is to be expected 
from the calculated PAs and GBs. But if sufficient energy (probably from the field) is 
introduced into the system, the traces of protonated ENFF, which must be formed, will 
fragment. Rather than consider the formation of the fragment ions in isolation, the 




Figure 1 Protonation site of enflurane. 
 
Table 1 Shows the details of protonation sites of enflurane. 
Site PA kJ mol-1 GB kJ mol-1    
1 657 638 
2 662 646 
3 625 596 
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Table 2 The energetics for the proton transfers of enflurane. 
Reaction Product ∆H kJ mol-1 ∆G kJ mol-1 
ENF + H3O
+ ENF1H+ + H2O +27 +15 
ENF2H+ + H2O +23 +7 
ENF3H+ + H2O +59 +58 






















Scheme 1 Shows the formation and fragmentation of ENF1H+ 
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Table 3 Formation and fragmentation of ENF1H+ and all energies are relative to ENF + 
H3O
+. 
Products ∆H kJ mol-1 ∆G kJ mol-1 
ENF1H+ + H2O +27 +15 
m/z165a + HF + H2O +69 +28 























Scheme 2 Show the formation and fragmentation of ENF2H+. 
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Table 4 Formation and fragmentation of ENF2H+ and all energies are relative to ENF + 
H3O
+. 
Products ∆H kJ mol-1 ∆G kJ mol-1 
ENF2H+ + H2O +23 +7 
m/z165b + HF + H2O +60 +14 























Scheme 3 Show the formation and fragmentation of ENF3H+. 
 
Table 5 Formation and fragmentation of ENF3H+ and all energies are relative to 
ENF+H3O
+. 
Products ∆H kJ mol-1 ∆G kJ mol-1 
ENF3H+ + H2O +59 +58 
m/z51 +HOCF2CHFCl + H2O +169 +120 
m/z117 + CHF2OH + H2O +158 +63 
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Table 6 Shows the formation and fragmentation of ENF4H+and all energies are relative 
to ENF + H3O
+. 
Products ∆H kJ mol-1 ∆G kJ mol-1 
ENF4H+ + H2O +90 +80 
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UNIVERSITY OF BIRMINGHAM 
APPLICATION FOR ETHICAL REVIEW 
 
Who should use this form:  
 This form is to be completed by PIs or supervisors (for PGR student 
research) who have completed the University of Birmingham’s Ethical 
Review of Research Self Assessment Form (SAF) and have decided that 
further ethical review and approval is required before the commencement 
of a given Research Project. 
 Please be aware that all new research projects undertaken by postgraduate 
research (PGR) students first registered as from 1st September 2008 will 
be subject to the University’s Ethical Review Process. PGR students first 
registered before 1st September 2008 should refer to their 
Department/School/College for further advice. 
Researchers in the following categories are to use this form:  
 
1. The project is to be conducted by: 
o staff of the University of Birmingham; or  
o postgraduate research (PGR) students enrolled at 
the University of Birmingham (to be completed by 
the student’s supervisor); 
2. The project is to be conducted at the University of 
Birmingham by visiting researchers. 
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Students undertaking undergraduate projects and taught postgraduate 
(PGT) students should refer to their Department/School for advice. 
NOTES: 
➢ An electronic version of the completed form should be submitted to the 
Research Ethics Officer, at the following email address: aer-
ethics@contacts.bham.ac.uk. Please do not submit paper copies. 
➢ If, in any section, you find that you have insufficient space, or you wish to 
supply additional material not specifically requested by the form, please it 
in a separate file, clearly marked and attached to the submission email. 
➢ If you have any queries about the form, please address them to the 
Research Ethics Team. 
 
 
 Before submitting, please tick this box to confirm that you have consulted 
and understood the following information and guidance and that you have 
taken it into account when completing your application: 
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UNIVERSITY OF BIRMINGHAM 






1.TITLE OF PROJECT  
Breath Profiles and Washout Characteristics for Peppermint Oil 
 
 
1. THIS PROJECT IS:  
 University of Birmingham Staff Research project  
 University of Birmingham Postgraduate Research (PGR) Student project X  
     Other  (Please specify):    
 
 
2. INVESTIGATORS  
 
a) PLEASE GIVE DETAILS OF THE PRINCIPAL INVESTIGATORS 
OR SUPERVISORS (FOR PGR STUDENT PROJECTS)  
 
Name:   Title / first name / 
family name 
Chris Mayhew 
Highest qualification & 
position held: 
Reader 
School/Department  Physics and Astronomy 
Telephone: 44729 
Email address: c.mayhew@bham.ac.uk 
  
Name:   Title / first name / family 
name 
 
Highest qualification & position 
held: 
 
School/Department   
Telephone:  
Email address:  
  
 




b) PLEASE GIVE DETAILS OF ANY CO-INVESTIGATORS OR CO-
SUPERVISORS (FOR PGR STUDENT PROJECTS) 
 
Name:   Title / first name / family 
name 
 
Highest qualification & position 
held: 
 
School/Department   
Telephone:  
Email address:  
 
 
c) In the case of PGR student projects, please give details of the student 
 


















1.  ESTIMATED  

















 List the funding sources (including internal sources) and give the status of each 
source.  
   








 If you are requesting a quick turnaround on your application, please explain 
the reasons below (including funding-related deadlines). You should be 
aware that whilst effort will be made in cases of genuine urgency, it will not 
always be possible for the Ethics Committees to meet such requests.  
 
 
The student has only a limited time to complete her PhD. This proposed study will provide her 





3. SUMMARY OF PROJECT 
 
 Describe the purpose, background rationale for the proposed project, as well as the 
hypotheses/research questions to be examined and expected outcomes. This 
description should be in everyday language that is free from jargon. Please explain 
any technical terms or discipline-specific phrases.   
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This study is in part based on a larger one proposed by was proposed by Prof Paul Thomas 
(Loughborough University, UK), during the 2016 International Association of Breath 
Research (IABR) Standardisation Focus Group Meeting at Zurich, with the ultimate aim of 
standardising breath analysis across Europe. However, another objective for us is to obtain 
date for metabolism of key volatiles contained in peppermint oil in order to get data through 
non-invasive breath sampling of liver function for healthy volunteers. 
 
This study entails the comparison of breath volatile organic compounds (VOC) data between 
different groups acquired by different analytical platforms after a standardised intervention of 
ingesting peppermint oil sweet. Preliminary studies have been performed previously by the 
group at Loughborough University. Peppermint oil capsules will be provided to the volunteers 
willing to participate within this study. Subjects will swallow the peppermint oil capsule. 
Breath samples will then be taken to monitor the subsequent release of menthone/menthol and 
other volatiles over time recorded. 
 
The aims of this particular study are  
(i) To aid in the benchmarking endeavour to estimate the range of results between 
participating laboratories 
(ii) To provide breath data for healthy volunteers which would then be followed-up in a 
separate study with patients who are suffering from liver disease (a separate ethics 
approval will be made for that). 
 
Why are we interested in taking breath samples and how are we approaching this? 
Exhaled breath analysis of volatile chemicals offers the potential to develop more effective 
biomarkers or diagnosing disease non-invasively. This study is original and important as it 
aims to standardise breath analysis across Europe and to obtain details on healthy liver 
function. There are no previous published research papers evaluating the benchmarking of 
breath analysis. We consider that washout characteristics following breath profiles may be 
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4. CONDUCT OF PROJECT 
 
 Please give a description of the research methodology that will be used  
 
We will be collecting breath samples after a volunteer has ingested a peppermint capsule (these are 
health supplements available over the counter at Boots, Holland and Barret etc. see 
http://www.boots.com/boots-peppermint-oil-200mg-60-capsules-10115320). The instruments used to 
analyse the breath will be a Proton Transfer React Mass Spectrometer. Proton-Transfer Reaction 
Mass Spectrometry (PTR-MS): this platform allows the direct and real-time detection of volatile organic 
compounds (VOCs) that are present in the exhaled human breath. It requires no sample preparation 
or handling and offers on-line and off-line measurements. For real-time measurements the volunteer 
will be provided with a mouthpiece connected to a one-way non re-breathing valve. For off-line 
measurements, a CO2 sensor will be used to collect alveolar air. 
 
All participants will be provided with a volunteer information sheet upon recruitment and Informed 
consent procedures will be followed. Participants will be provided with the needed breath sampling 
and asked to breathe normally for up to 5 minutes before commencing the study. 
 
Participants will be asked to take a peppermint oil 200 mg supplement tablet and provide breath 
samples using the different instruments (nsampling point = 7, nbreath samples= 7 per platform, time 
for washout sampling = -30, 30, 60, 90, 120, and 150 up to 5 hours) 
 
Also, participants will be asked to answer a designed questionnaire to determine the factors that could 




5. DOES THE PROJECT INVOLVE PARTICIPATION OF PEOPLE OTHER  
 THAN THE RESEARCHERS AND SUPERVISORS? 
  
     Yes X No   
 
Note: ‘Participation’ includes both active participation (such as when participants take 
part in an interview) and cases where participants take part in the study without their 
knowledge and consent at the time (for example, in crowd behaviour research). 
 
If you have answered NO please go to Section 18. If you have answered YES to 
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this question please complete all the following sections. 
 
 
6. PARTICIPANTS AS THE SUBJECTS OF THE RESEARCH 
Describe the number of participants and important characteristics (such as age, 
gender, location, affiliation, level of fitness, intellectual ability etc.). Specify any 
inclusion/exclusion criteria to be used. 
 
Up to 50 participants will be recruited (this number has been selected to provide a good statistical 
number for analysis). Criteria: 
 
Healthy adults (18-80 years old), with no history of chronic or recent acute illnesses. 
 
People who associate with any of the following categories will not take part in the study 
People with serious allergies  
People who smoke or vape 
Pregnant women 
      People who use anti-inflammatory drugs regularly 
      People with metabolic disease 
Vegetarians/people who do not eat beef products (gelatine is present in the capsule shell) 
 




Please state clearly how the participants will be identified, approached and 
recruited. Include any relationship between the investigator(s) and participant(s) 
(e.g. instructor-student). 
 
 Note: Attach a copy of any poster(s), advertisement(s) or letter(s) to be used for 
recruitment. 
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Campaign, e-mails and social media to the staff, students, and their social networks, of the 
University of Birmingham.  
 
Interested participants will be given a participant information sheet and a consent form. 
 
8. CONSENT  
a) Describe the process that the investigator(s) will be using to obtain valid consent. 
If consent is not to be obtained explain why. If the participants are minors or for 
other reasons are not competent to consent, describe the proposed alternate source 
of consent, including any permission / information letter to be provided to the 
person(s) providing the consent. 
 
See attached sheets.  
  Note: Attach a copy of the Participant Information Sheet (if applicable), the 
Consent Form (if applicable), the content of any telephone script (if 
applicable) and any other material that will be used in the consent process.  
 
  b) Will the participants be deceived in any way about the purpose of the study?
 Yes  No X 
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If yes, please describe the nature and extent of the deception involved. Include how and 





9. PARTICIPANT FEEDBACK 
Explain what feedback/ information will be provided to the participants after 
participation in the research. (For example, a more complete description of the 
purpose of the research, or access to the results of the research). 
 
No feedback is planned. However, participants will be given the opportunity to 
request a copy of any paper that results from the study. 
  
10. PARTICIPANT WITHDRAWAL  
 
a) Describe how the participants will be informed of their right to withdraw from 
the project.  
 
b) Explain any consequences for the participant of withdrawing from the  
Participants will be informed verbally and by written information that they are free to withdraw from the 
study at any point, without reason, and can request that their data is destroyed. They will be able to 
withdraw up until the completion of the study. The final deadline for the completion of the study will be 
the 30th September 2018. After this time the participants will not be able to withdrawal from the project. 
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study and indicate what will be done with the participant’s data if they 
withdraw. 
 
None. Participant’s data can be destroyed if requested before the deadline above. 
 
11. COMPENSATION       
Will participants receive compensation for participation? 
i) Financial        
 Yes  No X 
ii) Non-financial  
     Yes No X 
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12. CONFIDENTIALITY  
a) Will all participants be anonymous?      Yes 
 No X 
b) Will all data be treated as confidential?     
Yes X No  
Note: Participants’ identity/data will be confidential if an assigned ID code or 
number is used, but it will not be anonymous. Anonymous data cannot be 
traced back to an individual participant. 
 
Describe the procedures to be used to ensure anonymity of participants and/or  
confidentiality of data both during the conduct of the research and in the release of  
its findings. 
 
It is important to note that your information will anonymised and none of the 
researchers will be able to trace the information back to you or anyone. The index 
of the participants and their identifier codes is kept under lock and key by the 
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If participant anonymity or confidentiality is not appropriate to this research 
project, explain, providing details of how all participants will be advised of the fact 




13. STORAGE, ACCESS AND DISPOSAL OF DATA 
 Describe what research data will be stored, where, for what period of time, the 
measures that will be put in place to ensure security of the data, who will have 
access to the data, and the method and timing of disposal of the data.  
 
The index of the participants and their identifier codes is kept under lock and key 
by the principle investigator, who does not work directly with individual records. 
 
  
                                                                                                              Appendices    
319 
 
14. OTHER APPROVALS REQUIRED?  
e.g. Criminal Records Bureau (CRB) checks or NHS R&D approvals.  
 
 YES  NO X NOT APPLICABLE 
 





Outline the potential significance and/or benefits of the research  
 
Two key benefits: 
 
1. Detailed washout characteristics of chemicals in the body will lead to a 
database for use at a later stage for comparison with patients suffering from 
liver disease. This could lead to a non-invasive method for determining 
liver function and severity of liver disease. 
2. We are seeking to standardise breath analysis and measurement to 
accelerate the development of new and more sensitive tests for serious 
diseases. Many different breath methods have been developed to sample 
and analyse breath. At the moment little is known about the differences 
between them. This study will contribute towards a larger study aimed at a 
standardised breath experiment that will enable benchmark data to be 
collected by different researchers using their own methods. The data that 
will be produced will allow researchers to evaluate and compare their 
methods in an evidential manner for the first time. 
This is important because the speed at which research in breath diagnostics 
is progressing is hindered because it is difficult for researchers to compare 




    16. RISKS 




 a) Outline any potential risks to INDIVIDUALS, including research staff, research 
participants, other individuals not involved in the research and the measures that 
will be taken to minimise any risks and the procedures to be adopted in the event of 
mishap 
 
This study poses little to no risk of discomfort to the volunteers. Peppermint oil 
capsules can be purchased over the counter and are used as health supplements. If 




Breath samples are acquired using different types of mouthpieces or masks, and 
the volunteer may find these unfamiliar and uncomfortable to being with. If this is 
the case the participant can stop immediately. 
 
There are no risks to the research staff. 
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b) Outline any potential risks to THE ENVIRONMENT and/or SOCIETY and the 
measures that will be taken to minimise any risks and the procedures to be adopted 





















16. ARE THERE ANY OTHER ETHICAL ISSUES RAISED BY THE  
  RESEARCH? 
 
 Yes  No X 
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17. EXPERT REVIEWER/OPINION 
You may be asked to nominate an expert reviewer for certain types of project, 
including those of an interventional nature or those involving significant risks. If 
you anticipate that this may apply to your work and you would like to nominate an 





























Please mark if the study involves any of the following: 
 
• Vulnerable groups, such as children and young people aged under 18 years, those with learning 
disability, or cognitive impairments  
 
• Research that induces or results in or causes anxiety, stress, pain or physical discomfort, or poses 
a risk of harm to participants (which is more than is expected from everyday life)  
 
• Risk to the personal safety of the researcher  
 
• Deception or research that is conducted without full and informed consent of the participants at 
time study is carried out  
 
• Administration of a chemical agent or vaccines or other substances (including vitamins or food 
substances) to human participants. X 
 
• Production and/or use of genetically modified plants or microbes  
 
• Results that may have an adverse impact on the environment or food safety  
 
• Results that may be used to develop chemical or biological weapons  
 
 
Please check that the following documents are attached to your application.  
 
 ATTACHED NOT 
APPLICABLE 
Recruitment advertisement  X   
Participant information sheet  X   
Consent form  X   
Questionnaire     X 
Interview Schedule 
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19. DECLARATION BY APPLICANTS 
 
I submit this application on the basis that the information it contains is confidential and 
will be used by the 
University of Birmingham for the purposes of ethical review and monitoring of the 
research project described  
herein, and to satisfy reporting requirements to regulatory bodies. The information will 
not be used for any 
other purpose without my prior consent. 
 
I declare that: 
• The information in this form together with any accompanying information is 
complete and correct to the best of my knowledge and belief and I take full 
responsibility for it. 
• I undertake to abide by University Code of Practice for Research 
(http://www.as.bham.ac.uk/legislation/docs/COP_Research.pdf) alongside any 
other relevant professional bodies’ codes of conduct and/or ethical guidelines. 
• I will report any changes affecting the ethical aspects of the project to the 
University of Birmingham Research Ethics Officer. 
• I will report any adverse or unforeseen events which occur to the relevant Ethics 
Committee via the University of Birmingham Research Ethics Officer. 
 
 








   
Please now save your completed form, print a copy for your records, and then email a 
copy to the Research Ethics Officer, at aerethics@contacts.bham.ac.uk. As noted above, 
please do not submit a paper copy. 
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PARTICIPANT INFORMATION SHEET 
BREATH PROFILES AND WASHOUT CHARACTERISTICS FOR 
PEPPERMINT OIL  
4 Investigators:  
Professor Dr. Chris Mayhew 
Ms. Prema Devi Chellayah 
University of Birmingham 
 
5 What is the purpose of the study? 
Primary aim: 
To benchmark and standardise breath analysis across Europe. 
Secondary aims: 
• To compare breath volatile organic compounds (VOC) data between different 
groups.  
• To evaluate breath volatile organic compounds (VOC) data from different 
analytical platforms.  
• To perform multivariate statistical analysis on the collected data from all 
partners.  
• To estimate the range of results between participating laboratories.  
• To provide a database for washout characteristics of volatiles in peppermint oil from 
healthy volunteers, which will later be used to compare with washout characteristics 
from patients suffering from liver disease (not this study) 
 
6 What are we doing, and why is this study important? 
This study has been proposed by Prof. Paul Thomas (Loughborough University, UK) and 
developed by an international team of researchers who met during the 2016 International 
Association of Breath Research (IABR) Standardisation Focus Group meeting at Zurich.  
They are seeking to standardise breath analysis and measurement to accelerate the 
development of new and more sensitive tests for serious diseases. 
• Many different breath methods have been developed to sample and analyse breath.  
• At the moment little is known about the differences between them.  
• This study will provide a standardised breath experiment that will enable 
benchmark data to be collected by different researchers using their own methods. 
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• The data that will be produced will allow researchers to evaluate and compare 
their methods in an evidential manner for the first time.  
• This is important because the speed at which research in breath diagnostics is 
progressing is hindered because it is difficult for researchers to compare and share 
data. 
• This study is intended to improve this situation. 
6.1 Description of the standardised breath experiment: Peppermint 
The peppermint breath experiment is designed to produce a temporary and well-defined 
change in the breath profile of a participant that will reduce over time. The change is 
defined by the participant swallowing a peppermint oil 200 mg food supplement1 capsule 
and drinking 150 ml of water afterwards. The capsule dissolves and releases peppermint 
oil into the stomach of the participant. The volatile (aroma) compounds in the oil (e.g. 
menthone/menthol) enter the bloodstream of the participant and are subsequently 
detectable in their breath. As the participant metabolises and eliminates these compounds 
their concentrations in breath reduce over several hours. Although the peppermint oil 
washout profiles vary between participants, the way the levels of the volatiles in breath 
change over time is similar and statistical analysis of the washout profiles provides useful 
information about the reproducibility (precision) and sensitivity (limit of detection) of the 
analysis. 
All participants will be provided with a patient information sheet upon recruitment and 
Informed Consent procedures will be followed. Also, participants will be asked to answer 
a designed questionnaire to determine all the factors that could affect the quality of breath 




Who is doing this research and why? 
                                            
 
 
1 Peppermint oil is claimed by the manufacturers and suppliers to support a healthy digestive system and 
aid the normal functioning of the digestive tract. 
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This study is original and important as it aims to standardise breath analysis across 
Europe. There are no previous published research papers evaluating the benchmarking of 
breath analysis. 
 
Who are we asking to participate in this research?  
Healthy adults (18-80 years old), with no history of chronic or recent acute illnesses. 
7  
8 Are there any people who should not take part? 
People who associate with any of the following categories should not take part in the 
study 
• People with serious allergies  
• People who smoke or vape 
• Pregnant women 
• People who use anti-inflammatory drugs regularly 
• People with metabolic disease 
• Vegetarians or people who don’t eat beef products (Beef Gelatine is present in the 
capsule shell) 
 
9 If I agree to take part can I change my mind and stop? 
• Yes.  
• You will be asked to complete a participant Informed Consent Form after reading 
this information sheet.  
• Any questions you may have must be answered to your satisfaction before you 
give your consent to participate.  
• You may withdraw at any time before, during or after the study.  
• You will not be asked to give any reasons for your withdrawal.  
• If you wish to withdraw, please just tell the investigator.  
• Even after you have finished participating in this study you can instruct us to 
destroy all data about you and excluded it from future analysis. You can do this at 
any time up to the final deadline for the completion of the study, which is the 30th 
September 2018. After that you will not be able to withdraw the data from the 
project. 
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10 How long will it take? 
Please study the experiment schedule notes below. These show that that the study is 
planned to take 6.5 hours. Once you have given your first two breath samples and 
completed the questionnaire you can come and go between giving further samples.  
You will give between 6 and 18 breath samples depending on the instruments and 
techniques allocated to your test. Each breath sample will take no more than 15 minutes. 
Some of the instruments collect a breath sample in a few seconds. 
 
11 Is there anything I need to do before the experimental 
session? 
• The day before the experimental session we ask you not to use any perfume or 
fragrances until after the experimental session.  
• We ask you not to eat or use anything that contains mint flavour or fragrance (e.g., 
toothpaste or chewing gum).  
 
12 What will I be asked to do during the experimental 
session?2 
• We will provide a mouthpiece or a mask for you to breath into. The breath 
sampling is easy and effortless, allowing only allow collection of alveolar air. 
• You will be asked to breathe normally for up to 10 minutes and during this time 
your breath will be sampled automatically; you need do nothing.  
• You will be asked to provide a preliminary breath sample and then complete a 
questionnaire about your diet and personal habits. 
• After this you will be asked to take a peppermint oil 200 mg supplement capsule 
and then provide more breath samples at 30 minutes intervals for up to 5 hours. 
• We will ask you not to eat or drink dairy products throughout this time as this may 
interfere with the release of the peppermint oil into your circulatory system.  
 
                                            
 
 
2 See detailed experiment description at the end of this document. 
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13 What is in the peppermint oil capsule? 
• Peppermint oil (200 mg) soya/sunflower oil and a capsule shell of beef gelatine 
and glycerol. 
• The peppermint oil capsule is a digestive health food supplement manufactured 
and supplied by Boots Pharmaceuticals or by Obbekjaers. 
 
14 Are there any risks with taking part? 
This study poses little to no risk of discomfort to you.  
Breath samples are acquired using different types of mouthpieces or masks, and you may 
find these unfamiliar and uncomfortable to begin with.  
If this is the case you can stop immediately.  
If you feel unwell or uncomfortable at any time just say so and the experiment will be 
stopped immediately. 
You may not enjoy the taste of the peppermint oil capsule. There are no listed side effects. 
The capsule is marketed to help support healthy digestion and function of the digestive 
tract. 
 
15 What personal information will be required from me? 
We will ask questions about your height (cm), and weight (kg), age (years), as well as 
questions about your diet, personal habits and life style. Your answers will enable us to 
exclude possible dietary or life style factors from skewing the results. 
It is important to note that your information will anonymised and none of the researchers 
will be able to trace the information back to you or anyone. The index of the participants 
and their identifier codes is kept under lock and key by the principle investigator, who 
does not work directly with individual records.  
 
16 Will my taking part in this study be kept confidential? 
• Yes. 
• We will use an ID code (e.g. P001) to refer to your data. 
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• The originals containing the index with your name and ID code will be held by 
Dr. Chris Mayhew in a closed locker.  
• No one else will have access to this information and it is kept so that we can 
contact you if we need to (perhaps you leave something behind when you visit) or 
if you want to leave the project and have your information destroyed (we will need 
to identify all the data that relates to you).  
 
17 What will happen to my data and the results of the study? 
• The data we obtain from you and your breath samples will be consolidated and 
combined with data from other research centres to enable us to compare and 
evaluate different sampling and breath measurement methods. It will be safely 
stored in a repository at Loughborough University following the safety and 
privacy university’s rules. 
• We will publish our findings as a research article in a scientific journal. (No 
personal information will be used with or for the publication) 
• We will also present this study at a conference organised by the International 
Association of Breath Research and copies of the slides will be available for 
anyone to download from our data repository. (No personal information will be 
used with or for the presentation) 
18 What if I am not happy with how the research was 
conducted? 
19 In the first instance, please contact: 
Dr. Chris Mayhew 
Email: c.mayhew@bham.ac.uk 
Tel: 0121-4144729  




1. Participant preparation 
a. Provide information sheet and obtain informed consent. 
b. -24 hr from capsule ingestion. Excluding peppermint and peppermint 
associated products from diet and personal care routines until completion 
of peppermint washout. Participants can follow their normal dietary 
requirements, no restrictions are being made, and this includes dairy 
products. 
2. Peppermint Washout experiment. This is based on a 1-D central composite design 
across an approximate exponential washout profile. Breath samples/measurements 
are to be taken at 30 min, 60 min, 90 min,120 min, 150 min, etc. . Sample alveolar 
air. 
a. -0.5 hr from capsule ingestion.  
i. Baseline sample measurement.  
ii. Start completion of participant information sheet and diet/lifestyle 
questionnaire. 
iii. Remind the participants about dairy products and provide them 
with a list of items to avoid eating (Participant information sheet).  
b. 0 hr  
i. capsule is ingested and 150 ml is swallowed as quickly as is 
comfortable.  
ii. Participant information sheet and diet/lifestyle questionnaires are 
completed. 
c. 30 min 
i. Washout sample 
d. 60 min 
i. Washout sample 
e. 90 min 
i. Washout sample 
f. 120 min 
i. Washout sample 
g. 150 min 
i. Washout sample 
Participants will be able to leave or remain in the laboratory in between measurements. A 
desk will be made available for participants. 
 
And so on up to 5 hours 
3. Environmental/ambient air sample. 
a. Select at random one of the sample points t = 60 min, 90 min, 165 min, 
285 min and 360 min.  
b. On completion of the breath sampling of that chosen sample point, collect 
an environmental/ambient air sample, or make a measurement.  
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c. Use the same sample/measurement volume as the breath 
samples/measurements while the researcher and participant are still 
present in the room.  
4. Collect an air supply/instrument blank sample after completion of a breath 
sampling. 
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 INFORMED CONSENT FORM 
BREATH PROFILES AND WASHOUT CHARACTERISTICS FOR 
PEPPERMINT OIL 
(The researcher should guide the participant through the participant information sheet and ensure that all 
queries or questions are answered to the participant’s satisfaction before completing this informed consent 
form.) 
 
1. Taking Part                                                        Please initial box 
 
The purpose and details of this study have been explained to me. I 
understand that this study is designed to further scientific knowledge and 
that all procedures have been approved by the University of 
Birmingham’s Ethics Committee. 
 
I have been given a copy of the participant information sheet and I have 
read and understood the information sheet and this consent form. 
  
I have had an opportunity to ask questions about my participation.  
  
I understand that I am under no obligation to take part in the study, have 
the right to withdraw from this study at any stage for any reason, and will 
not be required to explain my reasons for withdrawing. 
  
I agree to take part in this study. 
 
2. Use of Information 
 
I understand that all the personal information I provide will be treated in 
strict confidence and will be kept anonymous and confidential to the 
researchers unless (under the statutory obligations of the agencies which 
the researchers are working with), it is judged that confidentiality will 
have to be breached for the safety of the participant or others or for audit 
by regulatory authorities.  
 
I agree for the data I provide to be securely archived at the end of the 
project.  
 
3. Data  
  
I agree that the Data obtained during this study can be stored for future 
use in research associated with the aims and objectives theme as this 
study. 
 
________________________ _____________________ ________  
Name of participant [printed] Signature        Date 





__________________________ _______________________ _________  
Researcher  [printed] Signature         Date 
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20 Health Status Questionnaire for BREATHE study 
 
Participant identification number: 
Date:     Time: 
 
All the information you give in this questionnaire will be treated with 
confidence and will not be divulged to any third parties.  
Age      Sex   
Height     Weight  
 
1. Are you now, or have you in the past ever suffered from any of the 
following? 
a. Severe asthma 
b. COPD 
c. Emphysema 
d. Any other serious lung condition 
e. Serious heart condition 
f. Are you pregnant? 
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If the answer to any of the above questions is yes, then you may not take part in 
the study. 




3. Do you smoke?  
If yes: How many cigarettes a day? 
For how long have you smoked? 
           
 PTO… 
4. Have you ever smoked in the past?  
If yes: How long ago did you stop? 
a. How many cigarettes a day? 
b. For how long did you smoke?   
 
5. Have you been exposed to other people smoking in the past week? 
 
6. Do you have an open fire, or have you recently been exposed to any other 
source of open fire? 
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7. Are you taking any prescribed medication other than the Pill? Please give 
details. 
 
8. Are you taking any preparations or medications that have not been 
prescribed eg herbal remedies? Please give details. 
 
9. Are you taking any food supplements such as vitamin pills, cod liver oil etc? 
Please give details. 
 
10. Have you been eating normally in recent days? Eg would you say your 
appetite is normal? 
 
11. When did you last have something to eat or drink? 
 
12. What did you last eat or drink? 
 
 
13. Have you eaten or drunk any of the following things in the past 24 hours?  
20.1.1 Garlic     
 Coffee   
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Alcoholic drinks  
 
14. Have you used nasal decongestants or any product containing menthol eg 
chewing gum, cigarettes, in the past 24 hours? 
 
15. Do you normally eat food of drink with citrus flavours eg orange, lemon, 
grapefruit, including artificially flavoured drinks? Please give details. 
 
 
16. Have you eaten citrus fruit or any food/drink with citrus flavour in the past 
24 hours? Please give details. 
 
 
17. Have you been anywhere where citrus or pine scented air fresheners have 






Your signature …………………………… 
